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ABSTRACT 
Microparticles have been extensively investigated for pharmaceutical applications, more 
specifically they have been widely applied as carrier of drug molecules, proteins, enzymes, 
DNA and cells. In this work, the Membrane Emulsification (ME) technique was employed 
for the manufacturing of uniform sized emulsions with predictable drop size. The liquid drops 
produced were, in a second step, converted to microparticles. ME is a process which consists 
in pressing the dispersed phase through the micropores of a membrane into the emulsion 
continuous phase. The investigation of the best operating conditions of emulsion production, 
the emulsion composition and the optimization of the formulations for the production of 
microparticles using the technique of ME were the aim of this thesis work. For the 
preliminary tests the Dispersion Cell system (lab-scale device) was used with nickel or 
stainless steel microengineered disk membranes with cylindrical pores. W/O emulsions were 
mainly produced. During the process of emulsion production the main parameters studied 
were the shear stress applied, the dispersed phase flux, the membrane type and the emulsifier 
type.  
The use of a simplified model based on a force balance  was used for the drop size prediction. 
The maximum shear stress reached is used for the calculations. It was shown that the model 
gave a more accurate drop diameter prediction when the flux of the dispersed phase is low. 
For the solidification of the polymeric drops a reaction of (chemical or ionic) crosslinking or 
a physical method (thermal gelation) was employed. Influence of the solidification process 
was evaluated on the final product. The most important factors affecting the process of 
particles formation studied were the type of crosslinker used together with its concentration 
and the reaction time. It was shown that the crosslinking reaction is directly affecting the 
properties of the final product: the capability of the particles to swell in an aqueous media, 
the pH sensitivity of the material, the release rate of an encapsulated model compound.  
The microparticles produced were loaded with copper, sodium salicylate and Blue Dextran as 
model molecules and yeast as probiotic cells. The release was assayed with time and, 
accordingly with the application, in acidic (pH= 1.2- 3), neutral (pH= 7- 7.3) or basic (pH= 8) 
environment. Formulations were optimized to achieve a sustained release (using Poly (Vinyl) 
alcohol (PVA) as polymeric material), a release into the stomach acidic environment (using 
PVA blended with chitosan (CS)), a release (of probiotics) in the intestine- colon area having 
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a neutral- basic environment (using gelatine coated microparticles) or for cells 
immobilization (using alginate as polymeric matrix). 
The technique of ME was evaluated as a novel method for cell encapsulation, the use of 
membranes with the appropriate pore size led to the generation of drops containing cells and 
possible occurrence of cell filtration by the membrane was prevented. In order to demonstrate 
the cell survival to the encapsulation process, tests of the released yeast capability to 
metabolize glucose with time and cells dyeing with fluorescent probes were performed. 
For an industrial application of the process of microparticles production using ME, the 
Dispersion Cell was substituted by the Pulsed (Oscillatory) Flow system. The use of this 
device presents some advantages for the process scale up as the manufacturing of emulsions 
with a high dispersed phase concentration (emulsions concentrated up to 30% were 
successfully produced) with a single pass through the membrane module and possibility to 
solidify the drops right after their production. The operating parameters of the process were 
investigated for the production of W/O emulsions using this system, furthermore the possible 
application of a differently coated (FAS coated) membrane (instead of the classical PTFE 
coated) was evaluated for multiple uses.  
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1. INTRODUCTION  
1.1 AIMS AND OBJECTIVES 
When a drug is administered, the therapeutic effects are determined by the pharmacological 
properties of the pharmaceutically active compound; however independent to the 
effectiveness of the drug molecule the need to reach the target with the proper concentration 
that both minimizes the side effects and maximizes the therapeutic effects are crucial for the 
success of the therapy. In some cases, the existence of physiological barriers could preclude 
the use of an otherwise effective drug molecule. Specific drug carriers (e.g. drug delivery 
systems) have the purpose of enhancing and facilitating the action of a therapeutic molecule 
to provide the correct amount of drug at the specific site of action for the required time, or in 
response to specific environmental stimuli.  
Between the several possible routes for drug administration the most convenient, and well 
accepted, is oral which could provide systemic or topic effects. It affords the compliance of 
patients and it is generally less expensive than the parenteral routes as it does not require the 
presence of specialist medical staff and can be well controlled by the patient. There are 
several advantages related to the oral delivery of therapeutics, such as the large surface area 
available for the absorption of the drug (200 m2 in the small intestine) (Hillery et al., 2002). 
The complexity of the gastro-intestinal tract represents the main issue related to oral drug 
administration. Hence, common problems related to the oral administration of therapeutics 
are the low solubility, the high potency, and the poor chemical stability of the active 
substances. The therapeutic must be in a formulation that helps it resist the environmental 
conditions in which it would be after the ingestion (pH, enzymes, presence of mucus and 
food…) and reach in an unmodified state the site of action (Hillery et al., 2002).  
Within the variety of devices developed for drug delivery (polymer-based disks, rods, 
capsules, pellets…) biocompatible polymeric microparticles are the most common as they 
present many advantages: the possibility to encapsulate a wide range of materials of 
pharmaceutic interest such as small molecules, nucleic acids, proteins, enzymes and cells. 
Most common disadvantages associated with the use of microparticles in drug delivery are: 
difficulty of large scale industrial manufacturing, inactivation of the drug/cell death during 
the process of production, insufficient control over the drug release rate (Kim and Pack, 
2006). 
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Aim of this work was to propose an alternative technique for microparticles production using 
membranes for the encapsulation of ions, small molecules and probiotic cells for 
pharmaceutical advanced applications.  
Microparticles were obtained by the solidification of liquid drops produced using the 
Membrane Emulsification technique, hence aim of the first part of the research project was 
the production of uniform- sized W/O emulsion optimizing the process operating parameters 
and the phases composition. Membrane Emulsification has been extensively used for the 
production of W/O or O/W emulsions, as well as for the production of more complex 
microstructures such as multiple emulsions, Pickering emulsions, foams, micro- nano-
particles (Spyropoulos et al., 2014a). The technique presents many advantages over 
conventional methods of emulsion production (e.g. rotor-stator systems, high pressure 
homogenizers…) especially for the encapsulation of shear and temperature sensitive 
materials (e.g. cells, drugs). With this method, the emulsion drops are generated by pressing 
the dispersed phase through the pores of a membrane into the continuous phase, and the shear 
generated by the movement of the continuous phase produces the detachment of the drops 
from the membrane surface. This technique uses much lower shear compared to the classical 
methods of emulsion production and it is particularly useful for the encapsulation of 
temperature or shear sensitive compounds. A further advantage is the possibility to have fine 
control over the size of the drop produced by regulating some operating parameters of the 
process. Many devices for Membrane Emulsification have been proposed for process scale 
up, production of a high quantity of emulsion (Piacentini, Dragosavac, et al., 2017) or the 
production of highly concentrated emulsions (up to 50 vol.% of dispersed phase in the 
emulsion) and processes operating continuously are possible.  
In this thesis, a thorough investigation of emulsion composition was conducted using a lab-
scale device for Membrane Emulsification: the Dispersion Cell (Kosvintsev et al., 2005) 
system in association with disk hydrophobic membranes with a range of pore sizes between 
10 and 30 μm. With this device the process operating parameters were optimized for the 
production of uniform drops, hence parameters such as dispersed phase flux, shear stress, 
membrane type and membrane coating material were investigated. W/O emulsions were 
mainly produced and the influence of the oil type, emulsifier type, dispersed and continuous 
phase properties were evaluated. Microparticles were obtained by solidification of the liquid 
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drops, the process of solidification was varied accordingly with the type of polymer used in 
the formulation which was selected with the final use of the microparticles in mind:  
• Poly (Vinyl) Alcohol microparticles were produced by chemical crosslinking using 
glutaraldehyde for the sustained release of Cu2+ used as model very low molecular 
weight compound (Chapter 4.1); 
• Blended Poly (Vinyl) Alcohol and chitosan microparticles were obtained with 
chemical crosslinking using glutaraldehyde for the pH controlled release of Cu2+ and 
Sodium salicylate used as model drug (please refer to Chapter 4.2); 
• Blended chitosan and gelatine or pure gelatine microparticles were obtained by the 
thermal gelation and ionic crosslinking (using sodium hexametaphosphate). Particles 
were used to encapsulate yeast cells. pH controlled release suitable for intestine-colon 
area delivery was achieved using Eudragit S100 as a gastro-resistant coating material 
(please refer to Chapter 4.3); and 
• Alginate microparticles containing viable yeast cells were produced by solidification 
of the alginate drops by ionic crosslinking using Ca2+ or Mg2+ (please refer to Chapter 
4.4). 
In the last part of the research project the process scale up was addressed using the Pulsed 
(Oscillatory) Flow Membrane Emulsification (Holdich et al., 2012) device. The use of the 
Pulsed system was advantageous for the possibility to produce highly concentrated emulsions 
with a single pass of emulsion over the membrane surface. In addition it would be possible to 
connect in series to the membrane module (where the emulsion is produced) a plug-flow 
reactor for simultaneous and continuous drop solidification.  
The project methodology can be summarised within three main steps:  
Step 1. Droplet production; initially the composition of the emulsion was optimised and the 
process operating parameters investigated in order to obtain stable and uniform sized 
emulsions. In this step the material to be encapsulated was directly added to the emulsion 
dispersed phase in the appropriate concentration, thus Cu2+, Blue Dextran, sodium salicylate, 
or yeast cells were mixed with the polymeric phase. 
Step 2. Droplet solidification into solid particles; once the emulsion with the desired 
characteristics was obtained, the process of solidification of the liquid drops was investigated. 
A crosslinking chemical reaction: ionic crosslinking reaction, or thermal gelation, were 
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exploited. Time of reaction, presence of a catalyst and amount of crosslinker were 
investigated. Subsequently the process of recovery, washing and drying the produced solid 
polymeric microparticles was optimized accordingly with the formulation and compatibility 
with the encapsulated material. 
Step 3. Release studies and cell viability; the release of the encapsulated material inside the 
microparticles was investigated with time and using solutions at different pH (from 1.2 to 8) 
in order to mimic the variation of pH through the gastro-intestinal tract. Viability of the yeast 
cells encapsulated within the microparticles was confirmed using fluorescent probes and 
analysing the yeast cell glucose metabolism with time. 
1.2 RESEARCH QUESTIONS 
This doctoral thesis aims to address several “research questions” in the research field of the 
production of Micro-engineered particles for Oral Drug Delivery: 
1. Is it possible to produce highly uniform microcarriers for small molecules and cells of 
desired sizes? 
2. Can these microcarriers be used for the release of the encapsulated material 
(unmodified) into a specific section of the human gastro-intestinal tract after the oral 
administration exploiting the difference in pH? 
3. How suitable is the Membrane Emulsification technique for encapsulation of small 
molecules and cells? 
4. What would be the best method to scale up the particle production process?  
Possible answers to these questions are provided within this thesis and a summary of the 
results gathered is reported in the “Conclusions” chapter.  
All the experimental work presented in this thesis was done by the author, the only exception 
are the experiments about the production of the alginate microparticles which were performed 
by a visiting student, Clementine Sivelle, during her project (from April to June 2016) in 
which she was supervised weekly by Professor Holdich, and the thesis author on a daily 
basis.  
Some of the work presented here has been published in peer-reviewed journals and presented 
at international conferences.  
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1.3 OUTLINE OF THE THESIS STRUCTURE  
The literature review is presented in Chapter 2: an initial overview of the most common 
routes of drug administration is reported with a main focus on the oral way (Chapter 2.1). In 
Chapter 2.2 a review on the use of microparticles for pharmaceutical applications is provided, 
focusing the discussion on the encapsulation of therapeutic materials and cells. A 
classification of the most common polymeric materials (natural and synthetic) used for the 
production of microparticles intended for oral drug delivery is reported. In Chapter 2.3 is 
presented an overview of the conventional methods of microparticles production as well as 
the production of microparticles by emulsification process. Most used techniques of 
emulsions production will be compared with the Membrane Emulsification investigated in 
this thesis. A description of the available devices for Membrane Emulsification is provided, a 
description of the Shear-Capillary model for droplet size prediction is reported.  
The experimental section is provided in Chapter 3. The lab-scale device, Dispersion Cell 
System, used for formulations and process parameters optimization is illustrated and 
described in Chapter 3.1. In Chapter 3.2 is discussed the method of emulsions 
characterization, the analysis of the phases physical properties and the contact angle 
measurements. In Chapter 3.3 are reported the materials and methods used of the 
microparticles production accordingly with the type of formulation developed. In this chapter 
are described the methods of investigation of microparticles swelling and release, as well as 
the cell viability tests performed. Chapter 3.4 reports the method of microparticles 
characterization in terms of morphology and elemental composition. The scale-up system is 
discussed in Chapter 3.5 with a detailed description of the Pulsed (Oscillatory) Flow device 
(including membranes used and cleaning procedure) with an introductive section reporting 
the preliminary investigation on membrane coating type and optimization of the emulsion 
formulation. 
All the experimental results and discussions are reported in Chapter 4. Chapter 4.1 reports 
the experimental data regarding the PVA microparticles production process (optimization of 
the emulsification process and post-emulsification treatments) and time- related release 
studies. In Chapter 4.2 are displayed the data regarding the production of the PVA-Chitosan 
microparticles as well as the release tests performed with time and at different pH conditions. 
Resulting data on Gelatine- Chitosan microparticles production are reported in Chapter 4.3 
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with the yeast release studies performed at different pHs and the yeast cell viability tests. In 
Chapter 4.4 the results of the Alginate microparticles production process for cell 
immobilization are shown, encapsulated yeast viability tests are displayed. In Chapter 4.5 
data on the comparison between the performance of PTFE and FAS coated membrane are 
reported; for multiple production of W/O emulsions. The tests run using the Pulsed 
(Oscillatory) Flow system are shown in Chapter 4.6. Preliminary tests performed using the 
Dispersion Cell for the emulsion composition optimization and membrane type are also 
reported in this chapter. A summary of the main results is provided in Chapter 4.7.  
Chapter 5 reports the conclusions gathered from the experimental data obtained, a section of 
proposed future works is also provided. The conclusion chapter is followed by a list of all the 
papers referenced in this thesis (Bibliography) and by the Appendix where further 
information on the instruments, instruments calibrations and software used in this work are 
provided.   
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2. LITTERATURE REVIEW 
2.1 THE ORAL DELIVERY OF PHARMACEUTICS  
2.1.1 Overview of the routes of drug delivery  
Drugs and active compounds may be introduced into the human body by various anatomical 
routes. The choice of the appropriate delivery route depends on many factors such as the type 
of disease, the therapeutic effect to achieve, the possible side effects, and the formulation 
type available (Jain, 2008). Another distinction is based on the needed of a systemic effect, or 
a targeted action of the drug to a diseased organ. A classification of the drug delivery routes 
can be done on the anatomical site of administration (Jain, 2008): 
- Oral Drug Delivery 
- Parenteral Drug Delivery 
- Transmucosal Drug Delivery  
- Nasal Drug Delivery 
- Colorectal Drug Delivery 
- Pulmonary Drug Delivery 
- Cardiovascular Drug Delivery 
- Drug Delivery to the Central Nervous System  
All previously mentioned routes will have a certain systemic effect, although, if a systemic 
delivery of the drug is required the most effective routes of administrations are the oral, 
parenteral and pulmonary. Within the evaluation of the several routes of administration 
available, there are some general requirements to be taken into account:  
1. Large surface area for drug adsorption; the small intestine represents a fundamental 
region of drug absorption (surface area ~200 m2) (Levine, 1973; Hillery et al., 2002). 
The lungs surface area  is also extremely large (~ 100 m2) (Pilcer and Amighi, 2010) 
and it represents an alternative to the parenteral an oral routes.  
2. Presence of degradative enzymes could deactivate the drug before the adsorption, this 
represents one of the main disadvantages of oral administration.  
3. Time of contact between the drug and the absorbing tissue is also extremely 
important and can affect the amount of drug that will actually cross the mucosa.  
4. Blood supply is required to ensure the reaching of the “post-absorption” site of action 
of the drug and the “sink conditions”(Hillery et al., 2002).  
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5. Reduced variability of a certain site of absorption (physiological conditions) essential 
to ensure the reproducibility of the drug action. This is particularly true of high 
potency drugs with a narrow therapeutic window. 
2.1.2. The oral route of administration  
The oral administration route is certainly considered the most convenient and well-accepted. 
It helps with the compliance of patients due to its non-invasive nature, pain avoidance and 
possibility to formulate different types of drugs (Sastry et al., 2000). Oral delivery 
formulations are less expensive than other types because generally they do not require highly 
sterile conditions of manufacturing (Sastry et al., 2000) and specialized personnel for 
administration. The oral way is usually preferred for the achievement of a systemic effect of 
the drug, but with the appropriate formulation it is possible to obtain also local effects. 
Cathartics, antacids, and drugs used for the treatment of bacterial infections are some 
examples of active compounds with a local effect on a specific site of the GI (Levine, 1973). 
For that purpose, the formulation more than the drug molecule itself, plays a fundamental role 
on the achievement of the desired therapeutic effect and the reduction of the side reactions. 
Due to the importance of oral way of administration, over the past decades several drug 
delivery formulations have been developed; such as mucoadhesive, matrix systems, reservoir 
systems, microparticles, pH sensitive delivery systems (Hillery et al., 2002; Wen and Park, 
2011). The complexity of the GI has to be considered when designing an oral drug delivery 
system; factors such as pH variations, motility, presence of mucus or food, individual 
variations, and drug metabolism should be taken into account for the production of a 
successful formulation. In this chapter the structure and the physiology of the GI tract 
including the most important factors affecting oral bioavailability will be discussed. 
2.1.3 Structure of the gastrointestinal tract 
The gastrointestinal tract is formed of four main regions: oral cavity, stomach, small intestine, 
large intestine (Figure 1). The function of this system is digestion which involves the 
breaking down of complex molecules (deriving from the food) into simpler molecules to be 
absorbed into the blood and the lymph systems (Hillery et al., 2002). Each compartment of 
the GI in designed for a specific function; accordingly the physiology of each region is 
different. The epithelium, pH, motility and residence time are the main difference between 
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the four regions and they are also essential parameters affecting the behaviour of drugs and 
drug delivery devices.  
 
Figure 1 Structure of the human gastrointestinal tract and relative physicochemical 
conditions; image modified from http://en.wikipedia.org/wiki/Digestive_tract 
(Copyright free). 
 
Oral Cavity (Mouth) 
The initial food fragmentation occurs in the oral cavity; it is covered by a smooth and thin 
epithelium composed by several layers of cells. To promote the moisturising and initial 
digestion of dry food, the mouth epithelium secretes saliva making a slightly acidic 
environment (Levine, 1973).  
 
Stomach  
The stomach acts as food reservoir, completing the fragmentation started in the oral cavity 
and is the start of proper digestion. To accomplish this function, the stomach secretes 
hydrochloric acid and enzyme (pepsin) necessary for the breaking of proteins (Levine, 1973). 
Subsequently the gastric content is very acidic: pH of the stomach in a fasting state is ~1.5 to 
2.0 and in fed state is 2.0 to 6.0 (Hillery et al., 2002; Arora et al., 2005). The stomach pH is 
subject to individual variations and pathologic conditions. Although the stomach is not the 
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principal site of drug absorption, the rate in which the stomach empties (stomach emptying 
time) (Singh and Kim, 2000) is fundamental for the rate and the extent of drug adsorption in 
the small intestine (Hillery et al., 2002). The normal retention time in the stomach is 2-3h 
after a normal meal, or a maximum of 30 minutes after a glass of water (Khurana,2006). 
Viscosity, volume and caloric content of the meal can affect the gastric emptying time as well 
as the age, gender and presence of pathological conditions (diabetes, Chron’s disease); stress 
usually increases the gastric emptying rate while depression produces a reduction of it (Arora 
et al., 2005). If a topic action of the drug is required in the stomach, formulations able to 
increase the stomach retention time can be produced increasing the bioavailability of the 
drug, the drug solubility in acidic conditions improving the overall therapeutic effect. For 
controlling the gastric retention many mechanism can be exploited such as muchoadesion 
(Shah et al., 1999; Beri et al., 2013), flotation (Dave et al., 2004; Arora et al., 2005), 
sedimentation, expansion, or the simultaneous administration of substances to delay the 
gastric emptying time (Arora et al., 2005). 
 
Small intestine  
The main function of the small intestine is the absorption of the end-product of the digestion 
and their preparation to be available in a useable form by the organism (drug actions and 
interactions). As a consequence the small intestine also represents the main site of drug 
absorption. It consists of the duodenum, jejunum and ileum. The absorbing epithelium of the 
small intestine provides the structure to increase the absorbing surface area (Levine, 1973). 
All these microstructures increase the available area of absorption of the small intestine 
(approximately 2.3 m long with a 4 cm diameter) to 200 m2 (Levine, 1973; Hillery et al., 
2002). The environment through the length of the small intestine changes from slightly acidic 
(pH=4-5) in the initial part (duodenum) due to the content of the stomach emptied in this 
tract. Alkaline secretions from the pancreas and bile neutralize the pH rapidly alongside the 
rest of the small intestine to a pH of 6-7 (Levine, 1973). In normal conditions, 3-5h are 
required to pass from the one end, to the other, of the small intestine (Dressman and Reppas, 
2010). In contrast to the stomach, the residence time in the intestine is longer to enhance the 
sorption of the nutrients since mass transfer takes place along the entire length (Levine, 
1973). 
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Large intestine (Colon) 
The large intestine, or colon, is approximately 1.5 m long with a 6 cm diameter (Hillery et al., 
2002). in this area of the GI the pH is between 6 and 8 (Ashford and Fell, 1994). The terminal 
segment of the colon (rectum) may be used as site for drug administration when the oral route 
is not useable. This route prevents the inactivation of the drug operated by the liver, avoiding 
the so called “fist pass” metabolism (Levine, 1973). Contributing to the morphology and 
functions of the gastrointestinal tract is the intestinal microflora, which has significant 
metabolic activity, and participates in the metabolism (Friend, 1992). The human 
gastrointestinal microflora are very complex, it was estimated that the human GI tract 
contains more the 100 trillion of microbial microorganisms collectively called microbiota 
(Davis and Milner, 2009). A small portion of bacteria is present also in this region attached 
on the epithelium, or present in the mucus, as for example the Helicobacter pylori. This 
microorganism is responsible for 90% of stomach ulcers and it is implicated in gastric cancer 
(Tlaskalová-Hogenová et al., 2004). Colonic microflora contribute to the health of the bowel, 
and it has a role in reducing the cancer risk, production of essential nutrients, and stimulation 
of intestinal immunity (Davis and Milner, 2009).  
2.1.4 Formulation properties influencing oral bioavailability 
For oral drug delivery formulations (e.g. solutions, suspensions, emulsions, capsules and 
tablets) factors such as the particle size and type of additives have a great influence on 
formulation dissolution and drug absorption rate (Hillery et al., 2002).  
2.1.4.1 Particles size  
The size of particles generally accepted for oral drug delivery are in a range between 20-120 
µm because this size range provides the retention of the particles by the intestinal tissue and 
acts as sustained release depot (Rathbone et al., 2002). In terms of drug release rate from the 
dosage form, a reduction in particle size results in an increase in the total surface area, 
increasing the dissolution rate and, as a consequence, increasing the rate of sorption. 
Controlling the particle size is possible to control the release rate obtaining with a 
formulation (Berkland et al., 2002; Siepmann et al., 2004). The reduction of the particle size 
can also be a strategy to increase the solubility of poor water soluble compounds that are 
marketed as micronized, or microcrystalline, forms (Hillery et al., 2002). 
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2.1.4.2 Additives  
Additives are substances added to the pharmaceutical formulation to enhance the stability, the 
mechanical properties, or the dissolution of the formulation matrices. Wetting agents 
(surfactants) are commonly used to lower the interfacial tension and the contact angle 
between immiscible liquids, or between solid particles and liquid vehicles. The most 
commonly used in the formulation of oral delivery formulations are Polysorbate 80 and 
sodium dodecyl sulphate; these substances have been shown to increase the drug sorption 
across the human GI tract (Hillery et al., 2002). The chemical nature of the surfactant alters 
the dissolution rate of lipid materials, and membrane characteristics, increasing the sorption 
(Gad, 2009). Diluents are used as fillers, to bulk up the formulation. They are usually 
carbohydrates such as lactose, dextrose, sucrose or microcrystalline cellulose. They can 
promote the faster disintegration and release of the drug (Hillery et al., 2002). Substances 
such as starch, gelatine, polyvinylpyrrolidone (PVP) are used as adhesives, to bind powders 
together in the process of wet granulation. The adhesive can be hydrophobic (producing slow 
disintegration of the formulation and delayed drug release) or hydrophilic (increasing the 
disintegration rate of the formulation and producing an increase in the drug release rate) 
(Hillery et al., 2002). Disintegrants cause the formulation to disintegrate rapidly increasing 
the drug dissolution while the use of lubricants can enhance the flowing properties of 
granules; they are hydrophobic materials and can prevent the wetting of powders and retard 
the dissolution (Hillery et al., 2002). 
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2.2 POLYMERIC MICROPARTICLES FOR PHARMACEUTICAL APPLICATIONS  
Encapsulation is a technique by which a solid or a liquid active ingredient is packed within a 
second material in order to shield it from the surrounding environment, but at the same time it 
allows for the active ingredient to reach the area of action unmodified. This technology is 
being adopted in a variety of different fields: pharmaceutical, biological, medical, food or 
chemical industries (Dubey et al., 2009). Reasons of encapsulation include: separation of 
incompatible components, increasing of the solubility of lipophilic compounds, increasing the 
stability of delicate compounds (protection from the oxidisation or deactivation caused by 
environmental conditions), odour and taste masking, controlled or targeted release of active 
molecules in a specific site of action, easier product recover (Nedovic, V., & Willaert, 2006; 
Dubey et al., 2009). If a specific particle size is required for the delivery of the active 
ingredient in a determined region, it might be advantageous to form small particles called 
microparticles/microcapsules and the process of encapsulating the material within the 
micron- sized particles is called microencapsulation (Gharsallaoui et al., 2007). It is possible 
to classify the type of microparticles depending on their morphology: as monocored, 
polycored or matrix type. Monocored particles are characterized by a single internal hollow 
structure while the polycored microparticles have a number of different sized chambers 
below the shell. Monocored and polycored microparticles are both called microcapsules. 
Matrix type are internally full and the active ingredient is integrated within the matrix, matrix 
type are also called microspheres (Yoshizawa, 2004; Dubey et al., 2009; Chetty et al., 2010). 
Microparticles are extensively used for pharmaceutical/biological purposes, for 
controlled/sustained release of molecules of pharmaceutical interest (Dubey et al., 2009). 
Polymeric microparticles were produced for the encapsulation and delivery of DNA, for non- 
viral gene therapy (Denis-Mize et al., 2000; Truong et al., 2000; Mathiowitz et al., 2001; 
Little et al., 2005; Guliyeva et al., 2006; Bhavsar and Amiji, 2007) or for vaccine therapy 
(O’Hagan et al., 1998; Goh et al., 2004; Jiang et al., 2005). Particles were used for cancer 
treatment using different strategies: the embolization technique for liver cancer therapy which 
consists in injecting particles (usually made of gelatine or Poly (Vinyl) Alcohol) to block or 
reduce blood supply to the cancer (Madoff et al., 2003; Marelli et al., 2007; Rajput and 
Agrawal, 2010; Bonomo et al., 2010), or the use of radioactive microspheres commonly 
made of resins, or glass, for the release of the radiation locally to the cancer cells (Setoyama 
et al., 2006; Rajput and Agrawal, 2010). Microparticles were also produced for controlled 
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and targeted release of anticancer drugs (Cummings, 1998; Lin et al., 2005; Rajput and 
Agrawal, 2010; Kettenbach et al., 2008; Cerroni et al., 2011; Kim et al., 2013; Shi et al., 
2014; Rai et al., 2016). Microparticles for protein delivery (Yang et al., 2001; Yuan et al., 
2007) such as insulin (Déat-Lainé et al., 2013; Shrestha et al., 2014), growth hormones (Patel 
et al., 2008; Formiga et al., 2014), erythropoietin (Zhang et al., 2015) have also been 
produced. 
2.2.1 Polymeric microparticles for oral delivery  
Formulation of polymeric particles for the purpose of drug release systems has received 
increased interest over recent years (Freiberg and Zhu, 2004). Conventional oral drug 
administration methods, such as solutions, suspensions, tablets, capsules (Hillery et al., 
2002), often do not provide protection from the acidic environment present in the stomach 
(Hillery et al., 2002) and do not provide a constant therapeutic blood concentration of the 
drug over time (Shah et al., 1997; Hoffman, 2008). A re-administration of the drug is 
required and the possibility of the drug reaching toxic levels. Encapsulating the drug into a 
polymeric matrix makes it possible to tailor the release, obtaining a site-specific release, 
prolonged action and/or sustained release (W. M. Saltzman, 2001; Sagiri et al., 2015). The 
use of polymers enables the production of formulations able to respond to specific 
environmental stimuli such as pH (Park et al., 2011), temperature (Hanga and Holdich, 2014) 
and magnetic fields (Dobson, 2006). Polymers are the most versatile class of compounds and 
they have been extensively used in pharmaceutical and biomedical (De Vos et al., 2013) 
applications due to biocompatibility (Freiberg and Zhu, 2004). A variety of devices have 
been produced using polymers for oral drug administration, such as polymer-based disks, 
pellets, rods etc. but the most common and versatile are the polymeric microparticles. By 
varying the chemistry of the polymers, is possible to obtain a sustained release (Kim and 
Pack, 2006) or a site-specific release, for example through the stomach (Risbud et al., 2000) 
or the intestine (Kurkuri and Aminabhavi, 2004). 
The polymers used for pharmaceutical applications must be biocompatible, not toxic, and nor 
carcinogenic. In the class of polymeric systems for delivery of pharmaceutical it is possible to 
distinguish two categories: gels and hydrogels (Gupta et al., 2002). Commonly these two 
terms are used to describe the same type of polymeric network as gel and hydrogel can be 
chemically similar, but they are physically distinct. Gels are described as semi-solid systems 
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containing a small amount of solid, dispersed in a relatively large amount of liquid, but still 
characterized by a solid-like behaviour rather than liquid-like. Gels are polymeric networks 
already in the swollen state and the further addition of liquid only produces a dilution of the 
polymer. The hydrogels are crosslinked network of hydrophilic polymers, they are 
characterized by the ability to absorb more than 20% of their weight in water and swell 
maintaining their three-dimensional structure. According to the destruction profile of the 
polymer matrix, directly involved in the release mechanism of the encapsulated drug, 
polymers can be divided in to surface and bulk eroding polymers (Pillai and Panchagnula, 
2001). The surface eroding polymers are mainly hydrophobic (commonly used are 
polyanhydrides and poly(ortho esters) and Poly[1,3-bis(p-carboxyphenoxy) propane-co-
sebacic anhydride] P(CPP-SA) (Zhang et al., 2003)), and the monomers are linked with 
relatively labile bonds; they are able to resist the permeation of water into the bulk of the 
polymer, degrading quickly into oligomers and subsequently monomers via hydrolysis at the 
polymer-water interface (Kim and Pack, 2006; Saltzman, 2001) . In the bulk eroding 
polymers (most common are poly- (L-lactic acid) and poly(lactic-co-glycolide) (Zhang et al., 
2003)), the water can penetrate into the polymer matrix, dissolving the drug inside which is 
released in this way (Kim and Pack, 2006). The bulk eroding polymers are characterized by a 
initial burst release of the drug, this is a phenomena in which the drug is released 
immediately in a big amount (O’Donnell and McGinity, 1997) this process may cause a too 
high concentration of the drug inside the body, that could be toxic. On the contrary, the 
surface eroding allows a constant release of the drug, which is released primarily at the 
surface of the microparticles as quick as the polymer breaks down. Another classification of 
polymeric materials used for oral drug delivery, can be done depending on the nature of the 
polymeric material and the method of production, they can be classified as synthetic and 
natural polymers. (Pillai and Panchagnula, 2001). An overview of the synthetic and natural 
polymers used for the production of microparticles for oral delivery is provided below. 
2.2.1.1 Synthetic polymers used for oral drug delivery 
Synthetic polymers have the advantage of being available in a wide range of compositions 
with adjustable properties (Pillai and Panchagnula, 2001). With the possibility of processing, 
blending or copolymerization it is possible to modify the mechanical properties (Angelova 
and Hunkeler, 1999) and response to environmental stimuli. The most common synthetic 
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polymers used for the formulation of oral drug delivery systems and their main characteristics 
are summarized into the Table 1. 
Table 1 Most commonly used polymers for the preparation of microparticles for oral delivery 
of therapeutics. 
Synthetic polymers  Principal characteristic and comments  Reference 
Poly (lactic-acid), 
Poly(glycolic-acid) and their 
copolymers 
Biodegradable polymer, the copolymer 
ratio could be adjusted to regulate the 
degradation time. Used for the oral drugs 
and vaccine delivery and production of 
magnetically responsive microparticles 
for oral delivery of proteins. 
(Cheng et al., 2006; 
Wischke and 
Schwendeman, 2008; 
Jiang et al., 2014) 
Poly (acrylic- acid) based pH sensitive polymer, used for the 
production of sIPN (semi- 
interpenetrating network) for the oral 
administration of drugs and insulin.  
(Kurkuri and 
Aminabhavi, 2004; Yan 
and Gemeinhart, 2005; 
Sajeesh et al., 2010) 
Poly (hydroxy butyrate) 
Poly (ε-caprolacton) and 
copolymers 
 
Biodegradable polymer, proprieties can 
be changed for chemical modifications of 
the material. Microparticles were 
produced for oral immunization, oral 
delivery of steroids, drugs and cell 
microencapsulation.  
(Atala and Mooney, 
1997; Sinha et al., 
2004; Riekes et al., 
2011) 
Poly (vinyl alcohol) based Biocompatible, non-toxic, hydrophilic 
polymer with bioadhesive properties. 
Ease of processing. Strength, pH and 
temperature stability. Often used in 
association with other polymers to 
improve the mechanical properties of the 
formulation. Used for the production of 
microparticles for the encapsulation and 
oral delivery of drugs, DNA and proteins 
(Kurkuri and 
Aminabhavi, 2004; 
Agnihotri and 
Aminabhavi, 2005; 
Fundueanu et al., 2007; 
Mundargi et al., 2008; 
Ray et al., 2010; Kaity 
et al., 2013; Sullad et 
al., 2014; Kaity and 
Ghosh, 2016)  
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Methacrylic acid- 
methylmethacrylate 
copolymers (Eudragit® 
polymers) 
pH sensitive polymers, used for the 
production of enteric coating, and gastro-
resistant formulations, they dissolves at 
pH above 7. Microparticles were 
produced for intestinal-colonic release, 
enzyme encapsulation and as oral 
immune delivery system.  
(Hori et al., 2005; 
Rawat et al., 2007; 
Badhana et al., 2013) 
poly(N-
isopropylacrylamide) based  
Thermosensitive polymer, used in 
association with pH sensitive polymers 
for the production of microparticles for 
protein- peptide or drugs oral delivery  
(Serres et al., 1996; 
Ramkissoon-Ganorkar 
et al., 1999; Guo and 
Gao, 2007; Gao et al., 
2013) 
2.2.1.1.1 Poly (Vinyl) Alcohol 
Poly (Vinyl Alcohol) (PVA) is a biocompatible, not toxic and not carcinogenetic polymer 
included into the Handbook of Pharmaceutical Excipients (DeMerlis and Schoneker, 2003). 
PVA has a relatively simple-linear chemical structure with pendant hydroxyl groups as 
shown in the Figure 2 b. The production starts from the polymerization of the monomer 
acetate, to Poly (Vinyl Acetate) (PVAc), which is followed by the hydrolysis of the acetate 
groups to hydroxyl groups. The hydrolysis reaction that converts PVAc into PVA is not 
complete and resulting into the production of a polymer with a certain degree of hydrolysis 
that depends upon the protraction of the hydrolysis reaction. This means that PVA is always a 
co-polymer of PVA and PVAc (Hassan and Peppas, 2000) as visible in Figure 2 a. As a 
consequence, the degree of hydrolysis has a certain effect on the on the chemical properties 
of this material, crystallinity, the solubility in water (Mansur et al., 2008).  
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Figure 2 Chemical structure of (a) partially hydrolysed PVA and (b) fully hydrolysed PVA 
taken from the literature (DeMerlis and Schoneker, 2003). 
PVA with a high degree of hydrolysis (DH= 98-99%) or partially hydrolysed (DH= 87-88% 
or DH= 80%) is commercially available. It has been shown that PVA with a high degree of 
hydrolysis (higher than 98%) is characterised by a reduced solubility in water; (Hassan and 
Peppas, 2000) reported that the presence of the remaining carboxylic groups help weaken  the 
inter-intramolecular hydrogen bonds formed by the hydroxyl groups, so the temperature must 
be raised up to 70-80ºC for the dissolution to occur (Briscoe et al., 2000). Residual presence 
of acetate groups also influences the polymer crystallinity, as high hydrolysed PVA results in 
more difficult to crystallize by heat treatment form (Hassan and Peppas, 2000). PVA is a 
water soluble polymer and can form, after solidification, a hydrophilic network that swells in 
aqueous solutions, or biological fluids. This characteristic makes the polymer suitable for the 
production of microparticles for drug delivery; the water absorption produces the swelling of 
the material, which causes the release of the encapsulated molecule for diffusion through the 
polymeric matrix (Varshosaz and Koopaie, 2002). PVA can be chemically crosslinked using 
bifunctional crosslinking agents like: glutaraldehyde, acetaldehyde, formaldehyde, other 
monoaldehydes (Hassan and Peppas, 2000) and glyoxal (Zhang et al., 2009). The reaction 
needs the presence of acidic conditions to occur, strong acids such as sulphuric acid, acetic 
acid, hydrochloric acid are added as catalysts for the reaction. The chemical crosslinking 
reaction involves the formation of ether bonds between the hydroxyl groups of PVA and the 
carbonyl groups of the aldehydes (Mansur et al., 2008) forming acetal bridges as reported in 
Figure 3. 
(a) (b) 
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Figure 3 Poly (Vinyl) Alcohol chemical crosslinking reaction with glutaraldehyde. 
Liquid PVA can solidified with physical methods (Bolto et al., 2009) such as freeze-thawing 
(Hassan and Peppas, 2000) or electron-beam irradiation (Peppas and Merrill, 1976, 1977) or 
by photocrosslinking (Schmedlen et al., 2002). PVA hydrogels have the capability to 
incorporate water and swell, the diffusion of the solvent through the polymer matrix produces 
the extension of the polymer segments. The penetration of water is the “rate-limiting step” for 
swelling and as a consequence, for the drug release. The degree of crosslinking plays a 
fundamental role on the swelling proprieties of the polymer and the release behaviour as well. 
It was seen that, for lower concentrations of crosslinker, the polymer can incorporate a higher 
amount of water and the degree of swelling increases, so modifying the crosslinking degree is 
possible to modulate the swelling of PVA and prolong the drug release (Bolto et al., 2009).  
2.2.1.1.2 Methacrylic acid- methylmethacrylate copolymers (Eudragit polymers) 
Of all the synthetic polymeric materials, those most commonly used as pH dependent 
polymers are methacrylic acid copolymers; known by the commercial name of Eudragit®. 
Eudragit® L100-55, Eudragit® L100 and Eudragit® S100 are the main ones used and they 
dissolve at pH above 5.5, 6.0 and 7.0 respectively. In the present work, the acrylic polymer 
Eudragit S100 was used as a gastro-resistant polymer, to produce a coating able to dissolve in 
neutral to basic fluids; typical of the small intestine and colon tract. Eudragit S100 (Figure 4) 
is composed by units of methacrylic acid, and methilmethacrylate in a ratio 1:2 (Yoo et al., 
2011). 
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Figure 4 Chemical structure of Eudragit S100, ratio of carboxylic groups to ester groups is 
1:2, image taken from literature (Yoo et al., 2011). 
Due to its properties, Eudragit S100 is considered a material particularly suitable for the 
delivery to the distal region of the small intestine and to the colon (Mrsny, 2012). In some 
cases the Eudragit polymers were mixed in different ratios to manipulate the drug release 
within the desired range of pH (Khan et al., 1999; Zahirul et al., 2000). Other works report 
the use of Eudragit S100 for the coating of already produced microparticles for colonic 
release via oral delivery; for example coating of calcium pectinate beads encapsulating 
theophylline (Maestrelli et al., 2008) or the anticancer drug 5-fluorouracil (Jain et al., 2007), 
chitosan microparticles containing diclofenac sodium (Lorenzo-Lamosa et al., 1998), or 
mesalamine for the treatment of ulcerative colitis (Badhana et al., 2013), celecoxib loaded 
microparticles made of Poly ɛ-caprolactone (Ghorab et al., 2011), Poly Poly(lactide-co-
glycolide) (PLGA) microparticles containing budesonide (glucocorticoid) (Krishnamachari et 
al., 2007). Eudragit® S100 coating was also used for the production of gastroretentive 
microparticles for stomach delivery (Jain et al., 2005, 2006) due to its capability to float over 
the stomach fluids and release the therapeutic over an extended period of time (Jain et al., 
2006). In all the cases reported previously Eudragit® S100 was used as coating material, but 
microparticles were also entirely produced using Eudragit® S100: piroxicam loaded 
microparticles for enteric delivery were produced (Obeidat and Price, 2006) or microparticles 
for the oral delivery of enzymes (Rawat et al., 2007).  
2.2.1.2 Natural polymer for drug delivery 
Natural polymers are usually biocompatible and often have an outstanding biocompatibility 
(Pillai and Panchagnula, 2001), they are considered relatively safer than the synthetic 
polymers for pharmaceutical applications (Tiwari et al., 2014). A disadvantage is that they 
are affected by batch to batch variability due to the difficulty of the purification process 
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(Pillai and Panchagnula, 2001). The sources of natural polymers are many, they can be 
extracted from plants, parts of animals, microorganisms as bacteria, or fungi (Tiwari et al., 
2014). Table 2 reports the most common natural polymers used for the production of 
microparticles for the oral delivery of therapeutics with a summary of the main 
characteristics. 
Table 2 Most commonly used natural polymers for the production of microparticles for oral 
release of therapeutics.  
Natural polymers Principal uses and comments Reference  
Plant origin 
Cellulose  
Pectin 
Guar gum 
Acacia gum  
Starch 
Alginate  
Carrageenan  
 
 
Biodegradable, non-toxic materials. 
Used in association with other 
polymers for the production of 
microparticles for oral vaccine and 
drugs delivery, oral anticancer 
treatment. Cellulose microparticles 
were used as floating delivery 
systems for the release in the 
stomach. Pectin, guar and acacia gum 
were used for the release in the 
colorectal area. Starch microparticles 
were used as oral adjuvant. Alginate 
is an anionic polymer used for the 
delivery of proteins and drugs in 
intestinal fluids. Carrageenan forms 
biodegradable hydrogels, it was used 
for the oral administration of 
peptides, proteins and drugs.  
 
 
(Cellulose: Patel et al., 
2006; Mastiholimath et 
al., 2008; 
Pectin: Wong et al., 
2011 
Guar Gum: Chaurasia 
et al., 2006; George and 
Abraham, 2007;  
Acacia gum: 
Lamprecht et al., 2007; 
Starch: Sturesson and 
Wikingsson, 2000; 
Wikingsson and 
Sjöholm, 2002; 
Alginate: Suksamran et 
al., 2009; Zhang et al., 
2011;  
Carrageenan: Briones 
and Sato, 2010 ) 
Microbial source  
Xanthan gum 
 
 
Xanthan gum was used for the 
production of hydrophilic matrix for 
 
(Xhantan gum: Maiti 
et al., 2007; Ray et al., 
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Dextran  
 
 
 
Gellan  
oral release of drugs and proteins.  
Dextran is an anionic polymer with 
affinity for the proteins, used for the 
production of gastro- resistant 
formulations. 
Gellan gum forms strong gels even at 
low concentrations, it has 
mucoadhesive properties, and it is 
used for stomach specific release of 
drugs. 
2010;  
Dextran: Martins et al., 
2007; 
Gellan: Narkar et al., 
2010; Prezotti et al., 
2014) 
Animal origin  
Chitosan  
 
 
 
 
Gelatine 
 
Chitosan is a cationic, pH sensitive 
polymer with mucoadhesive 
properties. It was used for oral gene 
delivery, oral vaccination, delivery of 
proteins and drugs.  
Gelatine was used for the production 
of carriers for water soluble drug and 
gastro resistant formulations in 
association with other polymers.  
 
(Chitosan: Lubben and 
Verhoef, 2001; 
Guliyeva et al., 2006; 
Gelatine: Huang et al., 
2014; Phromsopha and 
Baimark, 2014) 
 
2.2.1.2.1 Chitosan  
Chitosan is a proven biocompatible natural polymer; it is the N-deacetylated derivative of 
chitin produced from crustacean shells, fungi, and insects. It is a polycation, soluble in acidic 
environment, with versatile mechanical proprieties (De Vos et al., 2013). It is composed by 
monosaccharides linked by linear β (1→4) bonds, in particular by 2-amino-2-deoxy-β-D-
glucan combined with glycosidic linkages. Chitosan has been used for several biomedical 
applications (Berger et al., 2004), in ocular applications (Felt et al., 1999), implants (Azab et 
al., 2006) and in the pharmaceutical industry as an excipient (Illum, 1998). An interesting 
property of this natural polymer is its pH sensitivity which comes from the presence of the 
amino groups making it interesting for pH sensitive formulations. Below their pKa (6.3) the 
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amino groups of chitosan become positively charged; leading to the swelling of the polymer. 
This process is called dynamic swelling (Krishna Rao et al., 2006; Gunasekaran et al., 2006), 
and depends on two principal mechanisms: a mass transfer in the bulk of the polymer, and an 
electrostatic repulsion (Gunasekaran et al., 2006) among the polymeric chain. The ionization 
of the polymer under a certain pH leads to the formation of positive charges, which produce a 
high concentration of ions inside the gel. This produces the migration of the counter ions 
inside the polymer matrix, forming a difference of osmotic pressure between the inside and 
the outside of the gel. The difference in osmotic pressure causes the transfer of water 
molecules from the surroundings into the hydrogel reducing the difference of concentration 
between the inside and the outside of the gel. The water intake represents the primary reason 
of swelling. In addition, with crosslinking the material can maintain its three-dimensional 
structure after swelling. The reverse process occurs if the polymer is in basic conditions, 
causing hydrogel shrinkage. Another mechanism proposed for the swelling at acidic pH of 
this polymer involves the electrostatic repulsion of the polymeric chains. After the ionization 
of the amino groups, an electrostatic repulsion can occur between the charged polymeric 
chains, causing a stretching of the crosslinked bonds and the swelling of the material 
(Gunasekaran et al., 2006).  
Microparticles can be produced by ionic crosslinking of chitosan with polyanions such as 
tripolyphosphate (TPP) (Shu and Zhu, 2002), hexametaphosphate (SHMP) (Gupta and 
Jabrail, 2006) or sulphuric acid (Cui et al., 2008). The ionic interaction with polyphosphate 
anions often produces microparticles with poor mechanical strength (Shu and Zhu, 2002; 
Angelova and Hunkeler, 2001). The use of SHMP produces more rigid microparticles due to 
the high density charge of SHMP anions, which provide strong electrostatic interactions with 
chitosan amino groups (Gupta and Jabrail, 2006). Chitosan has also been complexed with 
negatively charged materials such as alginate (Y. Zhang et al., 2011) and proteins (Kurukji et 
al., 2014) for the encapsulation and pH trigged release of molecules. Chemical crosslinking 
of chitosan is obtained by reaction with aldehydes (such as gutaraldehyde), glyoxal or 
ethylene glycol diglycidyl ether (Bhumkar and Pokharkar, 2006). The reaction with 
glutaraldehyde consists of a process involving the formation of a Shiff’s base with the amino 
groups of chitosan and the carbonyl groups of glututaraldehyde, as shown in Figure 5 (Wang 
et al., 2004). 
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Figure 5 (a) Chitosan chemical structure, (b) mechanism of crosslinking reaction of chitosan 
with GA with the formation of the Shiff’s base, modified from literature (Wang et 
al., 2004). 
The addition of another polymer able to react with the crosslinker, can reduce the chitosan 
crosslinking density and increase the number of protonable amino groups available. In this 
work the possibility to produce an interpenetrating network PVA-Chitosan for the production 
of pH-sensitive microparticles, using glutaraldehyde as crosslinker for both the polymers 
(Wang et al., 2004) and form a PVA-grafted-Chitosan particles for the delivery of drugs 
(Krishna Rao et al., 2006) was evaluated. 
2.2.1.2.2 Alginate 
Alginate is a water soluble linear anionic polysaccharide obtained from brown algae 
exhibiting excellent biocompatibility and biodegradability, it has many different applications 
in the field of biomedicine. It is composed of β-D-mannuronopyranosyl (called M blocks) 
and α-L-guluronopyranosyl (called G blocks), shown in Figure 6. Homopolymeric regions 
(composed by only M or only G blocks) are interspaced by MG heteropolymeric regions. The 
ratio and distribution of M blocks and G blocks influences the pH sensitivity of the material 
(b)  
(a)  
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and the interaction with cations because it affects the relative position of the carboxylic 
groups (Alvarez-Lorenzo et al., 2013).  
 
Figure 6 Chemical structure of Alginate, modified from literature (Alvarez-Lorenzo et al., 
2013). 
Alginate can be ionically crosslinked using divalent or polyvalent cations, it was reported that 
the ionic interaction with Ca2+ ion is preferred as it binds selectively the glucuronic acid units  
in a way that the Ca2+ ions are located into electronegative cavities (like eggs in a box) from 
which the name “egg-box model” was derived (Grant et al., 1973; Fundueanu et al., 1999). 
Crosslinking alginate with Mg2+ ions has also been reported, for the production of 
monodisperse microspheres via a microchannel emulsification device (Khalid et al., 2015). 
The Mg2+ crosslinked alginate spheres showed stability over 10 days and were used for the 
encapsulation of L-ascorbic acid. Other divalent cations, such as Pb2+, Cu2+, Cd 2+, Co2+, Ni2+, 
Zn2+, and Mn2+, will also crosslink alginate gels, but their application is avoided because they 
are reported to be toxic to cells (De Vos et al., 2013). Reports mention the production of 
alginate microparticles by ionotropic gelation with positively charged polymers such as 
chitosan (Y. Zhang et al., 2011; Wang et al., 2016) and polylisine (Ferreiro et al., 2002). The 
chemical crosslinking of alginate was obtained with glutaraldehyde (Kulkarni et al., 2000) 
even though the use of less toxic crosslinkers as genipin (Chen et al., 2004) is preferred for 
drug delivery. Due to its chemical structure alginate offers a wide range of functionalization 
possibilities making the polymer versatile for the use in drug delivery (Alvarez-Lorenzo et 
al., 2013). Alginate has become one of the most important biomaterials for several 
applications in drug delivery; often in association with other biocompatible polymers. 
Alginate- whey microparticles (Déat-Lainé et al., 2013) and alginate-chitosan (Y. Zhang et 
al., 2011) microparticles were produced for the oral administration of insulin. (Rastogi et al., 
2007) reported the production of Ca2+ crosslinked alginate microparticles for the prolonged 
oral release of isoniazid. Ionically crosslinked alginate (with Ca2+) was also used as coating 
material (of gelatine microparticles) to provide protection of a drug from the acidity of the 
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gastric juice due to its stability in low pH solutions; and for the subsequent delivery in 
intestinal fluids (Annan et al., 2008). Chitosan- alginate microparticles were used for the 
colon targeted delivery of drugs in the treatment of the “inflammatory bowel disease” (Wang 
et al., 2016) as well as for protein (Chen et al., 2004) and antineoplastic (Yu et al., 2008) drug 
delivery. Alginate and polylysine microparticles were produced for the encapsulation and 
delivery of nucleotides into the intestine (Ferreiro et al., 2002), the use of alginate has been 
reported for the production oral vaccine delivery vehicles (Kim et al., 2002). García-
González et al., (2015) produced aerogel microspheres (obtained by an emulsion-gelation 
process followed by a supercritical CO2-assisted drying) for the oral administration of poorly 
water soluble drugs.  
2.2.1.2.3 Gelatine  
Gelatine is a colourless, flavourless, brittle (when dried) material that comes from the partial 
hydrolysis of the collagen from skin, connective tissue, etc. of various animals such as fish, 
pigs, cattle (Tiwari et al., 2014). Gelatine is a heterogeneous mixture of amino acids, a typical 
structures contains many residues of glycine, proline and 4-hydroxyproline as shown in 
Figure 7 (Hamman, 2010). Gelatine is a material advantageous for medical and 
pharmaceutical uses because it is biodegradable and biocompatible (Young et al., 2005). This 
material has been used as excipient in the pharmaceutical industry, or as plasma expander and 
sealant for vascular prostheses (Young et al., 2005). Gelatine is particularly sensitive to 
variation in environmental temperature, and gelling and melting point are two important 
parameters to consider when using this material for the production of microparticles for drug 
delivery. Generically, mammalian gelatines are characterized by a higher gelling and melting 
temperatures: porcine and bovine gelatine gel in a range from 20 to 25ºC, and they melt 
between 28-31ºC. In comparison, gelling temperature for fish gelatine is between 8 to 25ºC, 
while the melting point is 11 to 28ºC. This can be due the lower imino groups content in fish 
gelatine compared to mammalian gelatine, which seems to reduce the propensity of 
intermolecular helix formations (Karim and Bhat, 2009). In some cases the gelatine is added 
to the formulation to improve the mechanical, or biological, properties of other polymers; for 
example gelatine with alginate microparticles were produced for the delivery of drugs in the 
intestinal fluid (Huang et al., 2014), Eudragit coated gelatine microparticles were used for the 
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production of a gastro-resistant formulation for the oral administration of Nifedipine (Li et 
al., 2009) 
 
Figure 7 A typical structure of gelatine (-Ala-Gly-Pro-Arg-Gly-Glu-4Hyp-Gly-Pro-) 
modified from literature (Hamman, 2010). 
2.2.2 Polymeric microparticles for cell encapsulation  
The encapsulation of a living microorganism as well as cells, for the purpose of a therapy, is 
a relatively recent and promising technique advantageous for a broad range of sectors, from 
medicine to the food industry. The technology of cell encapsulation is applied as a method to 
deliver therapeutics in a desired rate and for longer period by controlled, or triggered, release 
of an active ingredient. Unlike the encapsulation of proteins, encapsulated cells can 
synthetize the therapeutic product, giving a physiological concentration of a drug with time 
(Murua et al., 2008). Furthermore, due to the in-situ manufacture of the active ingredient the 
risk of a toxic release of a therapeutic is avoided in the case of unexpected breaking of the 
encapsulated particles (Murua et al., 2008). The immobilization of cells in particles is widely 
discussed in tissue engineering; the possibility to encapsulate non-human cells reduces the 
host’s immune system response, facilitating transplantation as an alternative to the limited 
donor tissues available (Murua et al., 2008). The technique of cell encapsulation is being used 
for the production of a “Bio artificial Pancreas” (Nedovic, V., & Willaert, 2006), 
immunobarrier for islet cells transplantation (Nedovic, V., & Willaert, 2006; Duvivier-Kali et 
al., 2001; de Vos et al., 2006), the encapsulation of stem cells (Ma et al., 2003; Wang et al., 
2009). Encapsulation of living cells was also adopted for the production of chemicals such as 
alcohol, organic acids, steroids, antibiotics, vaccines (Yoshida et al., 2003). Encapsulated 
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yeast in alginate and carrageenan beads were also used as biocatalysts in organic solvents for 
complex reduction reactions (Green et al., 1996). There are reports (Mandwal et al., 2004) of 
the use of immobilized yeast in a polyacrylamide hydrogel for the production of L-
phenylacetyl carbinol; an intermediate in the synthesis of L-ephedrine (used as anti-asthmatic 
and decongestant). A variety of materials have been tested for the encapsulation of living 
cells: alginate (Cheong et al., 1993; Green et al., 1996; Song et al., 2003; de Vos et al., 2006; 
Shintaku et al., 2007; Graff, Hussain, et al., 2008; Annan et al., 2008; Wang et al., 2009; De 
Vos et al., 2013) is the most common and versatile; chitosan (Raymond et al., 2004; De Vos 
et al., 2013); gelatine (Hyndman et al., 1993; Annan et al., 2008); cellulose (Schaffellner et 
al., 2005; De Vos et al., 2013); agarose (Eun et al., 2011; De Vos et al., 2013); dextran 
(Murua et al., 2008); carrageenan (Green et al., 1996; Raymond et al., 2004; Bhatia et al., 
2005); poly(lactide-co-glycolide) (PLGA) (Murua et al., 2008; De Vos et al., 2013); Poly 
(Ethylene Glycol) (Koh et al., 2002; De Vos et al., 2013) have all been used individually, and 
in blends (Bhatia et al., 2005; Murua et al., 2008). 
The release of probiotic cells (bacteria or yeast) in the intestinal-colon area is reported to be 
beneficial for the treatment of several pathologies (Anal and Singh, 2007), but to obtain the 
beneficial action it is crucial that the microorganism is viable when reaching the required site 
i.e. able to form colonies when re-cultured on solid agar. A severe loss of cell viability is 
reported after administration due to the harsh environment of the stomach (i.e. low pH) and 
the high bile salts concentration in the intestine (Cook et al., 2012). To overcome this 
problem, many formulations have been tested for the encapsulation of probiotics with the 
purpose of protecting them against the adverse conditions of the GI tract, some example are: 
the production of chitosan-coated alginate microparticles for the encapsulation of 
Lactobacillus gasseri and Bifidobacterium bifidum (Chávarri et al., 2010) for the specific 
release into the intestine; the encapsulation of Bifidobacterium adolescentis in alginate-coated 
gelatine microparticles to enhance their survival during the passage through the GI tract 
(Annan et al., 2008); and the intestinal delivery of Lactobacillus acidophilus and 
Bifidobacterium lactis by encapsulation in alginate with xanthan gum, or cellulose 
microparticles (Albertini et al., 2010). To achieve a targeted drug release in the intestinal 
area, it is also possible to coat the microparticles using a coating material resistant to the 
stomach acidic environment and which is soluble in basic-neutral conditions i.e. Eudragit 
S100 (L. Zhang et al., 2011). Eudragit coated microparticles were produced for the colonic 
release of therapeutics (L. Zhang et al., 2011; Paharia et al., 2007) or proteins (Hori et al., 
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2005), while it has not yet been applied for the coating of encapsulated cells. In this thesis the 
use of gelatine as an encapsulating material for yeast cell with Eudragit S100 as coating 
material, for the targeted release of the yeast in the intestine-colon tract, is reported. The 
Eudragit coating was selected due to its formation in mild conditions (no crosslinking 
reactions but the formation of a layer by solvent evaporation) and the mechanical strength of 
the formed coating layer over the delicate gelatine microparticles (obtained by thermal 
gelation). 
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2.3 MICROPARTICLES PRODUCTION METHODS 
2.3.1 Conventional techniques of microparticles production 
Along with the right material, the choice of the right encapsulation technique is fundamental 
for the success of an encapsulation process. An overview of the most common techniques of 
microparticle production is reported in this chapter. Conventional methods of particle 
production are derived from three basic techniques: spray drying, phase separation 
(coacervation) and solvent extraction/evaporation (Freitas et al., 2005). The method of 
electrospraying is also briefly discussed as it has received increasing interest for the 
production of particles for pharmaceutical applications (Bock et al., 2012).  
2.3.1.1 Spray drying technique 
The spray drying technique is based on three steps which are 1) atomization, 2) solidification 
of the droplets or solvent evaporation 3) particle collection (Nandiyanto and Okuyama, 
2011). The first and most important step of the process, is the atomization, where a solution 
(or slurry), called precursor, is converted in to small droplets. The choice of the right 
atomizer is one of the most important in order to produce droplets with the desired dimension 
and with a good size distribution. The most common atomization technique is “temperature 
assisted evaporation”, which consists of the vaporization of the solution- slurry under certain 
temperature, lower than the evaporation temperature of the precursor. One of the problems 
related to this atomization technique is the high price. To overcome the problem, on the 
market are available different types of atomizers, that use different driving forces to assist the 
atomization process, such as pressure, centrifugal, electrostatic, or ultrasonic energy. The 
most common atomizers are rotary (where the driving force is the centrifugal energy), a 
pressure nozzle (atomization by pressure energy), two-fluid nozzle (which use the kinetic 
energy) and ultrasonic nebulizer (atomization by ultrasonic energy). The solidification step is 
also called droplets-to-particles conversion. This part of the process is crucial for the removal 
of the solvent from the produced droplets, and their solidification into particles. The solvent 
can be principally evaporated by three treatments: solvent evaporation by heated carrier gas, 
solvent evaporation by heating in a hot furnace or reactor, solvent evaporation by solvent 
diffusion using a diffusion dryer. The last step consists of the collection of the solid particles 
produced; for that purpose principally cyclones, filter bags, or an electric field precipitator are 
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used. The principal problem related to this technique is the use of high temperature, and for 
that reason it cannot be used with highly temperature-sensitive compounds.  
2.3.1.2 Solvent extraction or evaporation 
Another method of particle production is the technique of solvent extraction or evaporation. 
This technique does not require high working temperature or phase separation inducing 
agents, which is an advantage for the production of particles designed for pharmaceutical 
uses. Although it needs a careful choice of the material that has to be used and the conditions 
of encapsulation (Freiberg and Zhu, 2004). The phase separation technique could principally 
be divided into the following steps (Freitas et al., 2005): 
I) The dispersion or dissolution of the therapeutic or the drug into a solvent (often an 
organic solvent) that contains also the polymeric material that will form the 
microparticles; 
II) The emulsification of this polymeric phase into a second one that is immiscible with it 
(often an aqueous phase containing an emulsifier); 
III) Removal of the solvent from the dispersed phase through the continuous phase (e.g. 
solvent evaporation) which produces the transformation of the liquid droplets into solid 
particles; 
IV) The last passage is harvesting and drying of the particles. 
2.3.1.3 Coacervation or phase separation 
The technique of the coacervation and phase separation is one of the first process reported as 
an industrial method of production of microspheres and microcapsules as well. It is defined 
as a partial desolvation of a homogenous polymeric solution, into two phases: the coacervate 
(rich of polymer) and the coacervation medium (poor of the polymer). The process requires 
the use of desolvation agents to produce the phase separation, this is case called simple 
coacervation. Complex coacervation involves the interaction (a complexaction) of polymers 
with opposite charge. For the production of the microspheres, the gradual introduction of the 
desolvating agents produces the formation the formation of thin droplets called “coacervate 
nuclei”, that contains a high concentration of the polymer compared to the bulk of the 
solution (coacervation medium). The further addition of the coacervation agents allows to the 
“primary droplets” to grow larger and larger, and to coalesce, forming bigger droplets. 
Adjusting parameters like stirrer speed, stabilizer concentration etc. it is possible to obtain 
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droplets with size range from about 100 µm upwards. After the formation of the droplets, 
with processes like solvent removal and crosslinking reaction, it is possible to obtain the 
corresponding microparticles (Arshady, 1990). 
2.3.1.4 Electrohydrodynamic atomization  
The Electrohydrodynamic atomization (EHDA) technique is also called electrospraying and 
is a method of production of micro-structured materials (Xie et al., 2015). The process 
consists in breaking up a liquid jet into fine drops by the action of an external electric field. 
The generated electric stress overcomes the surface tension forces producing fine drops 
(process of atomization). A normal EHDA setup consists of a few components: a syringe 
pump, a syringe with a metal needle serving as a nozzle, an electric power source and a 
grounded collector. Once the drops are emitted from the tip of the needle, solvent evaporation 
occurs increasing the solute and charge concentrations. The solute within the drops 
evaporates forming solid microparticulates on the collector. In some cases the EHDA setup is 
equipped with chamber with air/ nitrogen flow to collect the particles through a filter. The use 
of a closed chamber produces a slow evaporation of the solvent leading to the formation of 
smaller particles with a smoother surface. In the EHDA technique it is crucial to select the 
proper solvent to dissolve the polymer as the surface morphology and particle size is strictly 
dependent on the solvent physicochemical properties. For EHDA using water a controlled 
inert gas or vacuum environment is required. There are reports of the production of 
microparticles by electrospraying for pharmaceutical applications loaded with different types 
of drugs or proteins (Bock et al., 2012). 
2.3.2 Microparticles produced by emulsification  
2.3.2.1 Emulsions  
Emulsions are by definition colloidal dispersions of one or more immiscible phases: the 
discontinuous, dispersed or inner phase is presents as drops in a continuous or external phase. 
Presence of surfactants is required to avoid coalescence of the two phases, showing that the 
emulsions are thermodynamically unstable systems. Surfactants are required to reduce the 
interfacial tension existing between the two immiscible phases; the work (𝑊𝑊) required for the 
production of an emulsion can be expressed as (Kontogeorgis and Kiil, 2016): 
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𝑊𝑊 =  𝛾𝛾∆𝐴𝐴   Equ. 1 
where 𝛾𝛾 is the interfacial tension and ∆𝐴𝐴  is the change in the surface area. 
Destabilization of the emulsions can occur with three main mechanisms: creaming, 
flocculation or coagulation, and coalescence. Creaming or sedimentation phenomena can be 
caused by a density difference between the two phases, it is a separation caused by the 
upward or downward movement of the droplets. Flocculation is described as the aggregation 
of the droplets which collide due to attractive forces. Coalescence occurs when the drops 
merge losing their identity. Stability of the emulsions can be improved by changing the 
interfacial tension, providing a mechanically strong and elastic interfacial film, having a 
relatively small amount of dispersed phase and by narrowing the drop size distribution 
(Kontogeorgis and Kiil, 2016).  
Generally the emulsions can be classified as water in oil (W/O) or oil in water (O/W) 
according to the type of liquid forming the dispersed and continuous phase. These emulsions 
are called single emulsions, multiple emulsions can be produced by emulsifying a single 
emulsion into an outer continuous phase. Multiple emulsions can be water in oil in water 
(W/O/W) or oil in water in oil (O/W/O). The properties of an emulsion mainly depend on the 
emulsion microstructure which is a function of the mean droplet size and size distribution 
(Barbosa-Canovas et al., 2009). In order to obtain stable emulsions an emulsifying agent is 
required to lower the interfacial tension. A surfactant (or surface active agent) is an 
amphiphilic molecule composed by a “polar” head (ionic- anionic or cationic, or polar group) 
and a hydrophobic part (Kontogeorgis and Kiil, 2016). This chemical structure makes the 
surfactant able to absorb at the air-liquid surface or at the water-oil interface reducing the 
surface or interfacial tension. Surfactants can be classified depending on the nature of the 
head as anionic, non-ionic or cationic.(Kontogeorgis and Kiil, 2016). The decrease of the 
surface tension (and interfacial) is observed below a certain concentration called the Critical 
Micelle Concentration (CMC) above which the surfactants form a new entity often spherical 
called a micelle (Barbosa-Canovas et al., 2009). A second classification of surfactants can be 
done considering the hydrophilic-lipophilic balance (HLB). The HLB is an empirical 
parameter first introduced by William C. Griffin (Griffin, 1949) which gives information 
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about the hydrophilic-lipophilic nature of a surfactant or emulsifier, it can be calculated 
accordingly to Equ. 2. 
𝐻𝐻𝐿𝐿𝐻𝐻 =  20 × 𝑀𝑀ℎ
𝑀𝑀
  Equ. 2 
Where 𝑀𝑀ℎis the molecular weight of the hydrophilic portion of the surfactant molecule and 𝑀𝑀 
is the molecular weight of the whole molecule. In (Griffin, 1949) it is reported that surfactant 
with a HLB number between 4 and 6 is appropriate for the production of w/o emulsions while 
with HLB numbers in the range 8-18 it is possible to produce o/w emulsions. In this work 
o/w emulsions where mainly produced, the surfactant used to stabilize the water drops and 
their chemical structure are reported in  Figure 8.  
 Span 80 (HLB= 4.3) 
                      PGPR (HLB= 1.5- 2) 
 
     ABIL EM 90 (HLB= 5) 
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 Figure 8 Oil soluble surfactants used in this thesis: Span 80 (sorbitane monooleate), PGPR 
(polyglycerol polyricinoleate) and ABIL EM 90 (modified polyether–
polysiloxane).  
2.3.2.2 Methods of emulsion production  
Several conventional methods have been described for the production of emulsions, 
mechanical processes are the most frequently applied; these methods often involve the 
production of a primary emulsion by gentle stirring which is subsequently homogenized to 
obtain a further reduction of the drop size. Rotor-stator systems are applied for the continuous 
or discontinuous production of emulsions, the mechanical energy is the driving force for the 
droplet production. For the production of fine-dispersed emulsions high- pressure systems 
such as high- pressure homogenizers are commonly used; with this method the mechanical 
energy required for the drop formation is provided by a pressure difference. Emulsions are 
also produced by ultrasound systems in which the drop breaking occurs due to the turbulence 
caused by ultrasound waves. This method has been mainly applied for a lab scale production 
as it generates drops with a wide size distribution (Barbosa-Canovas et al., 2009). As 
discussed above these methods of emulsion production are based on droplet disruption, which 
can be potentially a disadvantage for the encapsulation of delicate compounds. Emulsions can 
also be produced by droplets formation from microstructured or membrane systems. The 
production of drops using microfluidic devices consists of injecting one liquid (the dispersed 
phase) through a single microchannel into a second perpendicular microchannel channel 
transporting the continuous phase; in a configuration called T-junction (Figure 9 a). In an 
alternative configuration the drops are introduced into a microchannel and subsequently 
break up in smaller drops while passing through a constriction (flow focusing devices) 
(Vladisavljevic, 2016) as shown in Figure 9 c and d. For these systems the drop generation is 
driven by the shear exerted by the flow of the continuous phase, the continuous phase can 
also flow with a cross-flow mode (i.e. T and Y junction) or co-flow mode (flow focusing 
systems) (Maan et al., 2015). Spontaneous drop break up systems are also available, they are 
characterized by two different channel depths forming a shallow structure called terrace. The 
dispersed phase is initially compressed in a disk-like shape on the terrace and when it reaches 
the continuous phase channel it spontaneously breaks into spherical drops (Maan et al., 
2015). The main advantage of the microchannel devices is the production of extremely 
uniform sized emulsions with a CV% of around 3% (Vladisavljevic, 2016), but the main 
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disadvantage is the low production rate and difficult scale up nature for larger throughput 
(Spyropoulos et al., 2014a). Using microfluidic emulsification devices drops can be formed 
by several microchannels in parallel, it was suggested that it may be possible to achieve a 
throughput up to 100 kg of emulsion per hour (Vladisavljević et al., 2012) with a CV% up to 
5%.  
 
Figure 9 Examples of microfluidic devices (a) T- junction (Ushikubo et al., 2014), (b) Y- 
junction (Ushikubo et al., 2014), (c) Flow- focusing system for the production of a 
single emulsion (Hughes et al., 2013) and (d) a double emulsion (Hughes et al., 
2013).  
2.3.3 Emulsions production by Membrane Emulsification  
With membrane devices the emulsion drops are generated by injection of the dispersed phase 
or an emulsified mixture through the pores of a membrane. The process is called Membrane 
Emulsification (ME) and uniform emulsions can be produced (CV% between 10- 20%) with 
a higher productivity compared to microfluidic devices (several tonnes per hour) 
(Vladisavljević et al., 2012). Nakashima and Shimizu in the late 1980, fabricated a particular 
glass membrane called SPG (Shirasu Porous Glass) (Nakashima and Shimizu, 1986), that was 
successfully used for the production of uniform emulsion of kerosene in water and water in 
kerosene. In the last 20 years the interest on this method increased thanks to the possibility to 
control effectively the droplet dimensions by varying the operating conditions of the process 
(Vladisavljević and Williams, 2005). The membrane emulsification technique overcomes 
(a) 
(b) 
(c) 
(d) 
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some of the disadvantages typical of the classical methods of emulsions production such as: 
unreliable scale-up, insufficient droplet uniformity, high mechanical stress due to high forces 
applied, and poor batch to batch reproducibility (Spyropoulos et al., 2011). The process 
involves the use of an applied force to press the dispersed phase through a porous membrane 
into the continuous phase. The droplets are formed by a direct permeation of the dispersed 
phase through the micropores of a membrane and a shear stress applied over the membrane 
surface produces the detachment of the formed droplets. Compared to the conventional 
method of emulsion production (Spyropoulos et al., 2011) the shear stress applied in the ME 
is lower allowing the use of highly sensitive ingredients. Furthermore, the ME process allows 
the production of emulsions with lower energy consumption (104-106 J m-3) compared to the 
conventional method mentioned above (106-108 J m-3) (Joscelyne and Trägårdh, 1999). It is 
possible to inject a pure dispersed phase, in this case the process is called direct ME, or a pre-
mixed dispersed phase (pre-mix ME process) (Charcosset, 2009). With the conventional 
method of the direct ME droplets are produced in situ by pressing through the membrane 
pores the pure dispersed phase, into an immiscible second phase (continuous phase). The 
membranes used can be hydrophobic or hydrophilic depending on the type of emulsion 
required: a hydrophobic membrane is normally used to produce W/O emulsions, otherwise a 
hydrophilic membrane is used for the production of O/W emulsions. Theoretically the 
membrane surface (where the droplets are formed) should not be wet by the dispersed phase 
(Nakashima et al., 1992). The detachment of the formed droplets is assisted by a shear stress 
applied over the membrane surface, recirculating the continuous phase with a low-shear 
pump or by its agitation (Vladisavljević and Williams, 2005). In pre-mix membrane 
emulsification instead, a preliminary emulsified phase (rather than a pure phase) is injected 
through the membrane into a third liquid. The first emulsion is generally produced by 
conventional methods like a stirrer or a homogenizer; then it is forced through the membrane. 
With the pre-mix higher dispersed phase fluxes are achieved (typically above 1 m3 m-2 h-1) 
compared to the direct ME (0.01-0.1 m3 m-2 h-1) due to the generally lower viscosity than pure 
dispersed phase (Lloyd et al., 2015), allowing the production of smaller droplets with the 
same type of membrane and phase composition (Vladisavljević and Williams, 2005).  
In the process of ME several factors affect the final drops size such as the shear stress 
applied, the membrane type and pore size, dispersed phase flux, surfactant used, viscosity of 
the dispersed and continuous phase (Joscelyne and Trägårdh, 1999; Vladisavljević and 
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Williams, 2005; Charcosset, 2009; Nazir et al., 2010; Spyropoulos et al., 2014a). Many 
different membrane types are now available for ME and choice of the most appropriate 
depends on the type of emulsion required (e.g. W/O or O/W). The first type of the membrane 
developed specifically for membrane emulsification was the Shirasu porous glass (SPG), 
which is characterized by interconnected pores and a wide range of dimensions of the pores is 
available (0.05 μm – 20 μm) (Nakashima and Shimizu, 1986). The SPG membranes have also 
a high porosity, between 50-60%  (Charcosset, 2009). The SPG membranes can also be 
rendered hydrophobic by chemical modifications (Kukizaki and Wada, 2008). Microsieve 
membranes (Holdich et al., 2012) are also often used in ME which are instead ultra-thin foils 
with linear pores and very low internal pore area, one of the advantages of this type of 
membrane is the possibility to reach high transmembrane flux with low transmembrane 
pressure (Wagdare et al., 2010). Most common microsieve membranes used in ME are: 
silicon nitride AquamarijnTM microsieves, nickel microsieves produced by using UV-LIGA 
process (Nazir et al., 2010), produced by Micropore Technology Ltd (Egidi et al., 2008), laser 
drilled alluminium and stainless steel foil (Vladisavljević and Williams, 2006). Nickel 
microsieve membranes can be produced with different geometry of the pores, including 
slotted pores (Holdich et al., 2006). Microsieve membranes are also less inclined to foul 
compared to the SPG membrane, which have low surface porosity and high tortuosity of the 
pores. Membrane pore size is a crucial parameter affecting the drop size; in literature there is 
reported a linear correlation between the average pore diameter of the membrane and the 
average droplet diameter (Vladisavljević and Williams, 2005). In ME an important role is 
also played by the emulsifier type, it quickly diffuse to the oil-water interface to facilitate the 
droplet detachment from the membrane and stabilize the emulsion reducing the interfacial 
tension (Vladisavljević et al., 2012). The surfactant should not reduce too much the value of 
interfacial tension because in that case the dispersed phase would just pass through the 
membrane pore without forming the droplets. The velocity in which the surfactant’s 
molecules reach the interface is also important: the faster the emulsifier absorbs at the 
interface, the smaller the resulting drops are (Vladisavljević et al., 2012). It should be avoided 
that the surfactant molecules are adsorbed on the membrane surface, because this could foul 
the membrane pores and, more likely, assist the dispersed phase to spread over the membrane 
(Vladisavljević, 2015). It was shown (Nakashima et al., 1993) that surfactant molecules 
should not have functional groups with opposite charge to that of the membrane surface to 
avoid membrane fouling. In order to obtain the detachment of the droplets from the 
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membrane surface, a shear stress is generated (in some cases obtained by the movement of 
the continuous phase) in a controlled manner to allow a better control over the drop size. 
Depending on the principle of the shear stress generation several ME techniques have been 
described (Spyropoulos et al., 2014a), they can be classified as stationary membrane 
systems (or moving continuous phase ME) as Crossflow ME (Figure 10 a); where shear is 
generated by the recirculation of the continuous phase across the membrane surface 
(Nakashima et al., 2000; Joscelyne and Trägårdh, 1999; Ho et al., 2013), the Stirred ME 
(Figure 10 b) (Santos et al., 2015); where the rotation of a stirrer generates the movement of 
the continuous phase, Pulsed ME (Figure 10 c) (Holdich et al., 2012) in which the cross-flow 
of the continuous phase is combined with its pulsation across the membrane surface, Pulsed 
back-and-forward ME (Figure 10 d) (Piacentini et al., 2014) where the continuous phase is 
moved back and forward tangentially to the membrane surface in a pulsed cyclic flow and 
nonstationary membrane devices (or moving membrane) such as Vibrating (Holdich, 
2010) or Rotating (Figure 10 e and f respectively) (Vladisavljević and Williams, 2006) ME 
where the shear is produced by the vibration or rotation of the membrane respectively, 
Azimuthally Oscillating ME (Figure 10 g); where a non- stationary cylindrical membrane is 
rotated backward and forward (Silva et al., 2015). 
 
 
Figure 10 Different ME systems classified dependently to the principle of shear generation; 
(a) Cross- flow ME, (b) Stirred ME, (c) Pulsed ME, (d) Pulsed back and forward 
ME, (e) Vibrating ME, (f) Rotating ME and (g) Azimuthally oscillating ME. 
(a) (b) (c) (d) 
(e) (f) (g) 
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2.3.3.1 Droplet size modelling  
There are several forces acting on a growing droplet at the membrane pore opening, those 
forces can be grouped in detaching forces and retaining forces (Spyropoulos et al., 2014b) 
Figure 11.  
 
Figure 11 Forces acting on a growing drop at the membrane pore opening.  
The key retaining force during the drop formation is the capillary force, FCa (Equ. 4) keeps 
the drop on the membrane surface and it is the effect of the dispersed phase adhesion around 
the edge of the pore opening. The key detaching force is the drag force (FD) (Equ. 5) it is 
created by the continuous phase flowing past the droplet and parallel to the membrane 
surface. The other detaching forces are: Fstat static pressure difference force which due to a 
pressure difference between the inside and the outside of the droplet, the dynamic lift force, 
FL which is the result of the asymmetric velocity profile of the continuous phase near the 
droplet, FB is the buoyancy force due to the density difference between the dispersed and the 
continuous phase (it is only important for very large drop sizes (Kosvintsev et al., 2008)), FI 
is the inertial force and it is associated with the mass of the fluid flowing out from the 
opening of the pore (Rayner et al., 2004). It was shown that FB and FI are from 6 to 9 times 
smaller than the drag and capillary forces therefore they can be neglected for force balance 
type model (Rayner et al., 2004). In this work for the droplet diameter calculation the 
simplest approach introduced in (Kosvintsev et al., 2005) was adopted. As the pressure inside 
a deforming drop will be uniform, it is possible to write a force balance between the two main 
forces acting on a drop growing at a single pore: the capillary force FCa and the net detaching 
force FD (Peng and Williams, 1998; XU et al., 2005; Kosvintsev et al., 2008) 
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𝐹𝐹𝐶𝐶𝑒𝑒 =  𝐹𝐹𝐷𝐷 Equ. 3 
𝐹𝐹𝐶𝐶𝑒𝑒is calculated from Young-Laplace equation for the capillary pressure, considering 𝜃𝜃= 0 
(fully wetting): 
𝐹𝐹𝐶𝐶𝑒𝑒 =  2𝛾𝛾𝛾𝛾𝑟𝑟𝑝𝑝 Equ. 4 
where 𝛾𝛾 is the interfacial tension between the two phases, 𝑟𝑟𝑝𝑝is the pore radius. The drag force 
is expressed as a modified Stoke’s equation for Newtonian liquids (Keh and Chen, 2001; 
Kosvintsev et al., 2005); 
𝐹𝐹𝐷𝐷 = 𝐻𝐻3𝛾𝛾𝑥𝑥𝜏𝜏��𝑥𝑥2�2 −  𝑟𝑟𝑝𝑝2  Equ. 5 
where B is a constant that was taken as equal to 3 (Kosvintsev et al., 2005) to consider the 
nearness of a wall (Keh and Chen, 2001), 𝑥𝑥 is the formed droplet diameter and 𝜏𝜏 is the shear 
stress. When the detaching force prevails on the retaining force the drop is detached from the 
membrane surface, solving Equ. 6 for 𝑥𝑥 gives the resulting drop diameter 
 2𝛾𝛾𝛾𝛾𝑟𝑟𝑝𝑝 = 9𝛾𝛾𝑥𝑥𝜏𝜏��𝑥𝑥2�2 −  𝑟𝑟𝑝𝑝2 Equ. 6 
𝑥𝑥 =  �18 𝜏𝜏2𝑟𝑟𝑝𝑝2 + 2 �81 𝜏𝜏4  𝑟𝑟𝑝𝑝4 + 4 𝑟𝑟𝑝𝑝2 𝜏𝜏2 𝛾𝛾2      3 𝜏𝜏  Equ. 7  
For the simple Dispersion cell system (discussed in subchapter 5.1) the value of the shear 
stress 𝜏𝜏 varies depending on the distance from the centre of the membrane, and it can be 
calculated from the following equations (Stillwell et al., 2007) using an approach described in 
(Ciofalo et al., 1996): 
𝜏𝜏 = 0.825 𝜂𝜂𝜔𝜔𝜂𝜂      𝑟𝑟 <  𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠  Equ. 8 
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𝜏𝜏 = 0.825 𝜂𝜂𝜔𝜔𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠 �𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠𝑟𝑟 �0.6 1𝜂𝜂              𝑟𝑟 >  𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠  Equ. 9 
Where η is the coefficient of dynamic viscosity of the continuous phase, ω is the angular 
velocity. In order to determine the drop dimension, it can be assumed that the appropriate 
shear stress to use in the equation is the maximum value, the maximum value of shear (τmax) 
is reached at distance rtrans from the centre of the membrane; 
𝜏𝜏𝑚𝑚𝑒𝑒𝑒𝑒 = 0.825 𝜂𝜂𝜔𝜔𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠 1𝜂𝜂 Equ. 10 
Where rtrans represents the transitional radius, the point in which the rotation of the continuous 
phase changes from a free to a forced vortex and it can be calculated using Equ. 11 
(Kosvintsev et al., 2005) 
𝑟𝑟𝑠𝑠𝑝𝑝𝑒𝑒𝑒𝑒𝑠𝑠 =  𝐷𝐷2  1.23 �0.57 + 0.35 𝐷𝐷𝑇𝑇� �𝑏𝑏ℎ𝑇𝑇 �0.036 𝑛𝑛𝑏𝑏0.116 𝐶𝐶𝑅𝑅1000 + 1.43 𝐶𝐶𝑅𝑅 Equ. 11 
where bh is the blade height, T is the cylinder width, D is the stirrer width, and nb is the 
number of blades. Re represents the Reynolds Number calculated for a stirred vessel Re = 
ρωD2/ 2πη, where ρ is the continuous phase density. The shear at the membrane surface is 
calculated assuming that it is equal to zero in the boundary layer over a thickness (δ) given 
from the Landau-Lifshitz (Landau and Lifshitz, 1959) equation: 
𝜂𝜂 =  � 𝜂𝜂
𝜌𝜌𝜔𝜔
 Equ. 12 
However, Equ. 7 (page 41) does not take into account the “necking” effect: the existence of a 
neck between the forming drop and the membrane pore. In (Dragosavac et al., 2008; Egidi et 
al., 2008) a modified expression of the capillary force is reported to include the effect of the 
“neck”.  
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When modelling the drop size for the Pulsed (Oscillatory) flow ME system (please refer to 
subchapter 3.5), the shear stress at the membrane surface was calculated on the wave 
equation for the shear stress (Holdich et al., 2012) 
𝜏𝜏 =  𝑣𝑣0�𝜔𝜔𝑓𝑓𝜇𝜇𝜌𝜌2 �sin�𝜔𝜔𝑓𝑓𝑡𝑡� − cos�𝜔𝜔𝑓𝑓𝑡𝑡� � Equ. 13 
Where 𝜔𝜔𝑓𝑓 is the angular frequency calculated as  
𝜔𝜔𝑓𝑓 = 2𝛾𝛾𝑓𝑓 Equ. 14 
where 𝑓𝑓 is the frequency of the oscillation while 𝑣𝑣0 is the peak velocity both related to the 
angular frequency and the amplitude of the oscillation (𝑎𝑎) 
𝑣𝑣0 =  𝜔𝜔𝑓𝑓𝑎𝑎 Equ. 15 
The peak shear event occurs when the value of wall shear provided by Equ. 13 is at 
maximum, the maximum shear is reached twice per cycle and this value is included in Equ. 7 
(page 41) for the determination of 𝑥𝑥 (Holdich et al., 2012; Piacentini et al., 2013; Silva et al., 
2015).  
𝜏𝜏𝑚𝑚𝑒𝑒𝑒𝑒 =  𝜔𝜔𝑓𝑓3/2𝑎𝑎(𝜌𝜌𝜇𝜇/2)1/2 = 2𝑎𝑎(𝛾𝛾𝑓𝑓)3/2 (𝜌𝜌𝜇𝜇)1/2 Equ. 16 
 
 
  
 
 
 
44 
 
 
3. EXPERIMENTAL 
3.1 DISPERSION CELL SYSTEM 
3.1.1 Membranes 
The W/O emulsions produced using the Dispersion Cell system were obtained using flat disk 
membranes all supplied by Micropore Technologies Ltd (Redcar, UK). The membranes used 
were nickel or stainless steel membranes, either PTFE or FAS (fluorinated compounds) 
coated to obtain the hydrophobicity. The membranes had uniform cylindrical pores with 
diameters of 10, 20 and 30 µm and distance between the pores of 80 or 200 µm. For some of 
the experiments the pores were distributed into a narrow ring portion placed at distance rtrans 
from the centre of the membrane; in this area the shear reaches its maximum value. This type 
of membrane is named “ring membrane”, further details are given in the experimental section 
(please refer to subchapters 4.1.1.2.1 and 4.1.1.2.2). A schematic representation of the whole 
and ringed membrane is shown in Figure 12 which also reports the diameters measured, area 
of the full membrane was 0.000855 m2 while the area of the ringed membrane was 0.000185 
m2. 
 
 
Figure 12 Schematic representation of the whole membrane (a) and the ringed membrane (b). 
The pores on the membranes are oriented in a perfectly hexagonal array with a pore in the 
centre of each hexagon as illustrated in Figure 13 a and b. Using Equ. 17 (Dragosavac et al., 
2008) the porosity of the membrane (𝜀𝜀) was determined,  
a b 
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𝜀𝜀 = 3𝐴𝐴𝑝𝑝𝑒𝑒𝑝𝑝𝑒𝑒
𝐴𝐴ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒
 =  3�𝑑𝑑𝑝𝑝2𝛾𝛾4 �3√32 𝐿𝐿2 =  𝛾𝛾2√3 �𝑑𝑑𝑝𝑝𝐿𝐿 �
2
 Equ. 17 
Where dp  is the pore diameter  L is the space between the pores 
a schematic explanation of the membrane porosity calculation is reported in Figure 13 a. 
 
 
Figure 13 Schematic representation of the hexagonal array of the pores on a disk membrane, 
L represents the distance between the pores (Dragosavac et al., 2008) (a) and 
microphotograph of a 30 µm pore size and 200 µm pore spacing membrane (b). 
The porosity measured for the membranes used in this work was between 0.2 and 12.8%. 
b 
a 
 
 
 
46 
 
 
3.1.2 General procedure  
The process of emulsification using the Micropore Technology Ltd. Dispersion Cell can be 
described reporting a general working procedure. A schematic illustration of the Dispersion 
Cell device is provided in Figure 14. The chamber at the bottom of Dispersion Cell base is 
initially filled with continuous phase and the remaining air is removed using a plastic syringe. 
The metallic membrane is then placed in the base (above the chamber) with the shiny side up, 
a PTFE o- ring is placed on the top of the membrane to ensure the sealing of the system after 
the positioning of the glass cylinder (the ring is resistant to the organic solvent as it does not 
swell). The glass cylinder is tighten at the base to avoid oil leakage. The required amount of 
continuous phase is gently poured into the glass cylinder, a maximum volume of 100 cm3 was 
used. Subsequently the two blades paddle stirrer is fixed on the glass cylinder right above the 
membrane surface. The stirrer is governed by a DC power supply INSTEK, model: PR3060 
which provides the shear at the membrane surface. The speed of the stirrer was tested from 1 
to 16 V providing velocities from 200 to 2600 rotations per minutes. The corresponding shear 
was calculated accordingly with the composition of the emulsion produced and reported in 
each section. The dispersed phase was injected by using a syringe pump (World Precision 
Instrument Inc., AL-1000, UK) which is connected to the base of the Dispersion Cell with a 
rubber tube and a T- junction to the tip of a glass syringe (containing the dispersed phase) and 
(on the other side) to the tip of a plastic syringe used to remove the air bubbles from the tube. 
The syringe pump provided a constant flow rate from 0.17 to 10 mL min-1 corresponding for 
the standard membrane to a flux between 12 to 702 L h-1m-2 and for the ringed membrane to a 
flux between of 54 to 3250 L h-1m-2. To produce the emulsion the desired amount of the 
dispersed phase is injected into the Cell while the stirrer provides desired shear stress. Once 
the emulsion is produced, the stirrer is removed from the top of the glass cylinder and the 
emulsion is simply recovered by pouring it into a beaker.  
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Figure 14 Schematic illustration of the Dispersion Cell device for Membrane emulsification. 
The Dispersion Cell was used to determine the optimal conditions for production of W/O 
emulsions using several formulations. The Dispersion Cell is particularly advantageous as a 
lab- scale device for the investigation of a specific formulation as it is portable, it requires 
low energy, and the amount of continuous phase used is quite low (maximum of 100 cm3). A 
summary of the principal formulations tested using the Dispersion Cell is reported in Table 3 
with the range of shear stress applied and the flux, membrane type and the membranes pore 
size and pore spacing is also reported.  
Table 3 Basic formulations of the emulsions produced with the Dispersion Cell and 
membrane types used. DP: dispersed phase, CP: continuous phase, DP flux: flux of 
the dispersed phase. 
Emulsion 
type 
DP CP Shear 
stress 
(Pa) 
DP flux 
(Lh-1m-2) 
Membrane 
type 
(coating 
material) 
Membrane 
pore size/ 
spacing 
(µm) 
W/O 15 wt.% PVA 2 wt.% 
PGPR in 
Miglyol 
2- 59 12- 1250 Nickel 
standard 
(PTFE)/ 
stainless 
steel ringed 
10/ 200 
W/O 15 wt.% 
PVA- 1 wt.% 
2 wt.% ABIL 
EM 90 in 
35 210- 270 Nickel 
standard 
10, 20/ 200 
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CS Miglyol (PTFE)/ 
stainless 
steel ringed 
W/O 5 wt.% PVA- 
1 wt.% CS 
2 wt.% ABIL 
EM 90 in 
Miglyol 
35 210- 351 Nickel 
standard 
(PTFE) 
20/ 200 
W/O 15 wt.% 
PVA- 3 wt.% 
CS 
2 wt.% ABIL 
EM 90 in 
Miglyol 
35 270 Nickel 
standard 
(PTFE) 
20/ 200 
W/O 3 wt.% CS 2 wt.% ABIL 
EM 90 in 
Miglyol 
35- 59 270- 434 Nickel 
standard 
(PTFE)/ 
stainless 
steel ringed 
10, 20/ 200 
W/O 5 wt.% 
gelatine- 2 
wt.% CS 
2 wt.% Span 
80 in 
kerosene 
1- 27 350 Nickel 
standard 
(PTFE or 
FAS) 
30/ 80, 200 
W/O 5 wt.% 
gelatine 
2 wt.% Span 
80 in 
kerosene 
7- 17 70- 350 Nickel 
standard 
(PTFE or 
FAS) 
30/ 200 
W/O 2 wt.% 
alginate 
2 wt.% Span 
80 in 
kerosene 
1- 17 350 Nickel 
standard 
(PTFE) 
30/ 200 
W/O 5- 30 wt.% 
fish gelatine 
2 wt.% ABIL 
EM 90 in 
Miglyol 
22 350 Nickel 
standard 
(PTFE or 
FAS) 
30/ 200 
 
3.1.3 Flat disk membrane cleaning  
After the production of the emulsion the glass cylinder is unscrewed from the base and the 
membrane is collected for the washing. For the hydrophobic (coated) membranes the 
prolonged washing in water, long time of sonication and the use of strong acid and base can 
damage or remove the hydrophobic coating. The PTFE coating is thermally bonded and it is 
less resistant comparing to the FAS coating which is chemically bonded. The PTFE or FAS 
membrane was washed initially with running water and washing up liquid for few seconds to 
remove the excess of oil and polymeric phase, subsequently it was placed in a beaker and 
submerged with warm soapy water. The membrane was then sonicated for maximum 30 
seconds and dried using the compressed air. To preserve the hydrophobicity the membranes 
were soaked in pure oil phase without any surfactant. The stainless steel membrane was not 
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coated, hence it was washed by sonication in warm soapy water for 1 minute and 
subsequently rinsed with pure water. Afterwards the membrane is placed in a beaker and a 
solution of 2 wt.% citric acid (Fisher Scientific, UK) was added. The membrane in citric acid 
is sonicated for 1 minute and rinsed in deionized water. After the drying the membrane was 
left in pure oil phase. 
3.2 EMULSIONS CHARACTERIZATION  
3.2.1 Droplet size analysis and uniformity determination  
The sizes of freshly prepared aqueous droplets in the oil phase, as well as solid particles were 
determined using a Leitz Ergolux optical microscope with an attached Pulnix TM-6CN 
monochrome camera, or an optical/ fluorescent microscope (GXML3201, GX microscope) 
with an attached Retiga 6000 colour camera. The scale was changed accordingly with the 
appropriate ratio pixels/ µm determined for each magnification lens depending on the 
microscope type. The droplets sometimes burst when placed on a microscopic slide due to 
surface tension effects, so photographs of the droplets had to be taken very quickly. For each 
experiment, numerous photos were taken and at least 300 droplets, or particles, were 
measured. The measurement of the drop size was done using the Java-based image 
processing package ImageJ available for the online download, or using the modified Matlab 
script “imfindcircles” available on line (more detailed description is reported in the 
Appendix D.2). The conversion pixels into µm was done using measuring a microscope 
graticule slide and the software Microsoft paint®. The droplet size was reported as Dav, mean 
average droplet diameter using the following formula:  
∑
=
=
n
i
ii
av N
dnD
1
 Equ. 18 
 
Where di is the ith diameter of the droplet,  
ni is the number of drops in the size range, 
N is the total number of the droplets counted.  
The uniformity of the emulsion is reported as a value of Coefficient of Variation % (CV%) 
calculated as follows:  
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Equ. 19 
3.2.2 Physical properties of dispersed and continuous phase 
The densities of both continuous and dispersed phases were measured using a specific glass 
density bottle (Pycnometer). The dispersed and continuous phase viscosities were measured 
using a Rheometer AR100-N (TA instrument, USA), with a cone- plate configuration. The 
cone geometries used were: a 4 cm in diameter, 1.59° geometry with a truncation of 56 µm 
for the more viscous solutions or a. 6 cm in diameter, 0.59º geometry with a truncation of 27 
µm for less viscous solutions. For the formulations containing the porcine skin gelatine (in 
order not to solidify) the viscosity measurements were performed at 40 °C (temperature 
during the emulsification process) while for all the other formulations the measurements were 
done at 20 °C. Most of liquids reported in Table 4 showed a Newtonian behaviour, the only 
exceptions were the phases composed by 3 wt.% CS, 15 wt.% PVA+ 1 wt.% CS and 15 wt.% 
PVA+ 3 wt.% CS. For these phases a slight reduction of the viscosity with the increase of the 
shear rate was measured, the values of (maximum) shear rate at which the measurements 
were taken are reported at the bottom of the table. The equilibrium interfacial tensions of the 
W/O emulsions were measured using the Du Nouy ring method (Lunkenheimer and Wantke, 
1981) using White Electric Instrument Tensiometer (model DB2KS). Further information for 
the use of the Tensiometer are reported in the Appendix A. All the physical measurements 
performed on the continuous and dispersed phase used are shown in Table 4. 
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Table 4 Densities, viscosities and interfacial tensions measured for the main formulations 
used in this work. PVA: Poly (Vinyl alcohol), CS: chitosan, PG: porcine skin 
gelatine, FG: fish gelatine.  
Continuous phase  Dispersed phase  Equilibrium 
interfacial 
tension      
(mN m-1) 
 Viscosity 
(mPa s)  
Density 
(Kg m-3) 
 Viscosity 
(mPa s) 
Density   
(Kg m-3) 
 
 
Miglyol  
 
8.1±0.1 
 
910.5±0.1 
PVA 
15 wt.%  
 
99.2±1.7 
 
 
1034.2±2.1 
 
6.6±0.1 
2 wt.% 
PGPR in 
Miglyol 
 
 
11.3± 2.2  15 wt.% 
15 wt.% 
PVA+    1 
wt.% CS 
99.2±1.7 
496.1(**) 
1034.2±2.1 
1045.2±0.1 
2.2±0.1 
3.1±0.2 
2 wt.% 
Span 80 
in 
Miglyol 
  15 wt.% 99.2±1.7 1034.2±2.1 1.6±0.2 
 
2 wt.% 
ABIL 
EM 90 in 
Miglyol 
8.4±1.2  10 wt.%  
15 wt.%  
20 wt.%  
25 wt.%  
 
Chitosan 
1 wt.% 
CS 
2 wt.% 
CS 
3 wt.% 
CS 
23.7±0.4 
99.2±1.7 
587.8±13.9 
2548.7±50.0 
 
 
36.8±2.5 
          
33.1±2.3 
              
61.4(*) 
1022.1±0.5 
1034.2±2.1 
1045.3±0.6 
1057.2±0.5 
 
 
1008.4±0.5 
     
1014.6±0.5 
     
1022.1±0.4 
1.6±0.1 
2.1±0.2 
2.7±0.1 
3.5±0.4 
 
 
1.7±0.3 
             
2.2±0.3 
            
3.1±0.3 
  15 wt.% 
PVA+    1 
wt.% CS 
496.1(**) 1045.2±0.1 2.6±0.3 
  5 wt.% 
PVA+    1 
wt.% CS 
217.0±5.3 1015.5±0.1 2.0±0.1 
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  15 wt.% 
PVA+ 3 
wt.% CS 
15,100.0(***) 1063.4±2.3 N/A 
      
  Gelatine 
20 wt.% 
FG 
59.6±0.79 1024.3±0.5 2.6±0.1 
2 wt.% 
Span 80 
in 
kerosene 
1.9±0.1 808.3±1.0 5 wt.%  
PG +       
2 wt.% 
CS  
5 wt.% 
PG 
46.3±2.1 
 
 
 4.5±0.1 
1026.6±1.2 
 
 
1010.82±0.6 
3.8±0.2 
 
 
3.1±0.1 
(*) Shear rate= 1,300 s-1 
(**) Shear rate= 200 s-1 
(***) Shear rate= 2.6 s-1 
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3.2.3 Contact angle measurements  
Contact angle measurements were done using pure deionized water or a solution of 15 wt.% 
of PVA on the surface of a nickel standard membrane made hydrophobic by a pre- treatment 
using PTFE (poly(tetrafluoroethylene)), and untreated stainless steel membrane. The 
measurements and photos were obtained using a Drop Shape Analyzer, DSA 100, Krüss, 
Germany. The results are reported in Table 5, and images of the drop sitting on the 
membrane surface are shown in Figure 15.  
Table 5 Contact angle measurements (dispersed phase on the membrane surface) 
Membrane Dispersed phase Theta(average) (deg) 
Hydrophobic nickel Pure water 122.2 ± 0.1 
Hydrophobic nickel 15 wt.% PVA 102.7 ± 0.1 
Stainless steel Pure water 60.1 ± 0.7 
Stainless steel 15 wt.% PVA 40.8 ± 0.4 
 
 
Figure 15 15 wt.% PVA drop on (a) the hydrophobic surface of the nickel membrane and (b) 
surface of the stainless steel membrane  
3.3 PARTICLES PRODUCTION 
3.3.1 Formulations and experimental procedure  
3.3.1.1 Poly (vinyl) alcohol emulsion in Miglyol  
Poly (Vinyl Alcohol) (PVA) droplets were obtained using the Dispersion Cell system. The 
continuous (oil) phase was obtained by mixing Miglyol® 840, propyleneglycol 
a b 
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dicaprylate/dicaprate (SASOL, Germany) with an oil soluble surfactant. According to the 
manufacture’s description (‘Miglyol® produc brochure’, 2016), Miglyol is suitable for 
pharmaceutical preparations (oral, parenteral, topical and rectal formulations) as carrier and 
solvent. Three emulsifiers were tested: 2 wt.% PGPR, polyglycerol polyricinoleate, 
(ABITEC, USA), 2 wt.% ABIL EM 90, modified polyether-polysiloxane (EVONIC 
industrials, Germany), and 2 wt% Span 80, sorbitan monooleate (Sigma Aldrich, UK). The 
dissolution of ABIL EM 90 and Span 80 in Miglyol was obtained mixing the solutions at 
room temperature using a magnetic stirrer and clear solutions were produced. For the 
preparation of the 2 wt.% PGPR in Miglyol phase heating to 50°C (Surh et al., 2007) of the 
oil was required to dissolve the emulsifier. The water phase in the W/O emulsions contained 
pure PVA in water (MW 13.000-23.000 g mol-1, degree of hydrolysis 87-88% Sigma Aldrich, 
UK) in different concentrations, PVA solution was prepared by dissolving the predetermined 
amounts of PVA in warm water containing HCl (Fisher Scientific, UK) (required for the 
PVA crosslinking reaction) in a final concentration of 0.1 M (unless differently specified). 
PVA was dissolved by heating up the solution up to a temperature of 70- 80 °C and stirred for 
at least 2h. Prior to the use the PVA solution was cooled to room temperature. The prepared 
PVA solution can be stored in a sealed bottle for a maximum of 1 week. Where appropriate, 
the inner polymer phase contained 3000 ppm of Blue Dextran (BD) (MW= 2,000 kDa) or 
with 20000 ppm of CuSO4×5H2O (MW= 249.685 g mol-1) corresponding to 5000 ppm of 
Cu2+ (both supplied by Fisher Scientific, UK). The BD or copper sulphate was directly added 
to the PVA solution and the solutions were gently mixed in order to complete the dissolution 
of the compounds. 
3.3.1.1.1 PVA microparticles solidification 
To crosslink PVA microparticles glutaraldehyde (GA) was used. Solution of 50 wt.% GA in 
water was used (Sigma Aldrich, UK) and was diluted to reach the appropriate concentrations. 
Production of the PVA particles was performed following a “two-step” procedure. A primary 
W/O emulsion was produced using the Dispersion Cell with nickel or stainless steel 
membrane both with 10 µm pore diameter and 200 µm pore spacing. Previous work by Pan 
et. al 2012 (Pan et al., 2012) showed that the contact angle of the hydrophilic membrane can 
be changed so the membranes were pre-soaked in Miglyol (pure continuous phase) for at 
least 30 min to increase the hydrophobicity of the membrane surface. The initial volume of 
continuous oil phase in the cell was 100 cm3 and the experiments were run until the dispersed 
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phase concentration reached 10 vol.%. Once the desired amount of polymeric phase had 
passed through the membrane, both the pump and the agitator were switched off, the droplets 
were collected and analysed. In a second step a secondary emulsion was prepared in a 
separate beaker using a homogenizer (IKA® T 10 ULTRA-TURRAX®, Germany) operating 
at 30.000 RPM for 3 min (giving the droplet sized between 5- 20 μm). The secondary 
emulsion was made of the GA diluted in water up to the required concentration and the same 
continuous phase of the primary emulsion. The volume ratio of GA solution and continuous 
phase in the secondary emulsion was 1:1. The volume ratio GA: polymer (PVA) was 1:1. The 
secondary emulsion was gently poured into the primary emulsion under continuous stirring 
using a magnetic stirrer. The reaction time for all samples was 90 min at room temperature. 
By homogenizing the crosslinker with the continuous phase at very high shear it was possible 
to obtain very small droplets of GA. In this way the surface area of GA droplets was 
increased promoting the GA diffusion through the continuous phase consequently reacting 
with the aqueous polymeric droplets. Using this method it was possible to avoid the 
“extraction step” reported by other authors (Thanoo, 1993; Wang et al., 2005) which consists 
of the extraction of GA into organic solvents to make it miscible with the oil phase of the 
primary emulsion. After the solidification, the stirring was stopped and particles were left to 
settle at the bottom of the beaker for few minutes; the oil was gently removed and the 
remaining solid particles were washed in toluene which dissolved the remaining oil. The 
toluene was left to evaporate and the particles were collected, freeze dried (AdVantage 2.0 
BenchTop Freeze Dryer) and stored in air tight containers until further analysis. A summary 
of the “two-step” procedure for the production of the solid particles is shown in Figure 16. 
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Figure 16 Scheme of the “two- step” PVA microparticles production: (a) the first step - 
production of the primary emulsion using the Dispersion Cell (DC), (b) the second 
step – production of solid microparticles using secondary emulsion which 
contained the crosslinker. 
3.3.1.1.2 Swelling of PVA microparticles  
The swelling study was performed on the PVA particles crosslinked with different 
concentrations of GA (1-50 vol.%). 0.35 g of PVA particles were placed in 20 ml of release 
media made of phosphate buffer saline solution (pH= 7.3) (Sigma Aldrich, UK). The 
prepared samples were placed in a shaking water bath at 37°C. The microparticles were left 
to swell for 24h (no further change in particle size was observed after this time) the excess of 
water was removed and the diameter of swollen particles was measured. For the 
determination of the Dav of the dried microparticles, a microparticles sample was initially 
washed with acetone and dried at room temperature; afterwards the sample was freeze- dried 
to ensure that no water remained inside the particles. 
(a) 
(b) 
Produced with the DC Produced with the homogenizer 
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3.3.1.1.3 In vitro release  
For the in vitro release microparticles were produced using the polymeric solutions 
containing BD or Cu2+. For the release of BD 1 g of the loaded microparticles was added to 
10 mL of a PBS solution (pH= 7.4), unless differently specified the release medium 
contained a small amount of 2 wt.% SDS (sodium dodecyl sulphate) added to the suspension 
to avoid the particle agglomeration. The samples were placed into a shaking bath at 37°C and 
the release was checked at regular time intervals up to 24h. Presence of BD in the release 
medium was detected using the UV-Vis spectrophotometer (Lambda 35 Perkin Elmer, UK) 
performing a scan of the wavelengths from 200 to 700. Peak of absorbance for the BD was at 
620 nm. Calibrations of the UV- Vis spectrophotometer for BD are reported in Appendix B. 
Presence of residual GA was also checked at 280 and 235 nm (Gillett and Gull, 1972). For 
the release of Cu2+ 0.35g of the loaded microparticles was placed in 20 ml buffer solutions 
with pH values of 3 or 7. The buffer solutions were made of acidified water (using HCl 
(Fisher Scientific, UK)) or pure deionized water in order to minimize the interference of other 
ions during the Cu2+ detection. At predetermined time intervals 5 ml of the release media was 
removed and replaced with 5 ml of fresh media to maintain the volume or the release media. 
The amount of Cu2+ released was assayed using an Atomic Absorption Spectrophotometer 
(AAS) (Spectra AA-200 Varian, UK operating at wavelength of 244.2 nm); The amount of 
Cu2+ was calculated from the corresponding calibration curve, made for each release media 
used (for further details please see Appendix C) Samples in triplicate were averaged for each 
experiment. The release profile of Cu2+ was reported as “Cumulative release percentage” 
which was calculated as follows: 
(%)100
1
1 ×
+
=
∑
−
=
m
CVCV
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n
i
noit
 Equ. 20 
where Vo is the volume of the release media (=0.02 L),  
Cn is the concentration of the compound determined at a specific time interval (mg L-1), 
Vt is the volume of the replaced media (= 0.005 L),  
Ci represents the concentration of the encapsulated compound in the previous sample 
(mg L-1), 
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m is the mass of the encapsulated compound in the sample (mg).  
3.3.1.2 Pure chitosan or PVA blended with chitosan emulsions in Miglyol  
For the preparation of pH sensitive formulations the chitosan polymer (CS) (MW 50.000-
190.000 g mol-1 Sigma Aldrich, UK) was used with or without the addition of PVA for the 
production of the water phase of the W/O emulsions. CS is slightly soluble in solutions of 
acetic acid with a pH below 6. The solubility of CS depends on the polymer charge: the 
acidic environment protonates the amino groups making the polymer water soluble, on the 
other hand, if the pH is increased the polymer loses the charge and becomes essentially 
hydrophobic (Pillai et al., 2009). CS was dissolved in warm (50- 60°C) 6 vol.% of 
CH3COOH. For the production of the polymeric blends, the solution of CS in the required 
concentration is mixed with the PVA solution prepared as described previously when 
producing pure PVA particles (chapter 5.3.1.1). Once the two polymers were dissolved 
separately, the solutions were mixed together according to the required polymer ratio and 
stirred constantly for at least 2h. In the blends final acid concentrations was 3 vol.% of 
CH3COOH (needed for CS) and 0.05 M of HCl (needed for the PVA crosslinking). Where 
appropriate the polymeric phase contained 13500 ppm CuCl2×2H2O (MW= 170.48 g mol-1 
supplied by Fisher Scientific, UK) as copper source. As  model drug (anionic) 3000 ppm of 
sodium salicylate (SS) (MW=160.11g mol-1 Sigma Aldrich, UK) were used. For the 
production of the W/O emulsions Miglyol was used as oil and 2 wt.% PGPR or 2 wt.% ABIL 
EM 90 were tested as emulsifiers. The membranes used for the production of the emulsions 
in this section were nickel or stainless steel membranes with 10 or 20 µm pore size and 200 
µm pore spacing. The 20 µm membrane was mainly used due to high viscosity of the 
dispersed phase. 
3.3.1.2.1 CS or PVA- CS microparticles solidification 
The solidification of the polymeric CS or PVA-CS drops of the primary emulsion was 
performed using the “two- step” procedure described Figure 16 the reaction time was 90 
minutes for all the samples and the reaction temperature for these formulations was raised to 
75 °C. Washing of CS or PVA- CS microparticles was done using isohexane; the obtained 
particles were subsequently freeze-dried and stored.  
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3.3.1.2.2 Swelling of CS or PVA- CS particles microparticles and in vitro release 
The release of Cu 2+ from the CS or PVA-CS particles was assayed following the same 
procedure described for the pure PVA microparticles (see section 5.3.1.1.2), while SS 
concentration in the sample was analysed using the UV- Vis spectrophotometer operating at 
wavelength of 300 nm. The instrument was previously calibrated for the sodium salicylate 
(SS) detection using standard solution at predetermined SS concentrations (calibrations for 
the UV- Vis spectrophotometer are reported in Appendix B). The release of SS with time and 
depending on the pH of the buffering solution is reported as “Cumulative release %” 
calculated using Equ. 20 (page 58).  
3.3.1.3 Pure gelatine (G) or gelatine-chitosan (G-CS) microparticles  
The continuous (oil) phase (O) of the W/O emulsion was mainly 2 wt.% Span 80 (Sigma 
Aldrich, UK) in low odour kerosene (Sigma Aldrich, UK). Also as a continuous phase 
Miglyol containing ABIL EM 90, PGPR or Span 80 was also tested. The dispersed (water) 
phase (W) was composed of pure gelatine (G) (porcine skin, gel strength 300, Type A (Sigma 
Aldrich, UK)) dissolved in deionized water or gelatine (G) was blended with chitosan (CS) 
(MW 50.000–190.000 g mol-1 Sigma Aldrich, UK). 30 µm standard nickel membranes with 
80 or 200 µm pore spacing were used for the emulsion produced. Chitosan and gelatine 
solutions were prepared separately and mixed together afterwards; CS was dissolved in warm 
(50-60ºC) 2 wt.% CH3COOH in water. Gelatine solution was prepared by dissolving gelatine 
in warm water (50-60ºC). For the preparation of the blend, the two polymeric solutions were 
mixed together in appropriate ratio and stirred for at least 2h, at 40ºC to avoid the gelatine 
solidification. For the production of the W/O emulsions the Dispersion Cell was placed in a 
water bath operating at 40°C to avoid the solidification of the gelatine presents in the 
formulations.  
3.3.1.3.1 Re-hydration and encapsulation of baker’s yeast cells (Saccharomyces 
Cerevisiae) 
Where appropriate, the dispersed phase contained Baker’s yeast cells (Saccharomyces 
cerevisiae) purchased from a local supermarket (sachets of “Fast Action Dried Bread Yeast”, 
Sainsbury, UK). The yeast cells were selected for the encapsulation due to its reported 
probiotic activity (Graff, Chaumeil, et al., 2008), furthermore it is easy to track the cell 
viability by checking glucose metabolism with time. The median size of the yeast cells was 4 
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µm, determined using ImageJ. An initial yeast suspension was prepared by adding 3.5 g of 
the dried yeast powder to 200 mL of ultrapure water (Pure Milli-Q water) or a Ringer’s 
solution (Sigma Aldrich, UK). The suspension was stirred for at least 10 minutes and 
centrifuged at 1200 RPM for 3 minutes. The supernatant was discarded and the washing 
procedure was repeated 3 times in order to make sure that all the salts, emulsifiers and other 
additives presents in the sachet are removed. The final volume of water removed was 175 
mL. Considering the yeast cell as having a spherical shape with an average diameter of 4 µm 
and a dry mass density of 1.33 g mL-1, the calculated maximum concentration of yeast in the 
suspension was 3.14 x 109 cells mL-1. The initial cell suspension was subsequently diluted for 
use by factors of 10 and 100, giving cell concentrations of 3.14 x 107 and 3.14 x 108 cells mL-
1. A manual cell counting using a hemocytometer was also performed to check the cell 
density. For the stock suspension higher value than 3.18 x 109 cells mL-1 was measured, thus 
the lower cell density calculated from the initial weighed yeast was considered more reliable 
for cell density characterization. It is worth of pointing out that the yeast cell density used is 
in accordance, or higher than, the generally accepted required dose of probiotics having 
health benefits (106- 107 cells mL-1 (Burgain et al., 2011)).  
3.3.1.3.2 Solidification of gelatine microparticles containing baker’s yeast cells 
(Saccharomyces cerevisiae) 
To obtain solid microparticles, the liquid drops in emulsion were solidified using either a 
thermal gelation (placing the emulsion in ice), or ionic crosslinking using Sodium 
hexamethaphosphate SHMP (Fisher Scientific, UK). Sodium sulphate and Sodium 
tripolyphosphate (purchased from Sigma Aldrich, UK) were also evaluated as ionic 
crosslinkers. For the dispersed phase composed by the blend of G:CS in a ratio of 5:2 (G:CS 
(5:2)) the emulsion was initially cooled with ice for 30 minutes to set the gelatine, 
subsequently 10 mL of a 10 wt.% SHMP solution was gently dripped into the emulsion to 
crosslink the chitosan. The reaction occurred under continuous stirring for 3h. When pure 
gelatine (5 wt.%) was used as dispersed phase, solidification was obtained by thermal 
gelation: the beaker containing the emulsion is placed in an ice bath, under continuous 
stirring for 4h to avoid the drops coagulation. In both cases the obtained solid particles were 
washed using 2 wt.% Tween 20 polyethylene glycol sorbitan monolaurate (Sigma Aldrich, 
UK) to remove any remaining kerosene phase.  
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3.3.1.3.3 Gastro resistant coating for gelatine microparticles  
Polymer Eudragit S100 (Evonik Industries, Germany) was used for the production of a 
gastro- resistant coating on the microparticles: Coating was performed on gelatine 
microparticles using the oil in oil (O1/O2) solvent evaporation method previously described 
by L. Zhang et al (2011) (the method of the solvent evaporation was also evaluated). The 
polymeric coating solution (O1) was prepared using 2 wt.% Eudragit S100 dissolved in a 
solution of ethanol:acetone (Fisher Scientific, UK) at a volume ratio of 4:1. To prevent 
microparticles aggregation during the subsequent coating process, 20 mg of zinc stearate 
(Sigma Aldrich, UK) was added to the organic phase which acted as an anti-sticking agent. 
The zinc stearate was not completely soluble in the coating solution therefore; to minimize 
the zinc stearate particle diameter the coating mixture was homogenized using a homogenizer 
(IKA® T 10 ULTRA- TURRAX®, Germany) at maximum speed (30,000 RPM) for 3 min.  
3 mL of gelatine microparticles suspension was added to 10 mL to the coating solution (O1) 
and stirred for 2 minutes providing a uniform dispersion of the particles. Coating solution 
(O1) containing the microparticles was gently poured in to 50 mL of 2 wt.% Span 80 in 
Paraffin oil (Sigma Aldrich, UK) (O2). The O1/O2 emulsion was stirred using the Dispersion 
Cell impeller at 5V (corresponding to 800 RPM) for 4h. The process of solvent evaporation 
was checked every hour; samples of the O1/O2 emulsion were withdrawn and examined under 
the optical microscope. Reduction of the O1 droplet size was observed until complete solvent 
evaporation and Eudragit polymer deposition on the gelatine microparticles occurred. The 
coated microparticles were washed using isohexane and dried at room temperature overnight.  
3.3.1.3.4 Gelatine microparticles loaded with yeast - in vitro dissolution study 
Simulation of the gastrointestinal transit conditions was obtained varying the pH of the 
dissolution medium over time: the acidic stomach fluid was reproduced using a pH 1.2 for 
2h, afterwards a pH 7 (or pH 8) medium was used to mimic the intestinal-colon area for a 
maximum period of time of 3h (or up to complete particle dissolution) (Paharia et al., 2007). 
The dissolution medium was prepared from a phosphate buffer saline (PBS, Sigma Aldrich, 
UK) solution (pH 7), adjusting the pH with HCl, or NaOH (Sigma Aldrich, UK). An initial 
amount of 15 mg of dried particles was added to 1 mL of dissolution medium at pH 1.2 and 
shaken in an orbital incubator (Sartorius Certomat BS-1, Sartorius AG, Germany) at 37ºC for 
2h. After 2h in an acidic environment, the microparticles were observed under the 
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microscope and subsequently collected from the acidic buffer and re-suspended in 1 mL of 
pH 7 buffer for maximum 3h with shaking. Again the microparticles were recovered, 
observed and re-suspended in pH 8 buffer in order to mimic the environmental conditions 
during the passage from the intestine to the colon (tests in- vitro). Microphotographs of the 
microparticles were taken at regular time intervals, until the dissolution of the particles and 
complete cell release.  
3.3.1.3.5 Viability of the yeast cells released from gelatine microparticles  
The viability of the released cells released from the microparticles was tested using two 
methods: 1. Consumption of D(+) glucose D(+)-Glucose anhydrous, (Fisher Scientific, UK) 
by yeast cells was determined with time 
2. Fluorescent probes LIVE/DEAD® Viability/Cytotoxicity Kit, for mammalian cells, 
Molecular Probes, Invitrogen (California, US).  
Once released from the microparticles, the yeast cells were centrifuged using an Eppendorf 
centrifuge at 1000 RPM for 2 minutes and re-suspended in a 1 mL of a 6 mM Glucose 
solution. The glucose solution with the yeast cells was subsequently placed in an orbital 
incubator at 37ºC and rotation speed of 150 RPM. At predetermined time intervals the cell 
suspension was centrifuged and 50 µl of the glucose solution was withdrawn and glucose 
concentration was determined using a glucose analyser (model G5, Analox Instruments Ltd., 
UK). The glucose consumed with time was calculated as % of the initial glucose present in 
the solution according to the following equation:  
 
Equ.21 
Where 𝐺𝐺𝐺𝐺𝐺𝐺𝑖𝑖 is the concentration of the initial glucose solution (6 mM), 
𝐺𝐺𝐺𝐺𝐺𝐺𝑒𝑒 is the amount of glucose measured in the sample at different time intervals 
Fluorescent probes were also used to determine the fraction of live/dead cells. Component A 
of the LIVE/DEAD ® Viability/Cytotoxicity Kit (Calcein AM) is retained in living cells 
giving a bright green fluorescence if excited using a fluorescein optical filter (485 ± 10 nm). 
In dead cells component B (Ethidium homodimer-1) enters the cells with a damaged 
membrane and binds to the nucleic acid giving a bright red fluorescence when excited under 
% 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝑅𝑅 𝐺𝐺𝐺𝐺𝑛𝑛𝐺𝐺𝐺𝐺𝑚𝑚𝑅𝑅𝑑𝑑 = (𝐺𝐺𝐺𝐺𝐺𝐺𝑖𝑖 −  𝐺𝐺𝐺𝐺𝐺𝐺𝑒𝑒) ∗ 100
𝐺𝐺𝐺𝐺𝐺𝐺𝑖𝑖
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a typical rhodamine optical filter (530 ± 12.5 nm). The samples were prepared by addition of 
the two probes to the yeast suspension and incubation at 37ºC for 40 minutes, prior to the 
observation with the epifluorescence microscope Nikon Ti Eclipse.  
3.3.1.4 Alginate microparticles  
Alginate (Sodium Alginate, MW= 216.121 g mol-1, Sigma Aldrich UK) drops were obtained 
using the Dispersion Cell system with a nickel hydrophobic membrane having 30 µm pore 
size and 200 µm pore spacing. The continuous phase (O) of the W/O emulsion was made of 2 
wt.% Span 80 in kerosene. The Alginate polymer was dissolved in warm (60- 70 °C) 
deionized water under vigorous stirring for a maximum of 2h. Where appropriate, the 
dispersed phase contained Baker’s yeast cells (Saccharomyces cerevisiae) rehydrated 
following the procedure described in section. 5.3.1.3.1. The predetermined amount of yeast 
cell dispersion was added to the alginate solution and the polymeric phase was agitated up to 
the formation of a homogenous phase. The amount of cells encapsulated was between 3x 107 
and 1.88x 108 cells mL-1 calculated according to the procedure described in section 5.3.1.3.1. 
The dispersed phase was injected using the Dispersion Cell and the final concentration of the 
dispersed phase in the emulsion was 10%. Once produced the emulsion was subsequently 
transferred in a beaker and stirred.  
3.3.1.4.1 Solidification of alginate microparticles (crosslinking procedure) 
Two positively charged ionic crosslinkers were tested for the solidification of the alginate 
drops with or without cell: MgSO4, magnesium sulphate (Sigma Aldrich, UK) or CaCl2 
calcium chloride (Sigma Aldrich, UK). Different concentrations of both crosslinkers were 
used.  
Two ways of solidification were tired: crosslinker addition directly to W/O emulsion and 
addition of W/O emulsion to the saturated crosslinker solution. Unless differently specified, 
the crosslinker solution (water solution) was directly added to the emulsion under continuous 
stirring for a maximum of 24h. Once solid, microparticles were recovered by filtration using 
a vacuum pump and washed using a mixture of acetone: water in a volume ratio of 1:2. Once 
washed the microparticles were left to dry at room temperature. Dried microparticles were 
recovered and stored for further analysis.  
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In a second approach the alginate drop solidification is obtained pouring the W/O emulsion 
produced using the Dispersion Cell into a saturated solution of CaCl2 constantly agitated 
using a magnetic stirrer. The solidification reaction is stopped after 1h and the microparticles 
were collected and washed as reported above.  
3.3.1.4.2 Viability of the yeast cells released from alginate microparticles  
Survival of the yeast to the encapsulation process was assayed adding 10 mg of the alginate 
microparticles containing the yeast in 1 mL of a 6 mM glucose solution, the samples were 
placed in the orbital incubator at 37ºC with a set rotation speed of 150 RPM. At regular time 
intervals sampling of the glucose solution was done using a micropipette and 10 µl was 
analysed using the glucose analyser.  
3.4 PARTICLES CHARACTERISATION   
3.4.1 Scanning Electron Microscopy (SEM) analysis with Energy Dispersive X-ray 
Spectrometer (EDX) 
The solid produced microparticles and membranes structure were observed by Scanning 
Electron Microscopy using the Tabletop microscope TM3030, (Hitachi, Japan) operated at 15 
kV for pure imaging. The samples were previously prepared applying an ultra-thin layer of 
electrically- conducting material (Gold/Palladium- Au/Pd) by sputter coating. For the 
observation of the internal structure of the microparticles the samples were mounted in a resin 
and cut into slices using a Base Sledge Microtome (Leitz, Weitezer, UK). Microparticles 
elemental analysis was done using the SEM coupled with the Energy Dispersive X-ray 
Spectrometer (EDX) for multiple elemental analysis (i.e. point/area analysis, line scan and 
mapping). 
3.5 FORMULATION OPTIMIZATION FOR THE SCALE UP AND USE OF THE 
PULSED (OSCILLATORY) FLOW SYSTEM 
3.5.1 Disk membranes used in the Dispersion Cell (preliminary investigation) 
For the continuous production of W/O emulsions the performance of a PTFE and FAS coated 
membranes were preliminary investigated using the Dispersion Cell. Surfaces of both tested 
nickel membranes where transformed to hydrophobic by coating the surface either by 
thermally bonded PTFE or using a chemical reaction to apply the FAS coating. Membranes 
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used in the Dispersion Cell had 30 µm pore size and 200 µm pore spacing. The membrane 
performance was evaluated considering the production of several emulsions and the required 
soaking time. For these tests the continuous phase was composed by 2 wt.% Span 80 in 
kerosene and as dispersed phase was 5 wt.% gelatine containing yeast cells. The use of the 
gelatine required the heating therefore the equipment (Dispersion Cell) was placed in the 
water bath.  
Where appropriate pig gelatine was substituted with fish gelatine. Fish gelatine compared to 
the pig gelatine remains liquid at 11 to 28 °C (Karim and Bhat, 2009) allowing operation at 
room temperature. Where appropriate Miglyol oil (‘Miglyol® produc brochure’, 2016) was 
used as a replacement of kerosene (‘Kerosene safety data sheet’, 2016) as it is not toxic nor 
flammable.  
3.5.2 Tubular membranes used in the pulsed flow system with experimental procedure 
For the production of the W/O emulsions using the Pulsed system 20 wt.% of FG in water 
was used as dispersed phase. The continuous phase was made of 2 wt.% ABIL EM 90 in 
Miglyol. The interfacial tension measured for this system is shown in Table 4 (page 51). The 
system was run at room temperature. The membrane used was a tubular membrane which 
was previously FAS coated with 20 µm pore size and 80 µm pore spacing, photograph of the 
membrane used is reported in Figure 17 a. The membrane had a working length of 60 mm 
with an internal diameter of 14 mm. The dispersed phase was injected in the system using a 
syringe pump (World Precision Instrument Inc., AL-1000, UK) (red pump shown in Figure 
17) with a flow rate of between 5 to 30 mL min-1 corresponding to a transmembrane flux 
between 103 to 620 L h-1m-2. The continuous phase was injected within the system using a 
peristaltic pump (Watson-Marlow Sci-Q 300, UK) (green pump reported in Figure 17) that 
can be operated up to a maximum flow rate of 2000 mL min-1. Once the whole system was 
assembled (with the membranes placed in the membrane module) it was filled up with the 
continuous phase, the pulsation was activated and the system is run for at least 30 minutes 
without injecting the dispersed phase. At this stage the recirculation of the oil phase is done 
with the peristaltic pump set at the maximum rate. This procedure is required to remove all 
the air entrapped within the system which could cause the formation of foam and coalesce of 
the drops during the emulsification process. The pulsation is generated by the oscillation of a 
bellow, designed for the use in a diaphragm pump, which is filled with the continuous phase. 
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The bellow is placed in the metallic case as shown in Figure 17 g. The oscillation of the 
bellow was regulated by an accelerometer connected to a National Instrument Analogue to 
Digital converter (NI cDAQ-9174) interfaced with a software (LabView). From the software 
is possible to obtain information about the frequency and the amplitude of the oscillation, as 
reported in (Piacentini et al., 2013) the frequency is determined by the direction of the travel 
while the amplitude is determined from the acceleration data. An example of the LabView 
software interface during a running experiment is shown in Figure 18, from the “control” 
panel showed in Figure 18 a it is possible to select the required value of frequency (e.g. 20 
Hz) and the target value of peak to peak displacement expressed in mm. It is possible to set 
manually the voltage from the “voltage generator” window or by clicking on the button 
“Feedback on” the voltage is automatically adjusted to reach the target value of displacement 
set. From the widow showed in Figure 18 b the actual value of frequency and displacement 
detected are reported. Shape of the oscillation is reported from the software and it was in 
regular waveform (i.e. sine wave) (Holdich et al., 2012).  
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Figure 17 Photographs of the tubular membrane (a) the membrane module (b) and the 
assembled Pulsed (Oscillatory) device (c) together with the peristaltic pump for the 
circulation of the continuous phase (d) and the syringe pump for the injection of 
the dispersed phase (e), with (g) is pointed the metallic case where the bellow is 
placed, (f) is the beaker where the emulsion is collected.  
b 
c 
d 
e 
f 
a 
g 
 
 
 
68 
 
 
 
Figure 18 Interface of the LabView executive program with (a) the control panel and (b) the 
detected values of frequency and peak to peak displacement 
For the production of the W/O emulsions using the Pulsed system the frequency used were in 
a range between 10 to 30 Hz while the displacement ranged between 0.5 and 3.5 mm. The 
Pulsed system was previously used for the production of O/W emulsions (Holdich et al., 
2012; Piacentini et al., 2013) using sunflower oil as dispersed phase and 2 wt.% Tween 20 in 
water containing polymers as continuous phase.  
In this work the system was adjusted for the production of W/O emulsions; the high viscosity 
of the dispersed and continuous phase of the formulation tested in this set of experiments 
could cause the vibration of the membrane. Breaking of the membrane was experienced 
operating with high fluxes and high values of shear stress. The use of more resistant 
membranes might be considered as an option for the optimization of the Pulsed (Oscillatory) 
Flow system for the production of highly concentrated and uniform W/O emulsions. 
a 
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3.5.3 Tubular membrane cleaning procedure 
After the production of the required amount of emulsion the pulsed system is dismantled and 
the membrane module is opened, the membrane was removed from the membrane module 
and the excess of oil and water phase is initially wiped away. The membrane is subsequently 
rinsed with tap water and washing up liquid, then is placed in a glass cylinder and warm 
soapy water is added up to complete submersion of the membrane. Washing is done using a 
sonicating bath for a maximum of 3 minutes, the membrane is then dried using the 
compressed air and it is left in the oil phase to increase the hydrophobicity.  
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4. RESULTS 
4.1 PVA MICROPARTICLES FOR DRUG DELIVERY 
4.1.1 W/O emulsion production  
4.1.1.1 Influence of the emulsifier type  
Droplets stability in W/O emulsions is not greatly affected by the hydrophobic membrane 
used to produce the emulsion, but it is by the type of the emulsifier used to stabilise the 
droplets within the emulsion. To investigate the influence of the oil soluble emulsifier on the 
drop size and stability the Dispersion Cell was used. The dispersed phase (W) was pure PVA 
(15 wt.%) dissolved in water containing 0.1 M HCl. Oil used for preparation of the 
continuous phase (O) was Miglyol and the emulsifier was changed in order to achieve the 
stability of the emulsion and avoid phenomena of coalescence and/ or breaking of the drops. 
The dispersed phase flux used in tests was 113 L h-1m-2, while the applied shear stress was 35 
Pa. Three oil soluble (non- ionic) emulsifiers were tested: Span 80, ABIL EM 90 and PGPR 
all in a concentration of 2 wt.%. This surfactant concentration was selected as it gave stable 
emulsions, in accordance with data reported in literature (Kukizaki, 2009). Once the 
emulsions were produced, samples were taken and observed under the microscope. 
Microphotographs were taken and analysed to determine the average droplet size (Dav) and 
the coefficient of variation (CV%). From Figure 19 it is possible to see that using Span 80 
the size of the drops produced is on average 86 µm, while for drops stabilised using ABIL 
EM 90 and PGPR have a similar average diameter of 30 µm. Furthermore, Span 80 produced 
emulsions with a high CV% (30 %) while the lowest CV% (18%) was obtained using PGPR 
as emulsifier in the continuous phase. Using the emulsifier ABIL EM 90 a CV% of 23% was 
obtained. Hence, Span 80 produced emulsions with larger and less uniform drops. This effect 
is confirmed by observation the microphotographs reported in Figure 20. Figure 20 a shows 
the emulsion prepared using as emulsifier 2 wt.% Span 80 characterized by a turbid 
background and big polymeric drops. Figure 20 b and c are respectively the emulsions 
obtained using ABIL EM 90 and PGPR as emulsifier, which displayed a similar Dav and 
CV%. Slightly less uniform emulsions were produced using ABIL EM 90 compared to the 
ones produced using PGPR; but in both cases the emulsions were stable and no coalescence 
was observed. In Table 4 (page 51) are reported the values of interfacial tensions measured 
for the different system tested. Compared to pure Miglyol all the tested emulsifiers were able 
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to reduce the interfacial tension, in some cases a drastic reduction of the interfacial tension 
could produce a flow of the dispersed phase through the membrane pores; without forming 
the drops at the membrane surface (Kim et al., 2014). The use of Span 80 reduced the 
interfacial tension from 6.6 mN m-1 (for the system composed by pure Miglyol and 15 wt.% 
PVA) down to 1.6 mN m-1 which could be too low for the right formation of the drops in this 
system. PGPR produced a slight higher interfacial tension if compared to the ABIL EM 90, 
as a consequence the resulting emulsions were more stable and more uniform. The molecule 
of Span 80 (Mw= 428.61 g mol-1) is slightly smaller than the ABIL EM 90 (Mw= 522.89 g 
mol-1) and PGPR (Mw= 520.704 g mol-1), hence the Span 80 molecules diffuse faster to the 
interface producing a higher reduction of the interfacial tension.  
Additionally, in (Taylor, 2011) it is reported cohesive forces at the interface are much 
stronger between the PGPR molecules than Span 80 molecules. Although both the 
emulsifiers have good surface properties, the extended structure of the ricinoleate chain (of 
PGPR) and the orientation of the molecules might produce a stronger interface than the oleate 
chain (of Span 80).  
 
Figure 19 Influence of the emulsifier type on average droplet diameter and droplet size 
distribution. Dispersed phase composition: 15 wt.% PVA in water, dispersed phase 
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flux= 113 l h-1m-2, shear stress applied= 35 Pa. Error bars represent the standard 
deviation of the measurements. 
 
 
Figure 20 Microphotographs of emulsions produced using different surfactants in continuous 
phase (a) 2 wt.% Span 80 in Miglyol, (b) 2 wt.% ABIL EM 90 in Miglyol, (c) 2 
wt.% PGPR in Miglyol. Dispersed phase 15 wt.% PVA in water.  
Based on these observations, PGPR and ABIL EM 90 were selected as more appropriate for 
the stabilization of the PVA drops into Miglyol.  
4.1.1.2 Effect of process operating parameters 
4.1.1.2.1 Influence of the shear stress and dispersed phase flux on droplet size and 
size distribution 
Using a standard nickel membrane with pore size 10 µm and pore spacing 200 µm, W/O 
emulsions were produced. The composition of the dispersed phase was 15 wt.% PVA in 
water containing 0.1 M HCl, the continuous phase was made of 2 wt.% PGPR in Miglyol. 
The dispersed phase flux was increased from 12 to 270 L h-1m-2, while the shear stress was 
a b 
c 
 
 
 
73 
 
 
varied from 22 to 59 Pa. Figure 21 reports the average droplet size as a function of the flux 
and shear stress; it can be seen that the increase of the dispersed phase flux produced on 
average an increase of the mean droplet size. For instance, at a constant shear of 22 Pa, a flux 
of 12 L h-1m-2 produced drops of 40 µm; increasing the flux to 112 and 270 L h-1m-2 droplet 
size 49 and 64 µm were produced respectively. This effect was already reported in previous 
work (Egidi et al., 2008; Dragosavac et al., 2008): assuming that the drop detachment time is 
constant, the increase of the dispersed phase flux produces an increase of the amount of 
dispersed phase flowing in the drop during the detaching stage generating larger drops. Same 
set of experiments was repeated applying a shear of 35, 43 and 59 Pa. It is interesting to 
notice that for 35 and 43 Pa the effect of the increase of the dispersed phase flux is still 
evident; while for the emulsions produced at higher shear (59 Pa) did not show a significant 
difference in size increasing the dispersed phase flux. The combination 59 Pa and 12 L h-1m-2 
gave droplet sized 36 µm; the increase of the flux to 112 L h-1m-2 produced droplet sized 38 
µm, while for the highest flux used (270 L h-1m-2) 43 µm drops were obtained. Reduction of 
the Dav is obtained increasing the shear stress applied; for instance, at constant value of 112 L 
h-1m-2 as dispersed phase flux; increasing the shear stress from 22 to 59 Pa produced a 
decrease of the Dav from 50 µm to 38 µm. Effect of the shear stress influence was more 
evident for the emulsions produced at 270 L h-1m-2 where the shear variation from 22 to 59 Pa 
gave a reduction from 64 to 44 µm of the average droplet size.  
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Figure 21 Variation of the mean droplet size (Dav) and coefficient of variation (CV%) 
depending on the dispersed phase flux and shear stress applied using a full nickel 
standard membrane with 10 µm pore size and 200 µm pore spacing (dispersed 
phase: 15 wt.% PVA in water + HCl 0.1 M , continuous phase: 2 wt.% PGPR in 
Miglyol). Error bars represent the standard deviation of the measurements.  
From Figure 21 it is possible to see that the less uniform emulsions were obtained at the 
lowest dispersed phase flux used, independently from the shear stress applied. The extreme 
case of very low dispersed phase flux and very high rotation speed (high shear stress) 
produced the emulsion with the lowest uniformity; corresponding to a CV% of 38%. A flux 
of 12 L h-1m-2 was considered insufficient for uniform emulsion production independently 
from the shear stress applied, while the use of a too high shear could produce a breaking up 
of the formed drops into smaller ones producing an increase of the CV% (Vladisavljević and 
Williams, 2005; Stillwell et al., 2007; M. Dragosavac et al., 2012).  
As a general rule for the formation of uniform drops in membrane emulsification a uniform 
shear field is required (Stillwell et al., 2007). For the Dispersion Cell system; the paddle- 
blade stirrer produces a varying radial shear field; which reaches its maximum value at the 
transitional radius (rtrans) where the vortex changes from free to forced (Kosvintsev et al., 
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2005; Stillwell et al., 2007). Hence, more uniform drops are generated by a narrow annular 
region on the disk membrane surface (Stillwell et al., 2007). To check this a ring membrane 
was used which had active pores only in the area of the maximal shear stress. Emulsions were 
produced keeping constant the composition of dispersed and continuous phase while varying 
the rotation speed of the paddle (hence the shear stress applied) and the dispersed phase flux. 
The stainless steel membrane was characterized by a mean pore diameter of 10 µm and 200 
µm as pores spacing. For this set of experiment the dispersed phase flux was gradually 
increased from 50 to 1250 L h-1m-2 and the shear was varied from 22 to 59 Pa. Figure 22 
shows the Dav and CV% measured for the produced emulsions, including (where applicable) 
the values of the standard deviation of the measurements as error bars. Increasing the 
transmembrane flux, larger drops were produced for all values of shear stress tested, and it 
was possible to produce droplet between 28 and 53 µm. It is interesting to notice that a little 
difference exists between the sizes of the resulting drops produced setting the shear at 22 or 
35 Pa. For the highest value of shear applied (59 Pa) the increase of the drop size depending 
on the transmembrane flux was less pronounced. As comparison, a similar trend is reported in 
previous paper (M. Dragosavac et al., 2012) for the production of W/O emulsions using a 
membrane with 20 µm as pore diameter and 200 µm pores spacing. The increase of the flux 
up to 3200 L h-1m-2 produced a small change in the drop size for high rotation speed of the 
paddle- blade stirrer. As expected the increasing shear stress produced smaller drops, for 
example at a constant transmembrane flux of 1250 L h-1m-2 53 µm drops were generated 
applying a shear of 22 Pa, this value gradually decreased to 39 µm applying a shear of 59 Pa. 
Figure 22 shows that uniform droplets were obtained for almost all the fluxes and shear 
stress applied, with CV% lower than 30%. As previously observed, the use of very high shear 
such as 59 Pa produced in some cases a CV% of 27- 35%; as breaking up of the drops is 
likely to occur (Vladisavljević and Williams, 2005; M. Dragosavac et al., 2012). When 
comparing Figure 21 and Figure 22 it can be seen that the use of the ring membrane reduced 
the CV% which can be contributed to the formation of the drops only in the region of the 
maximal shear.  
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Figure 22 Variation of the mean droplet size (Dav) and coefficient of variation (CV%) 
depending on the dispersed phase flux and shear applied using stainless steel 
ringed membrane with 10 µm pore size and 200 µm pore spacing (dispersed phase: 
15 wt.% PVA in water + HCl 0.1 M, continuous phase: 2 wt.% PGPR in Miglyol). 
Error bars represent the standard deviation of the measurements. 
4.1.1.2.2 Effect of the membrane type: comparison between nickel and stainless 
steel membrane 
Influence of the membrane type on emulsion droplet size and uniformity was investigated 
comparing the nickel membrane with the stainless steel membrane; both membranes had 10 
µm pore size and 200 µm pore diameter. Figure 23 reports the comparison of the results 
obtained using the nickel membrane and stainless steel membrane. Average droplet size and 
size distribution are reported as a function of the shear and flux. Dispersed phase used was 15 
wt.% PVA in water; the continuous phase was composed by 2 wt.% PGPR in Miglyol. Using 
a dispersed phase injection rate between 10 to 230 mL h-1, the transmembrane flux obtained 
for the nickel membrane was between 12 to 270 L h-1m-2. Applying a shear stress from 22 to 
59 Pa droplet sized between 36 to 64 µm were obtained. With the stainless steel membrane 
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the dispersed phase injection rate applied was between 10 to 50 mL h-1 producing a flux 
through the membrane between 54 to 270 L h-1m-2. At comparable values of shear stress (22- 
59 Pa) and dispersed phase flux generated using the nickel membrane, a slight reduction of 
the droplet size was observed for the stainless steel membrane; the mean droplet diameter 
was between 28 to 40 µm. Difference of the average droplet size and size uniformity between 
the two membrane tested could also be a consequence of the difference in the hydrophobicity 
of the membranes surface. The surface of the nickel metal membrane is hydrophobised by a 
thermally bonded PTFE coating on the metal surface (Morelli et al., 2017), while no further 
surface modification were made on the stainless steel membrane. Measurement of contact 
angles were made for water and 15 wt.% PVA on hydrophobic nickel and stainless steel 
membranes and the results are reported in Table 5, page 53. In addition the photographs of 
the droplets sitting on different membrane surfaces are reported within Figure 15, page 53. 
According to the contact angle measurements the PVA droplet wets the stainless steel 
membrane far more than the nickel membrane (Figure 15 a and b) giving a contact angle of 
60°. The stainless steel is more hydrophilic than the nickel and, therefore, one would assume 
that wetting of the membrane surface by the dispersed phase is more likely to happen for the 
stainless steel membrane. Hence, the smaller drops, and better size distribution, coming from 
the stainless membrane, cannot be attributed to the membrane surface wetting properties– 
nickel is more hydrophobic and should wet better with the oil phase. An SEM analysis of the 
membranes surface as well as the membranes pore cross- section was performed. A clean 
nickel membrane and stainless steel membrane were sliced and observed using the SEM. In 
Figure 24 is possible to see that the nickel membrane shows a conical surface above the 
pores (lines within SEM image, Figure 24 a–c); which could be a consequence of the coating 
treatment with PTFE. On the other hand, the pores of the stainless membrane show a 
cylindrical internal shape and sharp openings without conical configuration (Figure 24 d–f). 
During the formation of the drop, in the conical portion of the nickel membrane’s pores the 
droplets can grow before being detached by the action of the shear applied. Thus the smaller 
and more uniform drops are more likely to be (also) a consequence of the sharp pore opening; 
i.e. flat membrane surface. In addition having a polymeric phase highly acidic (PVA 15% + 
HCl 0.1 M) the use of the stainless steel as membrane material represents a further advantage 
as it is more resistant to acidic pH than nickel.  
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Figure 23 Influence of the dispersed phase flux and shear stress on average droplet size and 
size distribution. Comparison between the results obtained using the 10 µm nickel 
membrane (Nm) shown with the full signs and 10 µm stainless steel membrane 
(SSm) shown with the hollow signs. Dispersed phase: 15 wt.% PVA in water, 
continuous phase: 2 wt.% PGPR in Miglyol. Error bars represent the standard 
deviation of the measurements. 
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Figure 24 SEM analysis of hydrophobic 10 µm nickel membrane: (a) pore cross-section. (b) 
Pore top view. (c) Membrane side view. Red lines mark the pore edges. Stainless 
steel 10 µm membrane: (d) Pore cross-section. (e) Pore top view. (f) Top view of the 
membrane surface. 
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4.1.1.2.3 Model 
The shear- capillary model was used for the theoretical determination of the droplet size at a 
given value of the shear stress applied. This model has been validated in previous works 
(Kosvintsev et al., 2005; Stillwell et al., 2007; Dragosavac et al., 2008; M. Dragosavac et al., 
2012), it was reported that the model slightly underestimate the real drop size obtained 
(Stillwell et al., 2007). It has to be taken into account that the shear- capillary model does not 
consider the contribution of the dispersed phase flux as having an influence on the final drop 
size. Hence, it represents the size of the smallest drops that can be produced at a given set of 
operating parameters (Dragosavac et al., 2008). It is expected to be in very good agreement 
for emulsions obtained with a very low dispersed phase flux (Dragosavac et al., 2008; M. 
Dragosavac et al., 2012). The experimental values of droplet diameter were compared to the 
theoretical ones determined using the Equ. 7, page 41. Figure 25 shows the average droplet 
size of emulsions produced using from 12 to 270 L h-1 m-2, data from the nickel and stainless 
steel membrane were both included. The curve shows the theoretical values of the Dav 
calculated using Equ. 7 (page 41) at different shear stress. For all the experiments 15 wt.% in 
water was used as dispersed phase and 2 wt.% PGPR in Miglyol as continuous phase. It is 
noticeable that for low flux (12 L h-1 m-2) the experimental values are closer to the theoretical 
ones. An increase of the flux produces a gradually higher divergence between the 
experimental droplet size and the model predicted ones; as it was observed in previous works 
(Dragosavac et al., 2008; M. Dragosavac et al., 2012; Hanga and Holdich, 2014). It is 
reported that two main effects are responsible of this divergence (M. Dragosavac et al., 
2012). First, during the drop formation it was observed that a neck is formed which holds the 
drop connected to the pore opening (Van der Graaf et al., 2005); during this time the drop 
grows as an additional amount of dispersed phase flows inside (Van Der Graaf et al., 2006; 
M. Dragosavac et al., 2012). Consequently, the resulting drops are larger in size than the ones 
predicted by the shear- capillary model. The second reason of divergence is the reduced 
number of surfactant molecules covering the drop surface during the formation. In the model 
the equilibrium interfacial tension is taken into account; which is lower than the dynamic 
interfacial tension. The interfacial tension increases due to the insufficient surfactant 
molecules coverage of the drop surface, consequently the formed drops are larger (M. 
Dragosavac et al., 2012).  
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The influence of the dispersed phase flux on the drop formation and detachment has been 
previously investigated by Schröder and Schubert (1999). According to Schröder and 
Schubert the droplets formed on the membrane surface are influenced by the number of the 
active pores on the membrane surface. The number of active pores within the model has to be 
estimated which is an additional fitting parameter which needs to be taken into consideration 
(Holdich, 2010). 
 
Figure 25 Comparison between the theoretical droplet size calculated using the model (Equ. 
7, page 41) (line) and the average droplet diameter obtained under different 
conditions of shear and transmembrane flux. Nm – nickel membrane, SS – 
stainless steel membrane (dispersed phase: 15 wt.% PVA; continuous phase: 2 
wt.% PGPR). 
4.1.1.3 Influence of PVA concentration  
Viscosity of the dispersed and continuous phase have an effect on average droplet size and 
uniformity of the emulsions. The increase of the continuous phase viscosity is reported to 
have an influence on the diffusivity of the surfactant molecules; according to Z. Wang et al. 
(Wang et al., 2000) increase of the continuous phase viscosity leads to a decrease of the 
diffusion coefficient of the emulsifier. As a consequence the rate of reduction of the 
interfacial tension decreases as well producing emulsions with larger drops. The increase of 
the dispersed phase viscosity produces a reduction of the dispersed phase flux; according to 
the Darcy’s law (Joscelyne and Trägårdh, 1999; Charcosset, 2009; Kukizaki, 2009). In 
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Kukizaki’s work (Kukizaki, 2009) is shown that for a system composed by mixtures of 
decane and paraffin used as dispersed phase and 3 wt.% SDS in water was used as continuous 
phase, the increase of the dispersed phase viscosity produced a reduction of the average 
droplet size. This effect is a consequence of the reduction of the flow of dispersed phase in 
the drop during the formation. The values of measured interfacial tension is reported to be 
higher increasing the viscosity of the dispersed phase, which should theoretically produce 
larger drops. Reduction of mean drop size as a consequence of the more viscous dispersed 
phases used is also reported by I. Kobayashi et al’s work (2005) In this section a study of the 
effect of the amount of polymer used for the preparation of the dispersed phase is reported. 
Increasing concentrations of PVA in water were used as dispersed phase to produce 
emulsions using as continuous phase 2 wt.% ABIL EM 90 in Miglyol. Table 4 (page 51) 
shows that increasing the amount of PVA the viscosity of the polymeric phase is increased 
from 24 mPa s to 2550 mPa s. At the same time, an increase of the interfacial tension is 
measured as the dispersed phase viscosity becomes higher (from 1.6 to 3.5 mN m-1) (Table 4, 
page 51). The membrane used in this set of experiments was a stainless steel membrane with 
10 µm pore size and 200 µm pores spacing. Dispersed phase injection rate was constantly set 
at 80 mL h-1; giving a dispersed phase flux of 434 L h-1m-2. The shear stress applied was 35 
Pa. In Figure 26 is reported the average drop size and uniformity of emulsions obtained using 
from 10 to 25 wt.% of PVA solutions. It is possible to see that for all the PVA concentrations 
used, drops of 39- 42 µm were obtained, measured coefficients of variation were in the range 
of 16- 21%. In this case no difference in terms of size and size uniformity of the drops was 
observed increasing the viscosity of the dispersed phase. The interfacial tensions measured 
(using the Du Nouy ring method) and reported in Table 4 (page 51) are corresponding to the 
interfacial tension for the systems at the equilibrium (equilibrium interfacial tension). It is 
possible that the actual interfacial tension existing during the drop formation (dynamic 
interfacial tension) is higher and constant for the systems analyzed; giving the same drop 
size. On the other hand, it is possible that the effect of the increasing viscosity (which should 
lead to a reduction of the Dav) could be counterbalanced by the effect of the increasing 
equilibrium interfacial tension (which should produce larger drops).  
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Figure 26 Influence of the PVA concentration in the dispersed phase average droplet size and 
size distribution. Continuous phase: 2 wt.% ABIL EM 90 in Miglyol, membrane 
used: stainless steel membrane with 10 µm pore diameter, 200 µm pore spacing. 
Dispersed phase flux= 434 L h-1m-2, shear stress= 35 Pa. 
4.1.2 Droplets solidification 
Aim of this section is the production of uniform spherical PVA microparticles for the 
encapsulation and sustained release of active molecules by oral administration. According to 
Rathbone et al. (2002) the average particle size of the microparticles used for oral drug 
delivery is between 20 and 120 µm (Rathbone et al., 2002). PVA microparticles have already 
being produced using emulsification methods; where the drops formation was achieved by 
mechanical stirring (Thanoo, 1993; Bachtsi and Kiparissides, 1995; Shah et al., 1997; 
Varshosaz and Koopaie, 2002). Dispersion Cell was used in order to have a fine control over 
PVA droplets which were then converted to solid uniform microparticles after suitable 
crosslinking. Solidification of the liquid PVA drops produced with the membrane to solid 
microparticles was achieved by chemical reaction with the GA (crosslinking).Various authors 
have reported (Shah et al., 1997; Thanoo et al., 1993; Mandal, 2000; Varshosaz and Koopaie, 
2002) that the release pattern of a drug from the microparticles is strongly dependent on the 
extent of the crosslinking reaction; the release rate is reported to be inversely proportional to 
the crosslinking density which is directly proportional to the concentration of GA used. Effect 
of the crosslinking reaction was investigated as well as the swelling properties of the PVA 
microparticles obtained and release of model molecules is reported. 
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4.1.2.1 PVA crosslinking 
The chemical crosslinking reaction of PVA with GA is a condensation polymerization which 
removes two water molecules per each GA molecule used. The reaction is catalysed by the 
presence of a strong acid, and it consists in the formation of acetal bridges between the 
pendant hydroxyl groups of PVA (Hassan and Peppas, 2000). Hence, the process of droplet 
solidification into solid microparticles produces a shrinkage and reduction of the Dav. In 
Figure 27 is reported the effect of the crosslinking reaction on the Dav of the liquid drops 
during the solidification step. The starting emulsions were produced using as dispersed phase 
a solution of 15 wt.% PVA + HCl 0.1 M, as continuous phase Miglyol containing 2 wt.% 
PGPR as surfactant. The membrane used was a nickel membrane with 10 µm pore size and 
200 µm pores spacing. The dispersed phase flux was 270 L h-1m-2 for all the experiments. 
Droplets between 244 to 53 µm were produced varying the shear stress applied from 2 to 35 
Pa, solidification of the drops was achieved using 50 vol.% GA in water in a volume ratio 1:1 
with the volume of dispersed phase injected. To check that the solidification of the drops 
occurred, a small sample was withdrawn and washed with acetone. Acetone dissolves the oil 
and removes the excess water, thus establishing if the dispersion is of droplets, or solidified 
particles which do not dissolve. Using 50 vol.% GA in water in a volume ratio 1:1 with the 
volume of dispersed phase injected microparticles were formed after 90 min. Solid 
microparticles were re-suspended in water and observed under the optical microscope. Size 
of the solid un-swollen microparticles was between 160 to 35 µm. On average crosslinking 
using 50 vol.% GA in water in a volume ratio 1:1 reduced initial droplet diameter 
approximately 30%. Largest shrinkage was observed for the largest particles - starting form 
244 µm drops microparticles of 160 µm were obtained. At comparable GA concentration 
used for the reaction; larger drops are characterized by a lower degree of crosslinking. It is 
possible that during the washing step the acetone removes a higher amount of water from the 
larger microparticles.  
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Figure 27 Mean diameter of liquid droplet (dark blue) and of the solid microparticles 
obtained chemical crosslinking (light blue) at different values of shear stress used 
to produce the initial emulsion. Membrane used: nickel with 10 µm pore size and 
200 µm pore spacing, dispersed phase used: 15 wt.% PVA in water + HCl 0.1 M, 
continuous phase: 2 wt.% PGPR in Miglyol. Dispersed phase flux= 270 L h-1m-2. 
4.1.2.1.1 Influence of the crosslinker concentration  
Influence of the crosslinker concentration required to produce solid microparticles was 
investigated adding to the primary emulsion increasing concentrations of GA from 1 to 50 
vol.% in a volume ratio with the dispersed phase injected of 1:1. The reaction was conducted 
for a maximum of 90 min for all the samples under continuous agitation. Once solid 
microparticles were obtained, the stirring was stopped to allow the particles to settle at the 
bottom of the beaker. The remaining oil was removed by simply pouring it away from the 
beaker, remaining particles were washed with acetone and re- suspended in a solution of 2 
wt.% SDS in water allowing the complete separation (where possible) of the particles for the 
observation under the optical microscope. The whole process of washing and re- suspension 
in water was fast to avoid the microparticles drying at this stage; which could partially affect 
the final shape and size of the microparticles. Figure 28 presents microphotographs of the 
produced microparticles using different GA concentrations, the starting emulsion is also 
reported for comparison. It is possible to see that for 50 to 10 vol.% of GA the size of the 
particles is the same for all the samples. 5 vol.% GA microparticles show a slightly larger 
diameter and the shape of some of them is not perfectly spherical. 2 and 1 vol.% GA still 
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produced solid microparticles; from the observation under the optical microscope they 
appeared to have a soft consistency and they did not separate by resuspension in the 
surfactant solution. The size difference observed for less crosslinked samples (1- 5 vol.% 
GA) can be explained considering that a higher amount of water is retained by these particles. 
SEM analysis of the 50 and 5 vol.% crosslinked microparticles was performed and the 
images are presented in Figure 29. It is possible to see a difference of the microparticles 
surface depending on the amount of crosslinker used for the solidification: less crosslinked 
microparticles showed a corrugated surface which is less visible for higher crosslinked 
microparticles. The samples need to be completely dried for the observation with the SEM, 
hence the particles were freeze dried to remove all water present. As the less crosslinked 
particles are characterized by a more elastic polymeric network, during the drying stage the 
crosslinked polymeric segments collapse forming these creases. Internal structure of the 
produced microparticles for 5 and 50 vol.% of GA was examined by slicing the dried 
particles. The cross- section was observed on the SEM, internally the particles were solid and 
homogeneous as shown in Figure 30. It is believed that the GA can easily diffuse from the 
droplets of the secondary emulsion into the polymeric droplets of the primary emulsion. 
Having in mind that the droplets size is quite small GA molecules have quite short pathway 
for diffusion. According to this analysis the reaction of GA is not limited to the surface of the 
drops and solid spheres are produced.  
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50 vol.% GA Starting emulsion  
25 vol.% GA 10 vol.% GA 
5 vol.% GA 2 vol.% GA 
1 vol.% GA 
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Figure 28 Influence of the GA concentration on microparticles production; comparison with 
the initial emulsion produced. Operating conditions of production: as dispersed 
phase 15 wt.% PVA in water, continuous phase: 2 wt.% PGPR in Miglyol, shear 
stress: 35 Pa, dispersed phase flux: 434 L h-1m-2, membrane used: stainless steel 
with 10 µm pore diameter, 200 µm pore size. Solid microparticles washed and re- 
suspended in 2 wt.% SDS in water. 
 
Figure 29 SEM images of the microparticles surface once dried, crosslinked using (a) 50 
vol,% and (b) 5 vol.% of GA. 
 
 
Figure 30 SEM cross-section of PVA microparticles produced using (a) 50 vol.% and (b) 5 
vol. % GA for the crosslinking reaction. 
4.1.2.1.2 Influence of crosslinker amount on microparticles swelling properties 
PVA crosslinked network is reported as having the capability to sorb water and swell 
stretching the interconnected polymeric chains, the extent of this stretching is directly related 
to the degree of crosslinking. Furthermore, the capability of the crosslinked PVA 
a b 
a b 
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microparticles to incorporate water and swell is correlated to the release profile of an 
encapsulated substance within the particles (Varshosaz and Koopaie, 2002). PVA 
microparticles produced with different amount of GA showed a different swelling degree. 
The starting emulsion was prepared using the same operating parameters for all the 
experiments: the dispersed phase was 15 wt.% of PVA in water, the continuous phase was 2 
wt.% PGPR in Miglyol. The membrane used was the stainless steel membrane with 10 µm 
pore size and 200 µm pores spacing. The dispersed phase flux was 434 L h-1m-2 and shear 
stress of 35 Pa. Using these operating parameters, droplets sized 45 µm were obtained with a 
CV of the 20 %. GA in different concentrations (from 5 to 50 vol.%) was added to the 
emulsion in a volume ratio with the dispersed phase of 1:1. The reaction for all the 
experiments was stopped after a maximum of 90 min. Once solid microparticles were washed 
with acetone and left at room temperature for few seconds to dry. To remove completely the 
water the microparticles were freeze- dried. The particles were than observed under the 
microscope and microphotographs were taken. Pictures of the dried microparticles were 
analysed and the average microparticles diameter determined. In order to study the swelling 
properties of the differently crosslinked microparticles they were allowed to swell completely 
in water at 37 °C for 24h under continuous agitation using a shaking water bath. Again, 
samples of the swollen microparticles were taken and analysed under the optical microscope. 
Figure 31 shows mean particles diameter (in the dried and swollen state) as a function of the 
amount of GA used for the solidification. It is possible to see that for GA concentration 
higher than 10 vol.% the difference of Dav between the dried and swollen state is minimal. At 
these concentration of GA the swelling of the microparticles was limited. On the contrary, 
microparticles crosslinked with less than 5 vol.% GA showed on average a size in the dried 
state of 30 ± 2 µm approximatively, while after the swelling the particles size was of 47 ±2 
µm on average. For a higher GA amount the number of linkages between the polymeric 
chains is higher, this reduces the ability of the polymeric network to sorb water and swell. 
Furthermore, the reduction of the swelling can be attributed to the decrease of the free 
hydroxyl groups of PVA hence a reduced hydrophilicity of the material for high crosslinking 
densities (Shah et al., 1997). Microphotographs of the swollen particles are shown in Figure 
32, it is visible that microparticles crosslinked with 10, 25 and 50 vol.% of GA have the same 
diameter. Particles crosslinked with 2 and 5 vol.% GA incorporated the water and were able 
to swell and the spherical shape was not compromised by the swelling. For the particles 
crosslinked using 1 vol.% GA, the swelling produced a loss of the spherical shape for some 
 
 
 
90 
 
 
of them, showing the softness of the material as well as the stickiness as the particles 
aggregated and did not separate even after 24h under continuous shake in the presence of the 
surfactant (2 wt.% SDS in water).  
 
Figure 31 Average microparticles size crosslinked with different amount of GA in the dried 
(black squares) and swollen state (blue diamonds). Starting emulsion conditions of 
production: dispersed phase: 15 wt.% PVA + HCl 0.1 M, continuous phase: 2 wt.% 
PGPR in Miglyol, dispersed phase flux= 434 L h-1m-2, shear stress= 35 Pa. Volume 
ratio polymeric solution: GA solution= 1:1, time of reaction= 90 minutes.  
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Figure 32 Microphotographs of the PVA microparticles crosslinked using a different 
concentration of GA. The microparticles shown are in the swollen state obtained by 
leaving the samples to soak in water for 24h at 37 °C. 
4.1.2.1.3 Influence of the HCl concentration on the solidification process  
The crosslinking reaction of PVA with GA requires the presence of a strong acid as catalyst 
(as previously discussed in chapter 3.1.1.1). Hydrochloric acid was added to the PVA 
solution before the addition of the crosslinker. In order to determine the minimum amount of 
HCl required for the solidification, different concentrations of acid were added to the 
polymeric solution. Starting from a concentration of 0.1 M of HCl as reported in other papers 
50 vol.% GA 25 vol.% GA 
10 vol.% GA 5 vol.% GA 
2 vol.% GA 1 vol.% GA 
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(Mansur et al., 2008) the amount of acid was gradually reduced up to 0.0125 M in the 
polymeric solution. The acidified solution of PVA was subsequently emulsified in the 2 wt.% 
of PGPR in Miglyol using an homogenizer. Final concentration of the dispersed phase in the 
emulsion was 10 %. Crosslinking of the PVA drops was obtained adding 50 vol.% of GA 
solution to the emulsion in a volume ratio PVA solution: GA solution 1:1. The reaction was 
stopped after 90 min for all the experiments. A sample of the resulting microparticles was 
taken, washed quickly with acetone to remove the remaining oil and re-suspended in water. 
The sample was subsequently observed under the microscope and pictures were taken. 
Figure 33 reports the microphotographs obtained using a decreasing amount of HCl. It was 
observed that for concentrations of 0.1 and 0.05 M of HCl solid microparticles are be formed. 
For further decrease of the amount of acid at comparable conditions of reaction the PVA 
drops are not solidified by the action of the GA: by addition of the acetone the spherical 
shape is no longer maintained and clusters of polymer are visible. The amount of acid is 
directly affecting the crosslinking reaction and the formation of solid microparticles resistant 
enough to be dehydrated and stored. The role of the acid in the mechanism of crosslinking 
reaction is the protonation of the carbonyl oxygen of the GA to make the carbonyl carbon 
more electrophile; it also allows the loss of H2O as leaving group (McMurry, 2000). Hence, 
presence and amount of acid is essential for the reaction to happen. It was seen that at these 
conditions the minimum amount of acid required is 0.05 M of HCl. However, to ensure the 
amount of HCl always in excess; 0.1 M was used for the further experiments.  
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Figure 33 Microphotographs of the resulting microparticles prepared using different amount 
of strong acid (HCl) required for the crosslinking reaction. Dispersed phase used: 
15 wt.% PVA in water with appropriate HCl concentration, continuous phase: 2 
wt.% PGPR in Miglyol. Emulsions prepared using the homogenizer. 
4.1.3 Encapsulation of model compounds and release  
4.1.3.1 Blue Dextran (BD) Encapsulation 
PVA microparticles containing BD as water soluble model drug were produced. The 
operating conditions used for the microparticles production are summarized in the Table 6. 
The appropriate amount of BD was directly dissolved in the polymeric solution made of 15 
wt.% of PVA and 0.1M of HCl to obtain a final concentration of 3000 ppm. The liquid drops 
containing the sugar were subsequently solidified by reaction with GA.1 g of the obtained 
microparticles was added to the release medium (PBS solution pH= 7.4), samples at regular 
time intervals were taken and analysed. Sample A and sample B reported in the table below 
were crosslinked using respectively 25 and 50 vol.%, furthermore, the produced particles 
were different in size (sample A= 52 µm; sample B= 26 µm), providing a different pathway 
length for the Dextran diffusion. The release was checked at different time intervals by 
withdrawing few mL of the release medium and measuring the concentration of BD using a 
spectrophotometer, up to a time of 24h. Figure 34 shows the release of BD in 24h. The 
release was analysed using the UV-Vis spectrophotometer and a scan at several wavelengths 
0.1 M HCl 0.05 M HCl 
0.025 M HCl 0.0125 M HCl 
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(λ= 200- 700 nm) was performed for both samples. A peak at λ= 620 nm was expected, but 
(as shown in the Figure 34) it was not found any peak of absorbance at that wavelength for 
both the samples A and B. The sugar was not released from the two samples produced as no 
traces of it were found in the spectrum. This result can be explained considering that the BD 
can be itself crosslinked as polymer containing pendant groups able to react with GA in a 
crosslinking reaction (Brøndsted et al., 1998); the size of the sugar molecule (Mw~ 2,000 
kDa) could also prevent the diffusion through the polymer matrix of the crosslinked PVA 
particles produced. Peaks around 220 nm were found and attributed to impurities. According 
to Gillett and Gull, 1972; the pure monomeric GA absorbs at 280 nm and GA’s impurities (as 
its polymer) has an absorbance peak at 235 nm, no peaks were found after 24h in those 
regions of the spectrum. The particles were left in the release medium up to 5 days and no 
peaks were present. It was assumed that no unreacted GA is released from the produced 
particles. 
Table 6 Operating conditions for the production of microparticles containing BD as model 
molecule 
Sample 
name  
Continuous 
Phase 
Polymeric phase 
composition 
Crosslinker 
concentration 
(wt.%) 
Dispersed 
phase flux (L 
h-1 m-2) 
Shear 
(Pa) 
Particles 
size 
(µm) 
A Miglyol + 
ABIL 2% w/w 
PVA 15% w/w - 
BD 3000ppm 
50 270 35 52 ± 2 
B Miglyol + 
ABIL 2% w/w  
PVA 15% w/w - 
BD 3000ppm 
25 110 35 26 ± 2 
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Figure 34 Spectrum of the release medium analysed using the UV-VIS spectrophotometer 
within a range of wavelengths between 200 and 700 nm; release time= 24h.  
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4.1.3.2 Copper (Cu2+) encapsulation 
15 wt.% PVA crosslinked microparticles were used for encapsulation of copper ions. 
Different amounts of GA were tested for crosslinking of the particles containing Cu2+ in order 
to study the effect of the crosslinking reaction on the release profile. For this set of 
experiments 30 µm particles were used. Copper sulphate pentahydrate (CuSO4 5H2O) was 
directly added to the dispersed phase of the emulsion prior to the crosslinking reaction. 
Copper sulphate was selected because of the small dimensions of the molecule (CuSO4 5H2O, 
Mw= 249.68 Da) and possibility to detect small changes of concentration by using the 
Atomic Absorption Spectrophotometer. Previous papers have used Cu2+ as an analogue drug 
molecule (Imbrogno et al., 2015). The copper sulphate added to the dispersed phase of the 
emulsion (composed by 15 wt.% PVA and 0.1 M of HCl) could react with the hydrochloric 
acid producing copper chloride and sulphuric acid. Copper chloride is reported to be soluble 
in acetone; for this reason the washing of the particles for this set of experiments was done 
using toluene instead of acetone in order to prevent loss of the encapsulated Cu2+. 
Microparticles were subsequently freeze- dried. The behaviour of the particles was studied in 
acidic conditions (pH = 3) to mimic the gastric fluid, and neutral conditions (pH = 7) to 
mimic the intestinal tract. Normally, the gastric emptying time is about 3- 4h (Paradkar, 
2008), after a normal meal. Thus, the release was assayed up to 3h, required for possible drug 
absorption at stomach level. Figure 35 shows the release of Cu2+ from 15 vol.% PVA 
particles as a function of the time depending on the amount of GA used. The release of Cu2+ 
decreases with the increase of the crosslinker concentration; for example the particles 
prepared with 25 vol.% of GA released less than 1% of Cu2+ after 3h, while the particles 
prepared with the 1 vol.% of GA released up to 70% of Cu2+ in 3h. The results obtained are 
in accordance with the literature (Thanoo et al., 1993; Bachtsi and Kiparissides, 1995; Shah 
et al., 1997; Varshosaz and Koopaie, 2002) as the increase of the crosslinking density 
produced a reduction of the release rate. High initial release of Cu2+ was observed from the 
PVA particles, giving the so called ‘‘burst release” (Huang and Brazel, 2001). ‘‘Burst 
release” of Cu2+ in the early minutes, could be attributed to a diffusion of Cu2+ from the 
particles surface. It is interesting to notice that no release from PVA particles was observed if 
GA concentration for crosslinking was 10 vol.% or above. High crosslinking density (GA 
concentrations higher that 10 vol.%) prevented the swelling of the PVA hydrogels, as a 
consequence the amount of Cu2+ to diffuse out was limited. For the 2 vol.% and 5 vol.% GA 
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samples, after the reaching the “peak” concentration in the early minutes, the release reached 
a constant value. The release pattern obtained from 1 vol.% GA microparticles was a 
sustained release, as after the initial “burst” the detected concentration gradually increased 
over the 3h.  
 
Figure 35 Release with time of copper ion from microparticles of 15 wt.% PVA crosslinked 
with different amount of GA. The size of the dried microparticles used was 
approximately 30 µm ± 2 µm and CV%= 20 ± 3%. Error bars represent the 
standard deviation of the measurements. 
Figure 36 represents cumulative release of Cu2+ after 3h depending on the pH of the release 
medium. 15 wt.% PVA microparticles were crosslinked with 10 vol.% of GA. Even though 
the resulting concentration of Cu2+ is higher at pH 7, a maximum of 0.7 % of Cu2+ was 
released in 3h; showing that the microparticles crosslinked with 10 vol.% of GA do not show 
any significant Cu2+ release no matter the pH. In J. Varshosaz and N. Koopaie’s work (2002) 
even for lower concentration of GA (1.25 vol.%), the crosslinked PVA hydrogel did not 
respond to variation of the pH. Same result is reported by Yang et al. (2008), swelling 
behaviour of pure PVA hydrogels is reported to be independent to pH variations.  
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Figure 36 Cu2+ release pH dependent from 15 wt.% microparticles crosslinked with 10 vol.% 
GA after 3h. The size of the dried microparticles used was approximately 30 µm ± 
2 µm and CV%= 20 ± 3%. Error bars represent the standard deviation of the 
measurements. 
Based on these experiments, the produced PVA microparticles can be used to achieve a 
sustained release of a model compound after the oral administration. However, the release 
will not be specific for a section of the gastrointestinal tract. With the aim to have a targeted 
release into the stomach, a pH sensitive polymer was added to the formulation. In the next 
chapter the use of chitosan as material for the production of microparticles sensitive to the 
acidic environment will be evaluated.  
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4.2 PVA- CHITOSAN MICROPARTICLES FOR DRUG DELIVERY  
4.2.1 W/O emulsion production  
The use of chitosan as pH sensitive material for the production of polymeric blends with 
PVA or on its own was investigated for the manufacturing of microparticles for the release in 
acidic environment. Concentrations of chitosan from 1 to 3 wt.% were tested with or without 
PVA in the formulations. In the following sections a preliminary investigation of the 
emulsion composition and influence of the operating parameters is presented.  
4.2.1.1 Influence of the emulsifier 
Different blends of PVA and chitosan were used as a dispersed phase of the W/O emulsions 
production. Investigation of the appropriate emulsifier type was done using the Dispersion 
Cell device. For this set of experiments two blends were used as dispersed phase: the PVA 5 
wt.%- CS 1 wt.% and PVA 15 wt.%- CS 1 wt.% in water. Compared to pure PVA; viscosity 
of the blend PVA 5 wt.%- CS 1 wt.% was 2 times higher while the blend PVA 15 wt.%- CS 1 
wt.% was 5 times more viscous than pure 15 wt.% PVA solution, as reported in Table 4 
(page 51). The membrane used was full nickel membrane with 20 µm pore diameter and 200 
µm pores spacing. The dispersed phase flux was set to 270 L h-1m-2 and the shear stress was 
set to 35 Pa. 2 wt.%. PGPR and ABIL EM 90 in Miglyol were used to produce the emulsions. 
Figure 37 reports the effect of the composition of the continuous phase on the average drop 
size and size distribution of the emulsions prepared using the two polymeric blends as a 
dispersed phase. It is shown that the use of PGPR as oil soluble emulsifier produced the same 
size of drops for both the dispersed phases used (Dav= 45 µm). Using ABIL EM 90 droplet 
sized between 36 and 40 µm were obtained. At comparable conditions of production, slightly 
larger drops were obtained for the more viscous dispersed phase (PVA 15 wt.%- CS 1 wt.%). 
Un-uniform emulsions were produced using PGPR: the CV % for both the polymeric blends 
was higher than 34%. Better uniformity was achieved using ABIL EM 90, a CV% below 30 
% was obtained. In Figure 38 microphotographs of the produced emulsions are presented; it 
is possible to see that for the dispersed phase made of PVA 5 wt.%- CS 1 wt.% the use for 
PGPR as emulsifier produced a polydispersed emulsion (Figure 38 a), while using ABIL EM 
90 (Figure 38 b) an improvement of the size uniformity was achieved. From Figure 38 c is 
possible to see that with a dispersed phase PVA 15 wt.%- CS 1wt.% using PGPR as 
surfactant a very unstable emulsion is produced. The value of 34% as CV% measured is not 
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reliable as from the observation under the microscope it was seen that the formation of bigger 
drops occur rapidly after the production of the emulsion due to the instability and coalesce of 
the drops. Using ABIL EM 90 for the production of the PVA 15 wt.%- CS 1 wt.% polymeric 
drops (Figure 38 d) the stability improved and uniform drops were obtained. It was seen that 
the use of PGPR is not appropriate for the formation of the drops using these blends of 
polymers. It is hypothesized that after the emulsification process the phenomenon of coalesce 
is due to interactions of CS with the stabilizer (PGPR). The hydrophilic part of PGPR 
contains polyricinoleic acid, characterized by the presence of groups – COOH. An interaction 
between carboxylic groups and the CS amino groups in an acidic environment can occur, de-
stabilizing the emulsifier and interfering with its action. Thus, a slight increase of the 
interfacial tension was measured for the system 2 wt.% PGPR in Miglyol oil and PVA 15 
wt.%- CS 1wt.% (Table 4, page 51).  
 
Figure 37 Influence of the emulsifier type on average droplet size (Dav) and distribution 
(CV%). Dispersed phase flux= 270 L h-1m-2, shear stress= 35 Pa. Membrane type 
was a nickel membrane with 20 µm pore size and 200 µm pores spacing. Error bars 
represent the standard deviation of the measurements. 
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Figure 38 Microphotographs of the emulsions obtained using (a) PVA 5 wt.%- CS 1wt.% as 
dispersed phase, 2 wt.% PGPR in Miglyol as continuous phase, (b) PVA 5 wt.%- 
CS 1wt.% as dispersed phase, 2 wt.% ABIL EM 90 in Miglyol as continuous 
phase, (c) PVA 15 wt.%- CS 1 wt.% as dispersed phase, 2 wt.% PGPR in Miglyol 
as continuous phase, (d) PVA 15 wt.%- CS 1wt.% as dispersed phase, 2 wt.% 
ABIL EM 90 in Miglyol as continuous phase.  
4.2.1.2 Influence of the process operating parameters 
Figure 39 reported the average droplet size and size uniformity of the emulsions obtained 
using three compositions of the dispersed phase. The emulsions were produced using a nickel 
standard membrane with 20 µm pore size and 200 µm pores spacing, or a stainless steel 
membrane with 10 µm pore size and 200 µm pores spacing. The shear stress applied was for 
all samples 35 Pa. Using as dispersed phase the blend PVA 5 wt.%- CS 1 wt.%; the dispersed 
phase injection rate was varied from 3 to 5 mL min-1, giving a flux from 210 to 350 L h-1m-2 
for the nickel standard membrane. As expected, the increase of the dispersed phase flux 
applied produced an increase of the average drop size from 36 to 50 µm. For the dispersed 
phase made of PVA 15 wt.%- CS 1 wt.%; using a flux of 210- 270 L h-1m-2 droplets sized ~ 
a b 
c d 
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40 µm were produced. As comparison the resulting emulsion produced using the stainless 
steel membrane is shown, for a dispersed phase injection rate of 0.35 mL min-1 a flux of 114 
L h-1m-2 is generated, producing droplets sized on average 32 µm. Lower value of CV% was 
obtained using the stainless steel membrane (CV%= 23%) or the nickel membrane at lower 
dispersed phase flux (CV%= 20%).  
 
Figure 39 Influence of the dispersed phase flux on average droplet size and size uniformity. 
Blends of PVA and CS were used as dispersed phase, continuous phase used was 2 
wt.% ABIL EM 90 in Miglyol. Membrane types used: nickel membrane (Nm) 20 
µm pore size; 200 µm pores spacing, stainless steel membrane (SSm) 10 µm pore 
size; 200 µm pores spacing. Shear stress= 35 Pa. Error bars represent the standard 
deviation of the measurements. 
For the dispersed phase PVA 15 wt.%- CS 3 wt.% a CV % higher than 40 % was measured, 
due to the high viscosity of this dispersed phase (~ 15000 mPa s) the production of this 
emulsion was challenging as this polymeric blend was difficult to inject through the 
membrane pores even using low fluxes and the 20 µm membrane. Damage (bending) of the 
membrane was experienced. It was not possible to measure the interfacial tension for the 
system 15 wt.%- CS 3 wt.% as dispersed phase and 2 wt. % ABIL EM 90 in Miglyol as 
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continuous phase using the ring method, the viscosity of the dispersed phase was too high and 
unreliable values were registered.  
For the production of pure chitosan microparticles, several concentrations of the polymer 
were used for the preparation of the dispersed phase of the primary emulsion. 1, 2 and 3 wt. 
% of chitosan in water solutions were prepared adding 3 vol.% of CH3COOH to dissolve 
completely the polymer, as continuous phase was used 2 wt. % ABIL EM 90 in Miglyol. In 
Figure 40 are presented the resulting Dav and CV% of emulsions produced using a nickel 
membrane with 20 µm pore diameter and 200 µm pores spacing or; for the dispersed phase 
made of 3 wt.% of chitosan, a stainless steel membrane with 10 µm pore diameter and 200 
µm pores spacing. The shear stress applied was 59 Pa for all the samples while the flux was 
varied (270- 434 L h-1m-2). For a dispersed phase flux of 270 L h-1m-2 the increase of the 
chitosan concentration into the dispersed phase produced an increase of the average droplet 
size from 32 to 53 µm. From Table 4 (page 51) is it possible to see that the viscosity of the 1 
and 2 wt.% chitosan solution did not change significantly, while 3 wt.% chitosan in water 
was two times more viscous, nevertheless, increasing the amount of chitosan into the 
dispersed phase an increase of the measured value of the equilibrium interfacial tensions was 
measured, which is in accordance with the larger size obtained. Drops sized 56 µm on 
average were obtained using the 3 wt.% chitosan solution as dispersed phase injected through 
the stainless steel membrane with smaller pores than the nickel membrane; but using a higher 
dispersed phase flux. The uniformity of the emulsions produced was not as good as for the 
blends PVA- CS (CV%= 20- 23%) or pure PVA drops (CV% below 20%), as the lowest 
CV% measured was 23- 26%. The emulsions resulted to be stable and no obvious 
phenomenon of coalescence was observed. From Figure 39 and Figure 40 is noticeable that 
the use of the stainless steel membrane for both the formulations (PVA and chitosan blends 
or pure chitosan solutions) improved the uniformity of the droplet size. The material of the 
membranes is playing an important role in this effect: even though; as previously reported, 
the PTFE- coated membrane resulted to be more hydrophobic than the stainless steel (chapter 
4.1.1.2.2), the PTFE hydrophobic coating of the nickel membrane is thermally bonded on the 
membrane surface (Morelli et al., 2017) and the acidic nature of the dispersed phase injected 
could potentially remove it. It was hypnotized that the nickel membrane becomes less 
hydrophobic with multiple uses producing also less uniform drops.  
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Figure 40 Droplet size and size distribution of the emulsion as a function of chitosan 
concentration in the dispersed phase. Shear stress= 59 Pa. Membranes: SSm: 
stainless steel membrane, Nm: nickel membrane. Error bars represent the standard 
deviation of the measurements. 
4.2.2 Particle solidification using glutaraldehyde (GA) 
Chitosan and PVA can be chemically crosslinked using the GA. The reaction of chitosan with 
GA involves the amino groups of chitosan and the carbonyl carbon of GA. In this reaction (as 
well as the reaction of PVA with GA) the acid acts as catalyst. Due to the presence of the 
amino and carboxyl groups in the repeating unit of chitosan, the polymer is soluble in diluted 
acidic solution; hence the polymeric blends were acidified with 3 vol.% of CH3COOH and a 
0.05 M of HCl. Quantity of the acids used was not changed, the study of the crosslinking 
reaction was performed varying the concentration of GA into the secondary emulsion from 5 
to 25 vol.%. The volume ratio between the GA and amount of dispersed phase added in the 
primary emulsion was 1:1 for all the samples. The polymeric blends as well as the chitosan 
solution used for the preparation of the primary emulsion are reported in Table 7 including a 
summary of the concentrations of GA tested. It was determined a time of approximately 90 
min for the formation of the solid particles. At this stage acetone was used to wash the 
particles which were subsequently re- suspended in pure water for the observation under the 
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optical microscope. Acetone is used to determine the hardness of the microparticles since it 
removes the remaining oil of the emulsion and the water - if the microparticles were 
solidified they would not disintegrate when washed with acetone. Figure 41 shows the 
microparticles obtained by solidification of the PVA 15 wt.%- CS 1 wt. % drops using 
different concentrations of GA (5-25%). As it can be seen 10 vol.% was the limiting GA 
concentration to obtain solid microparticles. Particles crosslinked using 5 vol.% GA (Figure 
41 a), lost completely their shape and agglomerations is visible. Using 10 vol.% GA (Figure 
41 b) solid microparticles are formed, resistant to acetone washing, however a structure 
similar to a “deflated” sphere is shown. Figure 41 c reports particles crosslinked using 25 
vol.% GA sample Resulting particles were kept their spherical shape hence they were more 
rigid than the 10 vol.% GA crosslinked sample.  
Table 7 Conditions of microparticles production for the polymeric blends tested and pure 
chitosan.  
Continuous 
phase  
Polymeric phase composition Crosslinker 
concentrations 
tested (vol.%) 
Volume ratio  
(mL 
polymeric 
phase: mL 
GA solution) 
2 wt.% 
ABIL EM 
90 in 
Miglyol 
PVA 15 wt.%- CS 1 wt.% 5- 10- 25  1:1 
PVA 5 wt.%- CS 1 wt.% 10- 25 1:1 
PVA 15 wt.%- CS 3 wt.% 10 1:1 
CS 1 wt.% 5- 10- 25 1:1 
CS 2 wt.% 5- 10 1:1 
CS 3 wt.% 10 1:1 
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Figure 41 Effect of the GA concentration on the process of particles formation. Dispersed 
phase: PVA 15 wt.%- CS 1 wt. %. Continuous phase: 2 wt.% ABIL EM 90 in 
Miglyol. Dispersed phase flux= 210 L h-1m-2, shear stress= 35 Pa. GA 
concentration used for particles crosslinking: (a) 5 vol.%, (b) 10 vol.%, (c) 25 
vol.%. 
Figure 42 reports the microphotographs of the produced chitosan microparticles crosslinked 
with 5 and 10 vol.% of GA. It can be seen that for 1wt.% of chitosan (Figure 42 a and b) the 
crosslinking reaction did not produce solid microparticles resistant to the acetone treatment, 
independently from the amount of GA used for the solidification. 1 wt.% of chitosan was 
insufficient to obtain particles from the liquid drop. A similar result is observed by increasing 
the chitosan concentration to 2 wt.% (Figure 42 c) and using 5 vol.% GA for the crosslinking 
reaction; visually the particles formed are extremely soft and transparent, also they 
agglomerate forming clusters. 10 vol.% GA and 2 wt.% of chitosan produced solid particles 
shown in Figure 42 d which were separated and resistant. 3 wt.% chitosan drops were 
directly crosslinked using 10 vol.% of GA, in Figure 42 e is possible to see that solid and 
separated microparticles were obtained, resistant enough to be dried and stored for further 
a b 
c 
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analysis. 10 vol.% of GA was enough for the formation of all microparticles: PVA- CS 
blends and the 2- 3 wt.% chitosan solutions, hence it was the concentration selected. 
 
Figure 42 Effect of the GA concentration on the process of particles formation: (a) 1 wt.% 
CS particles crosslinked using 5 vol.% GA, (b) 1 wt.% CS particles crosslinked 
using 10 vol.% GA, (c) 2 wt.% CS particles crosslinked using 5 vol.% GA, (d) 2 
wt.% CS particles crosslinked using 10 vol.% GA, (c) 3 wt.% CS particles 
crosslinked using 10 vol.% GA. Continuous phase: 2 wt.% ABIL EM 90 in 
Miglyol. Dispersed phase flux= 270 L h-1m-2, shear stress= 59 Pa. 
e 
a b 
c d 
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4.2.3 Encapsulation and release of copper ions 
4.2.3.1 Optimization of the Cu2+ source and microparticles washing procedure 
For the analysis of the release profile of drug from the obtained particles, Cu2+was 
encapsulated as model compound. It was observed that the dissolution of CuSO4 directly into 
the dispersed phase of the emulsion made of blends of PVA and chitosan in different ratio or 
pure chitosan; produced a precipitation of the chitosan. It was hypothesized that the presence 
of the acidic environment of the dispersed phase could produce in a certain quantity sulphuric 
acid from the reaction of the copper sulphate with the HCl present in the blends PVA- CS or 
with the acetic acid present in the pure chitosan solutions. It is reported in literature (Kumbar 
et al., 2002) that chitosan can be ionically crosslinked using sulphuric acid as the anion SO42- 
can react with the positively charged amino groups of the chitosan forming ionic bonds. 
Hence the presence of the anion SO42- in the polymeric dispersed phase prevented the 
dissolution of chitosan. For this reason the source of Cu2+ was changed from copper sulphate 
to copper chloride for the formulations containing chitosan. To obtain a final concentration of 
5,000 ppm of Cu2+ in the dispersed phase, a polymeric phase containing 13,500 ppm CuCl2  
2H2O (MW = 170.48 g mol-1) was made. Polymeric microparticles were so produced using 
for all the compositions of the dispersed phase 10 vol.% of GA for the crosslinking reaction 
in order to use for all the samples the lowest concentration required to make solid 
microparticles. The washing procedure was carefully changed accordingly to the solubility of 
the CuCl2 in acetone (refer to section 4.1.3.2). Initially toluene was used to remove Miglyol 
from the microparticles; it is shown in Figure 43 that using toluene in the washing step of the 
microparticles was not appropriate. Microparticles were softened (Figure 43 a). Toluene was 
incompatible with the chemical composition of these microparticles, and was substituted with 
isohexane (Figure 43 b) which was effective to eliminate Miglyol but did not damage the 
microparticles.  
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Figure 43 Miglyol washing. (a) toluene, (b) isohexane. Dispersed phase: PVA 15 wt.%- CS 
1 wt.%. Continuous phase: 2 wt.% ABIL EM 90 in Miglyol. GA concentration: 10 
vol.%.  
4.2.3.2 Cu2+ detection and time dependent release 
PVA 15 wt.%- CS 1 wt.% microparticles and CS 3 wt.% microparticles were freeze- dried and 
subsequently observed using the SEM Hitachi desktop; EXD analysis of the elements present 
in the polymeric particles was done to check if Cu2+ was successfully encapsulated. An 
elemental mapping was tested as a quick method to determine encapsulation. Obtained images 
show presence of the elements using different colours. Figure 44 reports elemental maps for 
the sample PVA 15 wt.%- CS 1 wt.% crosslinked using 10 vol.% of GA.  
 
a b 
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Figure 44 EDX analysis (elemental mapping) of the PVA 15 wt.%- CS 1 wt.% sample 
crosslinked with 10 vol.% GA containing CuCl2 as model compound encapsulated.  
As expected, it is possible to see that the carbon is the element present in the largest amount; 
followed by the oxygen. Those two elements can be attributed to the chemical nature of the 
polymer and crosslinker used; while presence of Cu2+ (shown with the yellow colour in 
Figure 44) cannot be attributed to any the chemical composition of the two polymer used for 
the particles or the crosslinker. The presence of the encapsulated Cu2+ is also confirmed by 
the presence of chlorine (shown in purple in Figure 44). Even though the elemental mapping 
is a qualitative analysis, the intensity and the brightness of the colours in the obtained images 
have a correlation with the amount of the element present. In this case, is possible to see that 
the purple colour appears to be more intense than the yellow colour, which is in accordance 
with the chemistry of the material encapsulated as chlorine concentration is double compared 
to the Cu2+ concentration. Elemental mapping was also performed on 3 wt.% chitosan 
particles, and results presented in Figure 45. 
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Figure 45 EDX analysis (elemental mapping) of a 3 wt.% CS microparticles crosslinked with 
10 vol.% GA containing CuCl2 as model compound encapsulated. 
In this case a section of the particle was analysed. From the only SEM image is possible to 
see that internally the CS particles appear to have a porous structure. In Figure 45 detected 
carbon is shown with the red colour and again it represents the element presents in the largest 
amount. Oxygen is shown in green, carbon and oxygen are the main constituents of the 
polymeric particles hence the related colours are higher in intensity and delimiting the 
microparticles area. Cu2+ and chlorine were also detected, the yellow colour referring to the 
presence of Cu2+ resulted to be spread in the whole sample rather than being limited to the 
particles area. This effect could probably be the consequence of reduced quantity of Cu2+ 
present, the intensity of the colour is not enough to delimit the particles threshold. In purple 
the chlorine is showing the edges of the microparticles and as well as for the PVA 15 wt.%- 
CS 1 wt.% sample the intensity is higher than the one deriving from the presence of Cu2+.  
4.2.3.2.1 Atomic Absorption Spectrophotometry  
Release of the encapsulated Cu2+ was assayed with time in acidic conditions (pH= 3), the 
Cu2+ released in the medium was detected using the AAS (Atomic Absorption 
Spectrophotometer) as done for the previous samples produced in this work. As previously 
reported in section 4.1.3.2 it is generically accepted that the gastric emptying time is about 3-
4h (Paradkar, 2008), after a normal meal. For this reason the release from the particles was 
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tested within a maximum of 3h which is the limiting time for a drug to be absorbed at 
stomach level. Figure 46 shows the release from particles made by either pure CS or 
blending of PVA with CS in different ratios, all the samples were crosslinked using 10 vol.% 
of GA. For comparison the release of Cu2+ from pure PVA microparticles is also reported. It 
is visible that Cu2+ was gradually released over time reaching up to a maximum of the 80% in 
3h depending on the polymeric blend. Faster release is obtained from the polymeric blends of 
PVA 15 wt.%- CS 1 wt.% and PVA 5 wt.%- CS 1 wt.% which gave a similar release profile. 
Particles produced using 3 wt.% CS showed a very low release of Cu2+, only 5 wt.% of the 
encapsulated Cu2+ was released in 3h. This effect is due to the higher crosslinking density: at 
comparable amount of crosslinker used (10 vol.% of GA) the GA reacts with a lower 
concentration of polymer (3 wt.% of CS). The sample made by the combination of 15 wt.% 
PVA and 3 wt.% of CS, gave intermediate release. Such behaviour could be attributed to the 
high viscosity of this polymeric phase (Table 4, page 51), which as a result produces more 
dense particles, less able to swell and to release the Cu2+. As comparison the release of Cu2+ 
from pure PVA microparticles is also reported in Figure 46, it resulted to be extremely low 
(near to 0 %) even after 3h, in these conditions.  
 
Figure 46 Release of Cu2+ ions time dependent in acidic environment for microparticles 
made of either the polymeric blends of PVA and chitosan or pure chitosan. All the 
samples were crosslinked using 10 vol.% GA. The size of the dried microparticles 
used was approximately 30 µm ± 2 µm and CV%= 20 ± 3%. For comparison the 
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results obtained from pure PVA particles crosslinked with 10 vol.% of GA is also 
reported. Error bars represent the standard deviation of the measurements. 
4.2.3.3 Release of Cu2+- pH dependent  
To investigate pH sensitivity of the prepared formulations, the Cu2+ from the microparticles 
was tested at pH= 3 and pH= 7, and the results are reported in Figure 47. The release time 
was 3 h. Visually, the formulations containing both polymers, released more Cu2+ at acidic 
pH. More evident is the Cu2+ concentration difference at the two pHs for microparticles made 
of PVA 15 wt.%- CS 1 wt.% and PVA 5 wt.%- CS 1 wt.%: the release in acidic environment 
was approximately 82%, while about 1% of Cu2+ was released from the same microparticles 
in 3h in neutral conditions (pH= 7). Particles made with only CS (crosslinked with 10 vol.% 
of GA) did not show a significant release of Cu2+ at any pH. It is evident that even though CS 
is a pH sensitive polymer, pure chitosan crosslinked matrix shows a reduced pH sensitivity as 
the most of the amino groups present in chitosan react with the crosslinker in the formation of 
the chemical bridges (Berger et al., 2004). Presence of a second polymer in the formulation 
able to react with GA is required to produce pH sensitive particles, since it can reduce the 
crosslinking density of the CS and increase the number of free amino groups (Berger et al., 
2004). It was also observed that the viscosity of the polymeric blend does have an effect on 
the release trend; if it is too high, the density of the deriving polymeric network increases as 
well causing a lower diffusion rate of substances and molecules encapsulated in the particles; 
similar observation is reported in the work by T. Uhlich et al. (1996). None of the prepared 
microparticles showed a significant release in neutral conditions.  
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Figure 47 pH dependent Cu2+Release of for microparticles made of either the polymeric 
blends of PVA and chitosan or pure chitosan. All the samples were crosslinked 
using 10 vol.% GA. The size of the dried microparticles used was approximately 
30 µm ± 2 µm and CV%= 20 ± 3%. Error bars represent the standard deviation of 
the measurements. 
4.2.4 Release of sodium salicylate  
To study the behaviour of a drug molecule, sodium salicylate (SS) was encapsulated within 
the PVA- CS particles crosslinked with 10 vol.% of GA. The sample that gave the highest 
release of Cu2+ was chosen (PVA15 wt.%- CS1 wt.%) for these tests. The release was tested 
at pH =3 and 7. As shown in Figure 48, the release of SS with time in acidic environment is 
reported. It is possible to see that the microparticles released the SS slowly reaching only 
23% of the drug in 3h. SS is an anionic drug (Feng et al., 2009) (MW= 160.11 g mol-1) and it 
was hypothesized that in an acidic environment the ionic amino groups of CS can delay the 
diffusion of the negatively charged molecule of SS; which can interact ionically with the 
charged group of CS. Comparing the release of Cu2+ with the SS, the delay of the SS release 
can be explained considering the drug-polymer ionic interaction (Puttipipatkhachorn et al., 
2001) and the MW of the SS molecule which is much higher than the Cu2+ ion. On the other 
hand, Cu2+ is a positively charged ion, which can be repelled from the CS polymeric matrix, 
facilitating release. 
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Figure 48 Sodium salicylate cumulative release time dependent from microparticles of PVA 
15 wt.%- CS 1 wt.% crosslinked with 10 vol.% GA. The size of the dried 
microparticles used was approximately 30 µm ± 2 µm and CV%= 20 ± 3%. Error 
bars represent the standard deviation of the measurements. 
Figure 49 reports the release of SS depending of the pH of the release media; acidic (pH= 3) 
and neutral (pH= 7) solutions were used. It is shown that a little difference of the SS 
concentrations is measured in the two release media. A small amount of SS was released at 
pH=7 from the PVA-CS particles after 3h; approximatively 13%, while the release in acidic 
environment was slightly higher reaching up to 23%. However, this behaviour was expected 
since CS is not ionized at pH= 7 and the ionic interaction between the polymer and the SS do 
not occur. SS is released in a small quantity at pH 7 probably from the surface of the 
particles. Type and charge of the molecule encapsulated in the CS based microparticles play a 
fundamental role in the release profile that can be obtained. Amount of crosslinker must be 
also considered in order to achieve the desired release rate of the molecule with time.  
 
 
 
 
116 
 
 
 
Figure 49 PH dependent release of sodium salicylate from microparticles made of PVA 15 
wt.%- CS 1 wt.% crosslinked with 10 vol.% GA. The size of the dried 
microparticles used was approximately 30 µm ± 2 µm and CV%= 20 ± 3%. Error 
bars represent the standard deviation of the measurements. 
Using the technique of ME uniform microparticles were successfully produced, modifying 
the chemistry of the formulation it was possible to achieve a pH sensitive release of the 
encapsulated materials. The technology of ME has been already applied for the production of 
microparticles for the encapsulation of ions, molecules or enzymes (Imbrogno et al., 2015; 
Piacentini, Yan, et al., 2017; Piacentini, Dragosavac, et al., 2017). While, to- date, Song et al. 
(Song et al., 2003) is the only work reported for the encapsulation of cells using an SPG 
membrane. In that work there were no details of cell density used. ME is not an obvious 
choice for cell encapsulation: the microfilters used would be expected to filter out the 
suspended cells, rather than allow the passage of the cells from one side of the membrane to 
the other. In the following chapter the encapsulation of yeast into particles produced using the 
ME technique with the micro-sieve type metal membranes is investigated. The micro-sieve 
metal membranes are appropriate for cell encapsulation, as conditions that may cause 
membrane blockage, or cell filtration, can be avoided. A study of the most appropriate 
formulation to achieve a release of the cells into the intestinal- colon area is also reported.  
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4.3 GELATINE -CHITOSAN MICROPARTICLES FOR CELL ENCAPSULATION 
AND COLONIC RELEASE  
4.3.1 W/O emulsion– with and without yeast cells 
4.3.1.1 Effect of the emulsifier on drop size and emulsion stability 
Preliminary investigation of the emulsifier type using Miglyol as oil phase for the preparation 
of the W/O emulsions was performed. Using standard nickel membrane with 30 µm as pore 
size and 80 µm pores spacing, a dispersed phase made of 5 wt.% gelatine blended with 2 wt. 
% chitosan (G:CS (5:2)) with 2 vol.% CH3COOH was injected into the Dispersion Cell. 
Dispersed phase injection rate used was between 5 and 20 mL min-1 corresponding to a flux 
from 350 to 1400 L h-1m-2. Resulting average drop size and size distribution is reported in 
Figure 50, for all the experiments reported in the graph the rotation speed of the stirrer was 
set on 1500 rpm. It is possible to see that, independently from the emulsifier type used, the 
measured value of CV% was higher than 30%. The lowest value CV% for this set of 
experiments (CV%= 33%) was obtained using 2 wt.% of ABIL EM 90 in combination with 
an intermediate value of dispersed phase flux (700 L h-1m-2). The increase of the dispersed 
phase flux produced an increase of the average drop size (except for the very high flux used: 
1400 L h-1m-2); but corresponding CV% measured was high. The variation of the dispersed 
phase flux did not produce a consistent improvement of the drop size uniformity. Increasing 
the concentration of ABIL EM 90 to 4 wt.% polydispersed emulsions were produced with a 
CV% higher than 50%. The use 2 wt.% of PGPR in Miglyol was not successful for the 
production of uniform drops at any flux used. Figure 51 reports some example 
microphotographs of the emulsions obtained changing the emulsifier type, ABIL EM 90 
(Figure 51 a) and PGPR (Figure 51 b) gave drops with a wide range of size but no breaking 
of the drops was observed. 2 wt.% Span 80 was also tested as oil soluble emulsifier in 
Miglyol, Figure 51 c shows the obtained emulsion. It is visible that the drops are extremely 
unstable and they collapse when touching each other or the glass slide. Presence of small dots 
in the background can be attributed to the partial dissolution of the Span 80 in the oil phase, 
which could affect the stabilization of the drops. Variation of the emulsifier type and flux 
applied did not give satisfactory results in terms of stabilization of the drops and drop size 
uniformity. As a consequence, the use of a different oil type was considered for the 
subsequent tests. 
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Figure 50 Effect of the emulsifier on average drop size and uniformity at different fluxes. Oil 
used Miglyol. Standard nickel membrane with 30 µm pores and 80 µm pore 
spacing. Stirrer rotation speed 1500 rpm. 
   
Figure 51 Effect of the emulsifier on average drop size and size uniformity. Standard nickel 
membrane with 30 µm pores and 80 µm pore spacing. Flux= 700 L h-1m-2, stirrer 
rotation speed 1500 rpm. Dispersed phase: G:CS (5:2). Continuous phase Miglyol 
with: (a) 2 wt.% ABIL EM 90. (b) 2 wt.% PGPR. (c) 2 wt.% Span 80.  
4.3.1.2 Effect of the oil type used as continuous phase 
Figure 52 shows the emulsions produced using Miglyol or kerosene as oil phase. The 
dispersed phase used was G:CS (5:2). The membrane used for all the experiments in this 
a. ABIL EM 90 b. PGPR c. Span 80 
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section was a nickel standard membrane with 30 µm pore size and 80 µm pores spacing. 
Rotation speed of the stirrer was set to 1500 rpm. Most uniform emulsions produced with 
Miglyol were obtained adding to the oil 2 wt.% of ABIL EM 90 as surfactant and 700 L h-1m-
2 as dispersed phase flux (please refer to section 4.3.1.1). Using the same operating 
conditions, Miglyol oil was substituted with kerosene. 2 wt.% ABIL EM 90 was used as 
emulsifier. It is possible to see that on average larger drops were produced using kerosene 
with a CV% higher than 50%. The resulting emulsion was unstable and polydispersed as 
probably coalescence of the drops occurs. 2 wt.% Span 80 in kerosene was tested; the 
operating conditions were the same as reported above, from Figure 52 it is visible that the 
Dav resulted to be similar to the Dav obtained with the Miglyol oil but with a significant 
improvement of the size uniformity (CV%= 21%). Kerosene, with Span 80 as emulsifier, 
resulted to be more effective for the production of uniform sized emulsions with this 
composition of dispersed phase. 
 
Figure 52 Effect of the oil type used for the preparation of the continuous phase on average 
drop size and size uniformity for different values of dispersed phase flux. 
Dispersed phase: G:CS (5:2), rotation speed of the stirrer 1500 rpm. Membrane 
used was a nickel standard membrane with 30 µm as pore diameter and 80 µm 
pores spacing. 
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4.3.1.3 Effect of the operating parameters on drop size and uniformity 
4.3.1.3.1 Operating temperature 
Effect of the temperature used during the emulsification process is shown in Figure 53, the 
emulsions were prepared at room temperature or submerging the whole Dispersion Cell 
within a water bath set to a constant temperature of the 40°C. The membrane used for this test 
was a nickel standard membrane with 30 µm as pore diameter and 200 µm pores spacing. 
Continuous phase used was 2 wt.% Span 80 in kerosene and the dispersed phase was G:CS 
(5:2) with 2 vol.% CH3COOH. The gelatine present in the dispersed phase is liquid for 
temperatures higher than 25°C (Karim and Bhat, 2009), as soon as the solution cools down 
the gelatine starts to coagulate which is inconvenient during the emulsification process as the 
viscosity of the dispersed phase gradually changes. Initially the emulsification process was 
carried out straight after the heating of the dispersed phase, but having the Dispersion Cell at 
room temperature (room T). In a second set of experiments, to prevent the possible 
coagulation of the dispersed phase, a water bath was used. The dispersed phase flux used was 
350 L h-1m-2. In Figure 53 is possible to see that for comparable values of shear applied; the 
drop size of the emulsions produced at room T was similar to the emulsions prepared at T= 
40°C. The uniformity was comparable with CVs% lower than 30% for all the prepared 
samples. However, in order to avoid viscosity changes due to the fluctuation of the 
environmental temperature, the use of the water bath was preferred for the production of 
emulsions containing pig gelatine.  
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Figure 53 Effect of the temperature of operation on the Dav and CV% varying the shear 
stress. Dispersed phase flux= 350 L h-1m-2. Membrane used was a nickel standard 
membrane with 30 µm as pore diameter and 200 µm pores spacing. 
4.3.1.3.2 Membrane pore spacing  
Effect of the shear stress on the average drop size and size distribution of emulsions produced 
using as dispersed phase G:CS (5:2) and continuous phase 2 wt.% Span 80 in kerosene, is 
shown in Figure 54 compares the results obtained using two nickel membranes having 30 
µm pore size and 80 or 200 µm pores spacing respectively. The size of the drops decreased as 
the shear stress applied is increased in accordance with the data reported in literature 
(Kosvintsev et al., 2005; Egidi et al., 2008; Dragosavac et al., 2008; M. M. Dragosavac et al., 
2012; Holdich, 2010). It was observed that using the same membrane type (nickel standard 
membrane with 30 µm pore size and 200 µm pores spacing) the increasing of dispersed phase 
flux from 490 to 700 L h-1m-2 did not produce a significant change in the drop size for all the 
shear stress tested. It is also interesting to notice that at comparable values of shear stress 
applied and dispersed phase flux, the Dav and CV% were independent from the distance 
between the pores of the membrane. 
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Figure 54 Influence of the shear stress applied on the average drop size and distribution at 
different values of dispersed phase flux. Membrane types used were: a nickel 
standard membrane with 30 µm as pore diameter and 80 µm pores spacing (Nm 30/ 
80 μm) or 200 µm pores spacing (Nm 30/ 200 μm). 
The effect of the membrane pores spacing on the drop size and size uniformity has already 
been investigated in the presence of a shear field and different values of dispersed phase flux 
(Egidi et al., 2008). For membrane with a regular pore array, if the diameter of a drop formed 
at the pore becomes bigger than the distance between the membrane pores, the shape of the 
drops is deviated from spherical to spheroidal for high dispersed phase flux. Hence, 
increasing the dispersed phase flux, the drop sizes increase up to a point where each drop 
formed is influenced by the presence of the drops formed at adjacent pores. This produces a 
faster detachment of the drops from the membrane resulting in smaller and more uniform 
drops. This additional force acting on a forming drop at the pore opening is called push- off 
and it is a detaching force. In Egidi et al.’s work (Egidi et al., 2008) is reported that using a 
200 µm pore spaced membrane (with 20 µm pore diameter), no evidence of the existence of 
the push- off force was found. The increase of the dispersed phase flux produced an increase 
of the average drop size and the increase of the shear stress led to a reduction of the Dav. 
While, using an 80 µm pore spaced membrane, the trend observed was slightly different: for 
 
 
 
123 
 
 
high dispersed phase flux (higher than 1000 L h-1m-2) the further increase of the flux did not 
produce larger drops. For high shear stresses applied, highly uniform emulsions were 
obtained when the effect of the push- off force was predominant hence for high injection 
rates. For low shear stresses applied the increasing of the flux produced smaller drops. In the 
present work, the size of the produced drops was (in some cases) larger than the space 
between the pores in the case of the 80 µm pore spaced membrane. Using a flux of 700 L h-
1m-2 drops from 43 to 130 µm were produced with a 30 µm pore sized and 80 µm pore spaced 
membrane; but no evidence of the action of the push- off force was observed. At these 
operating conditions the two membranes resulted to be interchangeable. It was experienced 
that the membrane with 30 µm pore size and 80 µm pore spacing was less resistant to 
mechanical forces than the 200 µm pore spacing membrane and more susceptible to the 
bending. Hence, the 200 µm membrane was preferred for the subsequent set of experiments. 
4.3.1.3.3 Effect of transmembrane flux and shear stress 
Variation of average drop diameter and uniformity with dispersed phase flux and shear stress 
was investigated using as dispersed phase G:CS (5:2) or 5 wt.% of pure gelatine in water. The 
continuous phase for all the experiments was 2 wt.% Span 80 in kerosene. The membrane 
used was a nickel standard with 30 µm pore size and 200 µm pore spacing. Emulsions were 
produced with, or without, addition of yeast cells to the dispersed phase and the results are 
shown in Figure 55. Initially a dispersed phase flux of 350 L h-1m-2 was used and the stirrer 
rotation speed was changed from 200 to 1500 rpm generating a shear stress from 1 to 17 Pa. 
Consequently, the Dav decreased with increasing shear stress for all the samples. This trend is 
in accordance with data reported previously (Dragosavac et al., 2008; M. Dragosavac et al., 
2012; Morelli et al., 2016). Modifying the shear stress applied it was possible to produce 
drops sized between 60 µm to 340 µm using the 30 µm membrane. The corresponding CV% 
was in a range between 17 to 24%. The same set of experiments were repeated adding yeast 
cells in the dispersed phase; for comparable values of shear stress and dispersed phase flux 
the mean drop size and uniformity did not change significantly suggesting that the presence 
of the cells did not influence the emulsion characteristics. Furthermore, it is possible to see 
that the use of pure gelatine instead of a dispersed phase containing G:CS (5:2) did not 
produce a variation of the mean drop size and the CV% obtained was 23- 25% using 350 L h-
1m-2. On the other hand, reduction of the flux to 70 L h-1m-2 produced less uniform emulsions. 
The dotted line within Figure 55 reports the theoretical values of drop size calculated using 
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the shear- capillary model (Kosvintsev et al., 2005); as demonstrated in another work 
(Dragosavac et al., 2008) the shear stress is not uniform on the membrane surface, the 
maximum shear reachable is at radial distance from the centre of the membrane and the 
maximum shear is normally used in Equ. 7 (page 41) for the determination of the theoretical 
values of Dav. In Figure 55 the results obtained using a dispersed phase flux of 70 L h-1m-2 
were much closer to the theoretical values calculated using the model. The shear-capillary 
model does not include the dispersed phase flux as a parameter affecting the drop size, it is 
the theoretical ‘smallest’ drop size formed at zero flux rate, therefore reducing the 
transmembrane flux the divergence between real and theoretical drop size decreases. The 
literature does contain models that add a volume to the drops caused by the injection volume 
flow rate (𝐽𝐽) and the drop formation time (𝑡𝑡): 
𝐶𝐶 =  𝐶𝐶0 + 𝑡𝑡𝐽𝐽 Equ. 22 
where 𝐶𝐶0 is the volume of the drop predicted by a force balance, e.g. Equ. 7 (page 41), and 𝑡𝑡𝐽𝐽 
is the extra volume of the drop caused by operating at a high injection rate and the finite time 
required for droplet formation (Suárez et al., 2013). However, in order to apply Equ. 22 the 
drop formation time has to be assessed and this will depend on the fraction of pores that are 
actively generating drops, which is rarely a known value. Thus, for the purpose of illustrating 
the key parameters influencing the drop formation in the system studied here the simple force 
balance model, as represented by Equ. 7 (page 41), is presented. 
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Figure 55 Effect of dispersed phase flux and shear stress on size distribution and drop 
uniformity. The hollow square marks represent experiments performed using a 
dispersed phase of G:CS (5:2) with and without yeast respectively. Hollow circle 
and triangle marks represent experiments performed using a dispersed phase of G 5 
wt.% with and without yeast respectively. Error bars represent the standard 
deviation of the measurements. 
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Figure 56 Effect of the shear stress applied on the average drop size of emulsions prepared 
using 350 L h-1m-2 as dispersed phase flux; with and without yeast encapsulated 
7 Pa 1 Pa 
11 Pa 
7 Pa 11 Pa 
17 Pa 
No yeast No yeast 
With yeast With yeast 
With yeast 
17 Pa No yeast No yeast 
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within the dispersed phase. Continuous phase used was 2 wt.% Span 80 in 
kerosene. Membrane used was a nickel standard membrane with 30 µm pore size 
and 200 µm pore spacing. 
Figure 56 shows images of emulsions produced using the same dispersed phase flux (350 L 
h-1m-2) and varying the shear stress. The dispersed phase was G:CS (5:2) with and without the 
yeast cells; the continuous phase was 2 wt.% Span 80 in kerosene. The average drop size 
reduced gradually with increasing shear stress from 1 to 17 Pa. Visually, the size and size 
uniformity were the same at comparable values of shear stress for emulsions with or without 
the yeast encapsulated in the drops. The yeast solution added to the dispersed phase was 
prepared using only pure water, the obtained emulsions were stable: no bursting of the drops 
was observed. 
4.3.1.3.4 Effect of the salts present in the dispersed phase   
To encapsulate the yeast, a certain amount of the yeast suspension was added directly to the 
dispersed phase prior to the emulsification process. The preparation of the yeast suspension 
was described in section 3.3.1.3.1. For the re-hydration and washing of the cells a Ringer’s 
solution was initially used taking into consideration that cells placed in hypotonic solutions 
(such as pure water) will be affected by the low solutes concentration of the environment 
(Kent, 2000). The Ringer’s solution contains several salts as sodium chloride, potassium 
chloride, calcium chloride and sodium bicarbonate, which makes it isotonic with the body 
fluids of animals. Hence, in a first attempt, 1 vol.% of the yeast solution prepared using the 
Ringer’s solution (to avoid possible cell damage) was added to a dispersed phase made of 
G:CS (5:2) dissolved into buffer acetate (pH= 4.5) (CH3COONa with CH3COOH) in order to 
keep the pH constant. Formulation of the dispersed phase and specifically the amount of salts 
present has an effect of the final emulsion stabilization. In a second experiment the dispersed 
phase was prepared minimizing the amount of salts present: the yeast solution was now 
prepared using only pure water for the washing and it was added to the dispersed phase in a 
concentration of 1 vol.%. The dispersed phase was made of G:CS (5:2) in pure CH3COOH (2 
vol.%). Figure 57 are presented the resulting emulsions obtained, all the samples were 
prepared using a 30 µm pore size and 80 µm pore spaced nickel standard membrane, a shear 
stress of 17 Pa and a dispersed phase flux of 490 L h-1m-2. It is visible in Figure 57 a that the 
emulsion obtained was highly unstable, characterized by collapse of the drops and 
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coalescence, while reducing the amount of salts present in the dispersed phase, the stability of 
the emulsion was greatly improved, as visible in Figure 57 b. However, this it aspect might 
be optimized for the encapsulation of a different or more susceptible type of cell using the 
technique of Membrane Emulsification.  
  
Figure 57 Effect of the salts present in the dispersed phase: (a) emulsion produced using a 
dispersed phase containing G:CS (5:2) dissolved in buffer acetate and 1 vol.% 
yeast cell solution washed using the Ringer’s solution, (b) emulsion produced 
using as dispersed phase G:CS (5:2) dissolved in 2 vol.% CH3COOH and with 1 
vol.% yeast cell solution washed in pure water. Shear stress= 17 Pa, dispersed 
phase flux= 490 L h-1m-2. Membrane used: 30 µm pore size and 80 µm pore spaced 
nickel standard. 
4.3.1.3.5 Effect of the cells presence in dispersed phase 
Size and uniformity of emulsion drops was investigated as a function of the amount of yeast 
cells added to the dispersed phase. The initial yeast dispersion (3.14×109 cells mL-1) was 
prepared using dried yeast powder re-suspended in pure water. For the preparation of the 
dispersed phase, a calculated volume of the initial yeast dispersion was added to the 
polymeric dispersed phase. The dispersed phase was stirred for few minutes at 40°C until 
uniform dispersion of the cells within the phase was reached. The dispersed phase containing 
the cells was subsequently injected into the emulsification apparatus through a 30 µm pore 
sized membrane with 200 µm pore spacing. The amount of yeast dispersion injected was 
gradually increased up to a final concentration of 3.14×108 cells mL-1. During the emulsion 
production, the operating parameters were: dispersed phase flux 350 L h-1m-2, shear stress 17 
Pa. Figure 58 shows the mean drop size as a function of the yeast concentration: it is possible 
a b 
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to see that the amount of cells did not affect the size of the emulsion produced. Using these 
operating parameters, drops sized ~66 µm were obtained, a good uniformity was achieved 
with a CV between 19% and 23% as reported in Figure 58. Cell concentration of 3.14×108 
cells mL-1 was the maximum used in order to avoid membrane damage as formation of cell 
agglomerates was observed for higher yeast concentration. The agglomerates could 
potentially block the membrane. Images of the produced emulsions containing yeast cells are 
shown in Figure 59; the microphotographs were taken using a magnification of 20X and 40X 
objective lenses to show the cells trapped in the liquid drops. Uniform distribution of the cells 
within the drops was achieved; the cells did not agglomerate; shape and colour were normal. 
The emulsions showed a similar size of the drops and up to a concentration of 3.14×108 cells 
mL-1 no drops breaking or coalescence was observed, showing that the emulsions 
characteristics are not affected by the amount of cell encapsulated. Although the number of 
cells per drop was high (especially for a concentration of 3.14×108 cells mL-1), no yeast cells 
were found in the continuous phase, suggesting that the cells were successfully trapped 
within the drops. 
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Figure 58 Average drop size and CV at different cell concentrations. Dispersed phase: G5 
wt.%. Continuous phase: 2 wt.% Span 80 in kerosene. Transmembrane flux= 350 L 
h-1m-2, shear stress= 17 Pa. Membrane used was a nickel standard membrane with 
30 µm pore size and 200 µm pore spacing. Error bars represent the standard 
deviation of the measurements. 
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Figure 59 Microphotographs of emulsions produced increasing the concentration of cells in 
the dispersed phase; 3.14 x 107 cells mL-1 (a), 9.42 x 107 cells mL-1 (b), 1.88 x 108 
cells mL-1 (c), 3.14 x 108 cells mL-1 (d). Dispersed phase: G 5 wt.%, Continuous 
phase: 2 wt.% Span 80 in kerosene. Dispersed phase flux= 350 L h-1m-2, shear 
stress= 17 Pa. Membrane used was a nickel standard membrane with 30 µm pore 
size and 200 µm pore spacing. 
The passage of the cells through the membrane, i.e. no filtering effect, was checked by 
injecting the cell suspension with the highest cell density used (14 x 108 cells mL-1) through a 
membrane with 30 µm pore size and 200 µm pore spacing. For this test the yeast suspension 
in aqueous phase was injected through the membrane in the absence of any organic phase. 
After 10 mL of the cell suspension passed through the membrane, i.e. the same volume used 
in the ME, the pump was switched off and the suspension passed through the membrane was 
recovered and observed under the microscope. To check no cells were filtered, and remained 
below the membrane, the membrane was turned upside down and the cell suspension injected 
again. This is termed ‘back-flushed’ in Figure 60, which shows: a the cell suspension before 
the injection through the membrane; b the cell suspension injected through the membrane; 
and c the cell suspension using the membrane turned upside down and back-flushed. It is 
a b 
c d 
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possible to observe that the number of cells for the three images does not appreciably change 
and it is reasonable to deduce that they have the same cell concentration. Similar tests were 
done at the lower cell concentrations used and identical results were found: no membrane 
fouling observed. Hence, the non-tortuous pore channel membrane used did not appear to 
retain any of the yeast cells at the cell densities used in this work, and, therefore, the 
encapsulation efficiency of the yeast cells will be 100%. 
 
Figure 60 Microphotographs of the cell suspension with the highest cell density (3.14 x 108 
cells mL-1) used as dispersed phase; (a) starting cell suspension, (b) filtered cell 
suspension and (c) back flushed cell suspension. 
4.3.2 Microparticles formation: thermal gelation and ionic crosslinking  
4.3.2.1 Pure gelatine drops solidification by thermal gelation 
Formation of pure gelatine microparticles was obtained by thermal gelation; the starting 
emulsion was prepared using the Dispersion Cell. The dispersed phase was made of gelatine 
(in a concentration from 1 to 5 wt.% ) containing 9.42 x 107 cells mL-1 of yeast. 2 wt.% Span 
80 in kerosene was used as the emulsion continuous phase. Once produced the emulsion was 
a b
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cooled down using an ice bath. Samples of the particles were taken with time and observed 
under the microscope: the gelation was considered complete when particles were effectively 
containing the cells without leakage Increasing the amount of gelatine in the dispersed phase 
the gelation time was reduced from 5h (for the 1 wt.% gelatine) to 3h (for the 5 wt.% 
gelatine). Figure 61 shows the microphotographs of the produced samples; it is visible that 
the 1 wt.% gelatine microparticles were partially visible and not completely formed; some of 
the encapsulated cells were released in the surrounding medium as probably the amount of 
gelatine was insufficient for the formation of solid microparticles. Distinct particles were 
visible for the 2 wt.% and 5 wt.% gelatine samples, the formed particles contained the yeast 
without leakage. However, it was not possible to dry completely the pure gelatine particles, 
as they were not hard enough to keep the spherical shape. Therefore the gelatine particles 
were washed in 2 wt.% Tween 20 in water, centrifuged and stored (still wet) in the fridge to 
prevent the gelatine from melting. 
   
Figure 61 Gelatine microparticles formed by thermal gelation of the liquid drops in ice using 
increasing concentrations of gelatine in the dispersed phase. 
1 wt.% gelatine 2 wt.% gelatine 
5 wt.% gelatine 
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4.3.2.2 Ionic crosslinking of chitosan  
For the production of ionically crosslinked G: CS microparticles a preliminary investigation 
of the crosslinking of pure chitosan was done. 2 wt.% of chitosan dissolved in a 2 vol.% 
CH3COOH solution was used as dispersed phase, as continuous phase 2 wt.% Span 80 in 
kerosene was used. The emulsion concentration was 10% for all the samples. All the 
emulsions in this set of experiments were produced using the homogenizer for no longer than 
1 minute to avoid the formation of very small drops difficult to observe. Crosslinking was 
tested using the sulphate ion adding a solution containing 5 or 20 wt.% of sodium sulphate 
with or without 1N of NaOH directly to the emulsion. Sodium tripolyphosphate (STPP) was 
also tested as ionic crosslinker in a concentration from 1 to 10 wt.%. All the samples were 
left to react at least for 3h; images of the resulting particles are presented in Figure 62. It is 
visible that using sodium sulphate the drops were not solidified. The addition of acetone to 
the sample produced a collapse of the polymeric drops on the glass slide. It was observed that 
the sodium tripolyphosphate in a concentration of 1 wt.% did not produce solid 
microparticles as well, but increasing the crosslinker concentration slightly harder particles 
were obtained. Formation of aggregates is visible for 5 and 10 wt.% of tripolyphosphate. 
With the same method of investigation, sodium hexametaphosphate (SHMP) was used as 
ionic crosslinker in a concentration of 10 and 20 wt.% in water, the result is shown in Figure 
63. The obtained particles were solid and resistant to the drying process with acetone, but 
formation of agglomerates was observed for the 10 wt.% SHMP. The reaction occurred 
within 4h for all the samples. Increasing the temperature of reaction to 50°C did not produce 
a significant improvement; the obtained chitosan particles were melted and attached on each 
other.  
 
 
 
135 
 
 
  
   
Figure 62 2 wt.% CS crosslinked with sodium sulphate and sodium tripolyphosphate (STPP) 
in different concentrations. 
5 wt.%Na2SO4 + 1N NaOH  20 wt.%Na2SO4  
1 wt.% STPP 5 wt.% STPP 
10 wt.% STPP 
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Figure 63 2 wt.% CS microparticles produced using increasing concentrations of sodium 
hexametaphosphate (SHMP) as ionic crosslinker and increasing the temperature of 
reaction. The microphotographs were taken using magnifications of 10X 
(photograph of the 10 wt.% SHMP system) and 20X objective lenses (photographs 
of the 20 wt.% SHMP and 20 wt.% SHMP, T=50°C).  
4.3.2.3 Gelatine- CS microparticles formation  
4.3.2.3.1 Gelatine- CS microparticles production by thermal gelation 
G:CS (5:2) drops containing a concentration of yeast of 9.42 107 cells mL-1 were produced 
using the Dispersion Cell. To solidify the liquid drops, thermal gelation in ice was used. The 
beaker containing the emulsion was put in an ice bath for 4h. Afterwards the sample was 
washed using 2 wt.% Tween 20 in water and concentrated using the centrifuge. In Figure 64 
is shown the starting emulsion and the product of the crosslinking procedure. It is visible that 
after 4h in ice no particles were formed and all the yeast present in the liquid drops was 
released in the surrounding medium. The process of solidification by only thermal gelation is 
not appropriate for this formulation.  
10 wt.% SHMP 20 wt.% SHMP 
20 wt.% SHMP, T= 50°C 
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Figure 64 Gelatine: CS (5:2) solidification by thermal gelation (4h in ice). 
4.3.2.3.2 Gelatine- CS microparticles production by thermal gelation in 
combination with ionic crosslinking  
Considering the previous observations, a combination of thermal gelation of the gelatine and 
ionic crosslinking of chitosan was tested as solidification process to obtain solid G:CS 
microparticles. The starting emulsion was produced using the Dispersion Cell; the dispersed 
phase of the emulsion was made of G:CS (5:2) containing 9.42 107 cells mL-1 of yeast. As 
continuous phase 2 wt.% of Span 80 in kerosene was used. The final emulsion was 10% 
concentrated. Once obtained the drops; the emulsion was placed in the ice bath for 30 min. 
Subsequently, the SHMP was added. In Figure 65 are reported the microphotographs of the 
emulsion during the reaction process taken at different times. In this test 2 mL of a 10 wt.% 
SHMP solution was added to the emulsion after the cooling step. The starting emulsion is 
reported for comparison, it is visible that after 1h the drops are still liquid and removing the 
water the drops collapsed. After 3h of reaction the microparticles are visible but not solid 
enough to be dried. In 4h the reaction is complete, solid particles are formed and no 
aggregation occurred. A second test was done increasing the amount of the 10 wt.% SHMP 
solution to 10 mL and the whole procedure of solidification was repeated. Figure 66 shows 
the microphotographs taken during the crosslinking reaction; visually, after 1h of reaction the 
shape of the particles is already visible even though the particles are not completely solid. 
After 2h some of the drops were solidified into microparticles with a spherical shape; 
however the reaction was considered complete after 3h as all the microparticles were solid 
and the process of drying did not damage them. For this composition of the dispersed phase 
the use of a combination of thermal gelation and ionic crosslinking was considered the most 
appropriate for the production of solid microparticles which can be dried and stored. The 
Emulsion  4h in ice   
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optimal amount of SHMP was 10 mL (in a volume ratio with the dispersed phase injected of 
1:1) in a concentration of 10 wt.%. Lower amount of SHMP leads to a slower process of 
solidification and particle agglomeration. 
   
  
Figure 65 Gelatine: CS (5:2) microparticles crosslinked in ice for 1, 3 and 4h with 2 mL of 
10 wt. % SHMP. 
Emulsion  1h reaction  
3h reaction  4h reaction  
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Figure 66 Gelatine: CS (5:2) crosslinking in ice for 1, 2 and 3h with 10 mL of SHMP (10 
wt.%). 
4.3.3 Eudragit S100 coating of the gelatine- CS microparticles  
To achieve a release of the yeast specifically in the intestinal- colon area, the obtained 
microparticles were coated using a material resistant to the acidic stomach environment but 
which is soluble in basic-neutral conditions: Eudragit S100. 
4.3.3.1 Eudragit S100 solubility 
A preliminary study was done for the determination of the solubility of the Eudragit polymer 
in different solvents. Eudragit S100 is an anionic colpolymer of methacrylic acid and 
methilmethacrylate (‘EUDRAGIT® product brochure’, 2016). It is reported to be soluble in 
methanol, ethanol, isopropyl alcohol and 1M of NaOH giving clear to cloudy solutions; while 
is practically insoluble in water. Several concentrations of Eudragit S100 (from 2 to 10 wt.%) 
were used for the preparation of suspensions using different types of solvents. In Table 8 
summarises performed tests. 5 wt.% of Eudragit was dissolved in 1M NaOH or in 3 and 10 
Emulsion  1h reaction  
2h reaction  3h reaction  
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vol.% of water in acetone. It formed cloudy solutions by stirring; by heating up clear 
solutions were produced.  
Table 8 Summary of the solvents used for the dissolution of Eudragit S100 in different 
concentrations. 
Solvent Eudragit S100 wt.% Soluble Insoluble 
NaOH 1M 5 √  
3 vol.% acetone in water  5 √  
10 vol.% acetone in water  5 √  
Ethanol: Acetone (4:1) 2 √  
Ethanol: Acetone (2:1) 5-10 √  
Water 5  √ 
Ringer’s solution pH 7 2  √ 
PBS+ HCl pH 7 2 √  
PBS pH 7.4 2 √  
PBS + NaOH pH 8 2 √  
Mixtures of ethanol and acetone in different ratios were tested and formation of stable 
Eudragit suspensions were obtained up to a concentration of 10 wt.%. PBS and PBS with 
NaOH or HCl solutions were tested to mimic the gastrointestinal fluids during the 
microparticles dissolution tests. Eudragit in a concentration of 2 wt.% was added to the PBS 
solutions having different pHs; the produced suspensions are shown in Figure 67 a. It is 
possible to see that all the samples were milky suspensions but they were stable as no 
sedimentation was observed up to two days. At these conditions the variation of pH (from 7 
to 8) did not visibly affect the dissolution of the Eudragit. Eudragit was found to be insoluble 
in water (forming an insoluble film on the water surface) and in the Ringer’s solution; 
forming an insoluble precipitate at the bottom of the beaker. In Figure 67 b the suspension 
obtained adding Eudragit to the Ringer’s solution is shown, as comparison the suspension 
made of Eudragit it PBS+ HCl is also reported. With the arrow is indicated precipitate of 
Eudragit formed at the bottom of the beaker. It is also visible that a certain amount of 
Eudragit is floating on the liquid surface. From these observations it was hypothesized that 
solvents containing the hydroxyl or carboxyl groups or able to generate hydroxide ions are 
more likely to dissolve the Eudragit S100 compared to pure water or the Ringer’s solution. 
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Choice of the appropriate solvent for the coating process and dissolution of the coated 
particles was based on these data. PBS solutions at different pH were used for the release 
studies.  
 
 
Figure 67 Dissolution test for Eudragit S100 in different solvents; (a) PBS solutions at 
different pHs, (b) comparison of the Eudragit suspensions in PBS with HCl and the 
Ringer’s solution. 
4.3.3.2 Eudragit S100 coating process 
4.3.3.2.1 Coating by solvent evaporation  
Microparticles made of G:CS (5:2) without cells or 5 wt.% of pure gelatine microparticles 
containing the cells were coated using 5 or 10 wt.% of Eudragit S100 dissolved in a mixture 
of acetone and ethanol or either pure acetone. Table 9 reports the summary of all the coating 
tests performed using as the solvent evaporation method.  
 
 
PBS+ NaOH 
pH= 8 
PBS pH= 7.4 PBS+ HCl 
pH= 7 
PBS+ HCl 
pH= 7 
Ringer’s 
solution pH= 7 
a 
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Table 9 Summary of the coating operating conditions tested using the process of solvent 
evaporation. 
Microparticles type Coating solution Washing solution 
G:CS (5:2) 5 wt.% Eudragit S100 
dissolved in acetone: ethanol 
(2:1) 
Acetone: water (3:1)/ 
microparticles re-
suspended in water  
G:CS (5:2) 10 wt.% Eudragit S100 
dissolved in acetone: ethanol 
(2:1) 
Acetone: water (3:1)/ 
microparticles re-
suspended in water 
G 5 with yeast 10 wt.% Eudragit S100 in 
acetone  
Acetone/ microparticles 
re-suspended in water  
G 5 with yeast 1stcycle: 5 wt.% Eudragit 
S100 dissolved in acetone: 
ethanol (2:1) 
2nd cycle: 10 wt.% Eudragit 
S100 dissolved in acetone: 
ethanol (2:1) 
Acetone: water (3:1)/ 
microparticles re-
suspended in water 
 
0.1 g of G:CS microparticles were added to 10 mL of the coating solution (Table 9), the 
particles suspension was left to evaporate under continuous stirring. Once all the solvent was 
completely evaporated the washing solution was directly added to the beaker containing the 
particles and stirred again for few minutes. The microparticles were filtered and re- 
suspended in water. Figure 68 shows the coated microparticles using 5 or 10 wt.% of 
Eudragit respectively, for comparison the uncoated microparticles are also shown. The 
images refer to microparticles re- suspended in water after the coating and washing process. 
The material visible in the background of the Figure 68 a is diatomaceous earth added to 
keep the microparticles separated. Compared to the smooth surface of the uncoated 
microparticles, the coated ones (Figure 68 b and c) showed a roughened surface due to the 
deposition of the Eudragit polymer. In the background the presence of clusters of Eudragit 
polymer is visible. However, it was hypothesized that the coating layer is not uniformly 
distributed on the microparticles surface: it was expected a reduction of the microparticles 
size as the presence of the coating layer should have reduced the permeability of the 
microparticles to the water and subsequently the swelling; while the size of the coated 
microparticles did not change from the uncoated ones. As reported in Table 9, the G5 
microparticles containing yeast were also coated using the method of the solvent evaporation. 
The gelatine microparticles were not dried, the wet microparticles were directly added to the 
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coating solution. In the first attempt the coating solution was made of 10 wt.% Eudragit S100 
in acetone. The obtained microparticles were washed and dried at room temperature; 
subsequently they were observed under the optical microscope showing that the coating layer 
was not present as the microparticles collapsed. A second attempt consisted in coating the 
microparticles in two cycles: the first coating cycle was done using the same technique as 
described above; subsequently the obtained particles (in water) were coated again using a 
higher concentration of the Eudragit. Pictures of the obtained particles are shown in Figure 
69. After the first coating cycle a discontinuous layer surrounding the particle is visible; after 
the second coating cycle (using a higher amount of Eudragit) the microparticles size is visibly 
reduced but the microparticles were “trapped” in a film of Eudragit and it was not possible to 
recover them. The process of coating the microparticles using the solvent evaporation method 
was not efficient for the production of a uniform coating layer on the microparticles surface. 
The increase of the Eudragit concentration in the coating solution formed a layer of polymer 
in the beaker which trapped the microparticles.  
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Figure 68 G: CS (5:2) microparticles (a) without coating re-suspended in water (b) coated 
using as coating solution 5 wt. % and (c) 10 wt.% Eudragit S100 dissolved in acetone: 
ethanol (2:1). 
 
 
Figure 69 G5 microparticles coated using a solution of Eudragit S100 in acetone: ethanol 
(2:1) in two cycles. 
1st cycle  2nd cycle  
b  a  
c 
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4.3.3.2.2 Coating by oil in oil solvent evaporation 
The method of oil in oil solvent evaporation was tested for the formation of a uniform coating 
layer on the microparticles surface. The method was described previously in other work (L. 
Zhang et al., 2011). The coating reaction occurred in 4h, the reaction was monitored by 
observation of the particles in the O1/O2 emulsion (for the O1/O2 emulsion composition please 
refer to Chapter 3.3.1.3.3, page 61) during the formation of the Eudragit shell. Figure 70 a 
shows an uncoated gelatine particle suspended in water as comparison, an image of the early 
stage of the reaction (t= 0 minutes) is shown in Figure 70 b: a liquid shell surrounding the 
gelatine drop surface composed by the organic phase containing the coating material 
dissolved is visible. It is possible to see in the background of the image the presence of larger 
drops of coating solution (O1). With time, evaporation of the solvent of the coating solution 
is visible, the Eudragit polymer gradually formed a solid layer on the particle surface and in 
the background a reduction of the coating solution drop size is noticeable (Figure 70 c). The 
reaction was stopped and considered complete once the O1 drops were almost invisible 
leaving the solid Eudragit polymer. The particles were washed and dried at room 
temperature, giving a white powder. A small sample of coated particles was re-suspended in 
water and observed under a microscope. Figure 70 d shows one of the coated particles re-
suspended in water. Compared to the un-coated microparticles, the coated ones are smaller in 
size: the mean size of un-coated particles (in water) was 100± 2 µm, and water wet coated 
microparticles were 70± 2 µm in diameter. The water is extracted from the particles by the O1 
phase during the process of coating producing shrinkage. When re-suspended in water the 
coating layer prevents water absorption, thus swelling is reduced, proving that using this 
method the coating layer formed is continuous and the water cannot permeate. Furthermore, 
the uncoated gelatine microparticles were too delicate for the drying process, so the addition 
of a coating layer was also advantageous for the final formulation as the coated particles were 
dried and the storage for longer time was possible.  
Figure 71 shows the coated microparticles re- suspended in water after being dried at room 
temperature, in Figure 71 a the process of coating was done adding diatomaceous earth to the 
particles solution which was subsequently mixed with the coating solution. It is visible that 
the coating process led to the formation of aggregates of particles which were impossible to 
separate. The addition of zinc stearate as anti- sticking agent directly to the coating solution 
produced separated microparticles; in Figure 71 b is visible that the microparticles were 
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coated separately and the final dried product was a free flowing powder. However, presence 
of polymer residuals are visible in the background, the only washing procedure was 
insufficient for the complete removal of the debris.  
 
Figure 70 (a) Uncoated microparticle in water (b) O1/O2 emulsion during the coating process 
after 0 minutes and (c) 4h, (d) microparticle re-suspended in water after washing in 
hexane and drying at room temperature.  
 
Figure 71 Coated G5 microparticles using the oil in oil solvent evaporation method (a) 
without zinc stearate and (b) with the zinc stearate into the coating solution. 
4.3.3.3 Un-coated and coated particles: dissolution pH and temperature dependence 
release of the yeast cells 
In-vitro release studies were performed on the particles to test the yeast release with time at 
different pH of the medium. All the experiments were carried out at 37ºC. Three formulations 
were used for this test and compared. Figure 72 shows images of the particles at different pH 
and time intervals. The yeast encapsulated particles made of G:CS (5:2) did not show any cell 
release; this formulation was extremely resistant to the acidic environment (pH 1.2) and to 
neutral (pH 7) conditions even after 5 days. The crosslinked matrix did not dissolve as shown 
in Figure 72 a. The trapped yeast cells were immobilized within the polymeric matrix and 
the formulation failed to release the cells. Behaviour of the G:CS formulation at the tested pH 
a b c d 
a  b  
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can be explained by the formation of a strong ionically crosslinked polymeric matrix. A 
complex coacervation occurs between proteins and the polyanion (Wang et al., 2014) 
preventing the dissolution of the two polymers in the release medium. As the G:CS did not 
dissolve within the required timeframe and pH, the coating was not performed for this 
particles and no further analysis were conducted on this formulation. Figure 72 b shows the 
gelatine microparticles that were initially placed at pH 1.2, to mimic the stomach conditions. 
Unlike the previous formulation, the pure gelatine particles released very rapidly; they did not 
resist the acidic environment and released their contents after 5 minutes. The test was also 
conducted at neutral pH (pH 7), in this case the gelatine particles dissolved slower, after 15 
minutes the yeast particles were swollen and almost invisible, but the encapsulated yeast was 
still retained inside the polymer. After a time of 30 minutes, the gelatine particles were 
completely dissolved and the content released in the surrounding medium. The pure gelatine 
microparticles did not meet the requirements for a gastro-resistant formulation: they did not 
protect the yeast cells from the acidic environment of the stomach for a period of at least 2h 
(Paharia et al., 2007). Therefore, the Eudragit S100 coating was added to the gelatine 
particles to preserve the gelatine polymer during the residence at pH 1.2; allowing dissolution 
of the particles only in a neutral, or basic, environment (pH between 7 and 8) 
(‘EUDRAGIT® product brochure’, 2016) typical of the intestinal-colonic area. Eudragit 
coated microparticles were tested and the results are shown in Figure 72 c. In the images, 
background debris of the coating material is present. At pH 1.2, after 2h, the microparticles 
still encapsulate the yeast without alteration of their shape, or swelling. The coated 
microparticles were removed from the acidic medium and transferred to a neutral 
environment at pH 7; no change was visible after 30 minutes, but a significant modification is 
noticeable after 2h: the coating gradually dissolved, for some particles a visible breaking of 
the Eudragit shell exposing the gelatine internal part is noticeable. At this stage, however, the 
cells were not released from the internal gelatine matrix. After 3h the microparticles were 
completely dissolved and the structure was no longer visible, the yeast cells were released 
and they are visible as small spots on the background of the image. In a basic environment 
the release was faster: it is possible to see that after 15 minutes at pH 8 the external coating 
was almost dissolved, but the particle shape is still visible. In 30 minutes the microparticles 
released completely the content, some residual part of the particles is still visible. Although 
the yeast cells were already released, the complete dissolution of the residual polymer was 
observed after 1h. The Eudragit S100 methacrylic polymer is insoluble in acids, protecting 
 
 
 
148 
 
 
the microparticles from dissolution in the stomach environment. However, the formed 
Eudragit S100 layer on the microparticles dissolves at pH above 7, leaving the gelatine 
material exposed, and simple melting of the gelatine at 37°C produced the release of yeast 
cells in this medium. 
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Figure 72 Microparticles dissolution test with time at different pH; (a) G:CS (5:2) 
microparticles encapsulating yeast, (b) Un-coated G5 microparticles encapsulating 
yeast, (c) Eudragit S100 coated- G5 microparticles containing yeast. 
4.3.3.4 Yeast cells viability test 
4.3.3.4.1 The glucose consumption test 
Yeast cells released from Eudragit S100 coated gelatine microparticles (Figure 72 c) were 
collected and transferred into a 6 mM glucose solution. The glucose concentration was 
measured at regular time intervals to check for yeast cell viability. Figure 73 shows the 
reduction in glucose concentration measured with time, in terms of glucose consumed. The 
test was repeated for three samples and standard deviation of the three measurements is 
reported in the graph as error bars. All the glucose measurements were conducted using the 
glucosemeter, the standard deviation was high for some of the data as the instrument resulted 
to be extremely sensitive to little variations of the environment and solutions temperatures as 
well as the amount of solution injected in the reaction chamber (10 µl). However, for this 
type of test the accuracy of the measurements was considered sufficient as the purpose of the 
experiment consisted in checking if a reduction of glucose concentration occurred. In Figure 
73, the “% glucose consumed” refers to the amount of glucose consumed by the yeast as a 
percentage of the initial glucose concentration; calculated using the formula Equ.21 (shown 
in section 3.3.1.3.5). 
 
Equ.21 
 
After 24h the measured concentration of glucose was about 0.4 mM; hence the yeast were 
able to metabolize up to the 90% of the glucose in one day. The measurements were 
conducted up to 5 days but no further reduction of the glucose amount was measured. It was 
hypothesized that the consumption does not reach the 100% because of the cell death due to 
the absence of nutrients or the increasing amount of ethanol as by- product of the cell 
metabolism which is toxic for the yeast. The data from Figure 73 shows that the 
encapsulation process did not damage the cells and that they were successfully protected 
from an acidic environment (pH 1.2), equivalent to the conditions of the stomach, and after 
% 𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝑅𝑅 𝐺𝐺𝐺𝐺𝑛𝑛𝐺𝐺𝐺𝐺𝑚𝑚𝑅𝑅𝑑𝑑 = (𝐺𝐺𝐺𝐺𝐺𝐺𝑖𝑖 −  𝐺𝐺𝐺𝐺𝐺𝐺𝑒𝑒) ∗ 100
𝐺𝐺𝐺𝐺𝐺𝐺𝑖𝑖
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release when the conditions are no longer acidic the cells are viable and their metabolic 
activity is preserved. 
 
Figure 73 Released yeast glucose consumption with time as percentage of the initial amount 
of glucose consumed. Error bars represent the standard deviation of the 
measurements. 
4.3.3.4.2 Viability test using fluorescent probes 
Two Fluorescent probes for cell dyeing were used to distinguish living cells from dead cells. 
Using an epifluorescence microscope the yeast cells encapsulated in the Eudragit coated 
particles (Figure 72 c) and the yeast released from the particles (Figure 72 c) were observed. 
In Figure 74 a microparticles encapsulating the yeast is shown. From the image it is possible 
to see yeast cells coloured in green and a small number of cells coloured in red. The number 
of living cells is higher than the dead cells; however, the result may not be reliable as the 
cells are still held within a gelatine matrix. The polymeric material could interfere with the 
absorption of the fluorescent dyes and the results might be unreliable. For this reason the 
yeast cells released, as described above, were also dyed and checked by fluorescence: Figure 
74 b shows these results. The cells were treated with the fluorescent dyes right after being 
released from the particles. According to this analysis, the living cells are far greater in 
number compared to dead ones, showing that the encapsulation process was successful, the 
cells survived a period of time (2h) in acidic conditions and were successfully released (and 
viable) on returning the particles to a neutral aqueous environment. These conditions mimic 
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what would be expected to occur during the passage of the encapsulated particles through the 
human gastric system. Thus successfully delivering living cells to the colon.  
  
Figure 74 Fluorescent microphotographs of (a) yeast cell still entrapped into the particles and 
(b) the released cell from the particles. Green-yellow coloured cell are living, red-
orange coloured cell are dead. 
Possibility to immobilize the cells into particles (without having the release) is also an 
interesting field of research and it finds applications in medicine or the food and beverage 
industry (Yoshida et al., 2003; Murua et al., 2008). In the next chapter the use alginate as 
polymeric material for the production of porous microparticles (De Vos et al., 2013) is 
described for the immobilization of the yeast.  
  
a b 
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4.4 ALGINATE MICROPARTICLES FOR YEAST ENCAPSULATION  
4.4.1 W/O emulsion production 
4.4.1.1 Effect of the operating parameters of the emulsification process 
Drop size variation and emulsion uniformity depending on the shear stress applied was 
investigated using as dispersed phase a solution of 2 wt.% of alginate dissolved in water with 
or without addition of yeast. The use of higher alginate concentrations was inconvenient due 
to the increase of the dispersed phase viscosity, which could damage the membrane during 
the injection. Lower concentrations would be insufficient to solidify the drops into particles. 
Continuous phase of the emulsions produced was 2 wt.% Span 80 in kerosene. The 
membrane used was a hydrophobic nickel standard membrane with 30 µm pore diameter and 
200 µm pore size. The dispersed phase injection rate used for all the samples was 5 mL min-1 
corresponding to a flux of 350 L h-1m-2. The rotation speed of the paddle was increased from 
200 to 1500 rpm generating a shear stress from 1 to 17 Pa. Figure 75 reports the values of 
Dav and CV% obtained varying the shear. Error bars are reported showing the standard 
deviation of the measurements. Effect of the shear was evaluated on emulsions without yeast, 
it is visible that the increase of the shear led to a gradual reduction of the drop size from 270 
to 84 µm. For all the samples produced the CV% was below 24%, hence uniform drops were 
obtained at these operating conditions. For comparison, the graph shows the average drop 
size and CV% of emulsions obtained adding the yeast to the dispersed phase in a final 
concentration of 9.42x 107 cells mL-1 using 17 Pa as applied shear. At comparable value of 
shear and dispersed phase flux (350 L h-1m-2) the resulting drops were had the same size and 
the uniformity was consistent as well. This data suggested that the addition of the yeast did 
not have an effect on the emulsion properties. In Figure 76 are reported the 
microphotographs of the emulsions produced increasing the shear stress. As discussed above, 
smaller drops were produced by the action of the shear. Visually the emulsions obtained had 
a clear background showing that the emulsifier is properly dissolved in the continuous phase 
and it resulted to be appropriate for this formulation. No coalescence or drop bursting was 
observed for these emulsions. 
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Figure 75 Influence of the shear stress applied on emulsion drop size and size distribution, 
comparison between emulsions without yeast and with yeast encapsulated. 
Dispersed phase flux was 350 L h-1m-2. Membrane used was a hydrophobic nickel 
membrane with 30 µm and 200 µm pore spacing. Error bars represent the standard 
deviation of the measurements. 
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Figure 76 Microphotographs of emulsions produced increasing the shear stress applied (from 
1 to 17 Pa) without cells. Membrane type used was a standard nickel membrane 
with 30 µm pore size and 200 µm pore spacing. Dispersed phase flux was 350 L h-
1m-2. 
4.4.1.2 Influence of yeast cell content on droplet size 
The influence of the amount of cells encapsulated was examined adding the yeast to the 
dispersed phase of the emulsions; the appropriate amount of yeast was added to the 2 wt.% 
alginate in water and mixed up to complete dissolution. The amount of cells in the dispersed 
phase was increased from 3.14x 107 to 1.88x 108 cells mL-1. Emulsions were produced using 
as continuous phase 2 wt.% Span 80 in kerosene. The dispersed phase flux used was 350 L h-
1m-2 and the shear stress applied was 11 Pa; these operating conditions were the same for all 
the experiments performed. Resulting average drop size and size distribution are shown in 
Figure 77; it is possible to see that up to a concentration of 9.42x 107 cells mL-1 the size of 
the drops did not vary significantly and for all the samples the CV% was below 21%. Further 
increase of the yeast cells in dispersed phase (above 1.88x 108 cells mL-1) produced on 
average larger drops sized 140 µm and the CV% increased accordingly. In Figure 78 are 
1 Pa 7 Pa 
11 Pa 17 Pa 
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reported the images of the emulsions produced using a dispersed phase containing 9.42x 107 
cells mL-1 and 1.88x 108 cells mL-1 and the difference of the droplet size can be observed. For 
the highest cell density sample (1.88x 108 cells mL-1) presence of smaller and larger drops 
simultaneously is visible. For this sample the stability was not as good as for the less 
concentrated ones and phenomenon of coalescence was observed. The yeast solution was 
prepared using a dried yeast powder (Sainsbury's Fast Action Dried Yeast). The powder 
contained beside yeast (94%) calcium sulphate, sorbitan monostearate, ascorbic acid, alpha-
amylase, salt and wheat starch. Presence of additives, emulsifiers and salts in the dispersed 
phase deriving from the initial yeast preparation might destabilize the resulting emulsions 
producing polydispersed samples (bursting of the drops occurs due to the osmotic pressure). 
The yeast was washed several times to try and eliminate additional ingredients but it is 
reasonable to consider that the process of washing was less effective when higher amount of 
yeast powder was used. 
 
Figure 77 Influence of the amount of yeast encapsulated on emulsion drop size and 
uniformity. Operating parameters of the emulsification process were: flux= 350 L 
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h-1m-2 and shear stress applied= 11 Pa. Error bars represent the standard deviation 
of the measurements. 
  
Figure 78 Microphotographs of emulsions containing (a) 9.42x 107 cells mL-1 and (b) 1.88x 
108 cells mL-1 in the dispersed phase.  
4.4.2 Alginate drops solidification by ionic crosslinking  
4.4.2.1 Magnesium sulphate as ionic crosslinker 
The solidification of the liquid alginate drops into particles was obtained by ionic 
crosslinking. The positively charged magnesium ion was tested as ionic crosslinker, solutions 
of anhydrous magnesium sulphate (MgSO4) in different concentrations were used. A 2 wt.% 
(or 10 wt.%) MgSO4 solution was made adding the required amount of the salt in water and 
slight heating to facilitate the complete dissolution. The solution was cooled at room 
temperature. The starting emulsion was prepared injecting 10 mL of a 2 wt.% alginate 
solution as dispersed phase into the emulsification apparatus. Continuous phase was 2 wt.% 
Span 80 in kerosene. The dispersed phase flux was 350 L h-1m-2, the shear stress applied was 
11 Pa. Afterwards, 5 mL of the crosslinking solution (2 wt.% of MgSO4) was directly added 
to the emulsion and stirred continuously using the Dispersion Cell stirrer set at 1200 rpm. The 
reaction was run up to 24h. Figure 79 reports the microphotographs of the resulting particles; 
the starting emulsion is also reported for comparison (Figure 79 a). The Figure 79 b refers to 
the particles obtained after 24h of reaction; it is visible that solidification of the drops 
occurred but formation of aggregates was obtained. Rotational speed was too high and could 
cause droplet break-up. Rotation speed of the stirrer during the crosslinking reaction was 
reduced to 500 rpm. Figure 79 c shows the obtained particles after 24h of reaction; in this 
case no clusters were formed and the particles had a spherical shape. However, they resulted 
a b 
 
 
 
158 
 
 
to be extremely soft and “jelly-like”; hence the particles were not strong enough to go 
through the process of centrifugation or filtration. A different approach was then tested: to 
facilitate the crosslinker reaching the alginate drops of the emulsion; a secondary emulsion 
was produced by mixing 5 mL of 10 wt.% MgSO4 solution with 25 mL of 2 wt.% Span 80 in 
kerosene. The secondary emulsion was produced by homogenization for few seconds, 
afterwards it was added to the primary emulsion produced with the Dispersion Cell. The 
reaction was conducted for 24h and solidification of the particles was checked using the 
acetone procedure. From Figure 79 d it is visible that particles were formed but they resulted 
to be fragile and they did not resist to the washing procedure; thus it was not possible to 
recover the microparticles.  
  
  
Figure 79 Ionic crosslinking using MgSO4 as crosslinker; (a) starting emulsion, (b) 
crosslinking using 2 wt.% MgSO4 ; rotation speed= 1200 rpm, (c) crosslinking 
using 2 wt.% MgSO4 ; rotation speed= 500 rpm, (d) crosslinking using 10 wt.% 
MgSO4. (in a secondary emulsion), rotation speed= 500 rpm. Time of reaction= 
24h. Magnification used was 10X and 20X objective lenses. 
a b 
c d 
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4.4.2.2 Calcium chloride as ionic crosslinker; effect of the crosslinking process on the 
yeast glucose consumption 
The use of calcium chloride as ionic crosslinker was evaluated. The starting emulsion was 
obtained using the Dispersion Cell; the dispersed phase was composed by 2 wt.% alginate in 
water (containing 9.42x 107 cells mL-1) which was injected into a continuous phase made of 2 
wt.% of Span 80 in kerosene. A first approach consisted in adding directly to the starting 
emulsion 100 mL of a solution on CaCl2 with a concentration of 40 wt.%. The reaction was 
stopped after 24h; solid microparticles were obtained. The microparticles were recovered by 
filtration under vacuum using as washing solution a mixture of acetone and water in a volume 
ratio of 1:2. The use of a small amount of acetone produced a further hardening of the 
particles which are shown in Figure 80 a. Visually the obtained particles did not have a 
perfect spherical shape but it was possible to dry them obtaining a powder. In a different 
approach a saturated solution of CaCl2 (CaCl2 solubility in water= 7.45 g ml-1 at 20°C) was 
used for the crosslinking. While stirring continuously the W/O emulsion was added slowly 
into 100 mL of CaCl2 saturated solution. The mixture was stirred for 1h. The resulting 
microparticles are reported in Figure 80 b. The microparticles were solid and resistant to the 
drying process; however, shape of particles was elongated. This form is a consequence of the 
rapid solidification due to the ionic crosslinking with the calcium ion, the liquid alginate 
drops start to solidify as soon as they touch the calcium solution but the reaction does not 
occur instantaneously, forming a “tail” while they sink. The ionic crosslinking using the 
calcium ion resulted to be more effective for the production of hard microparticles resistant to 
the washing and drying process. Although, the spherical shape is lost during the solidification 
of the drops into solid microparticles.  
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Figure 80 Images of the obtained microparticles using (a) 40 wt.% CaCl2 as crosslinking 
solution and (b) a saturated solution of CaCl2.  
4.4.2.2.1 Crosslinking time 
Influence of the crosslinking time was evaluated using a very low concentration of 
crosslinker (5 wt.% CaCl2 solution) to solidify the alginate drops. Ideally, for higher 
crosslinker concentrations (as 40 wt.% of the first attempt) the reaction occurs faster; hence 
the reaction time required for the 5 wt.% solution to solidify the drops was considered the 
maximum time. 100 mL of the crosslinking solution was added directly to the starting 
emulsion produced with the Dispersion Cell; the reaction was monitored with time showing 
that solid particles are formed after 1h. For comparison pictures of the particles were taken 
after 24h of reaction. The samples produced at these operating conditions were named sample 
1. Figure 81 reports respectively the images of samples 1.1 crosslinked in 1h, and sample 1.2 
crosslinked in 24h. As shown in the images; the particles are formed and solid after 1h of 
reaction although the crosslinking using 5 wt.% of CaCl2 produced a loss of the spherical 
shape and formation of debris. Increasing the time of reaction up to 24h produced particles 
with an irregular shape as well and particles aggregates were formed. Hence, the reaction was 
considered complete after 1h as the particles obtained were resistant to the drying process 
with acetone, subsequently they were washed with a mixture of acetone: water in a volume 
ratio of 1:2 and dried at room temperature.  
a b 
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Figure 81 Microparticles crosslinked using 5 wt.% of CaCl2 (a) sample 1.1; picture taken 
after 1h, (b) sample 1.2; picture taken after 24h. The microparticles shown are re-
suspended in water. 
To check the influence of crosslinking time on the cell viability, the two samples produced 
(sample 1.1 and 1.2) were re- suspended in a 6 mM glucose solution and the glucose 
concentration reduction with time was checked. Figure 82 shows the percentage of glucose 
consumed by the encapsulated yeast in sample 1.1 and 1.2 with time up to 150h. From the 
graph is possible to see that the % of glucose consumed by sample 1.1 and sample 1.2 was 
similar. A slight reduction of the consumption rate was observed for sample 1.2 however, the 
glucose metabolism reached the 90% within 50h, showing that yeast viability was not 
affected by the longer time of reaction. It is reasonable to consider that 1h is a sufficient time 
to crosslink the drops forming solid alginate particles.  
 
 
a b 
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Figure 82 Percentage of glucose consumed with time depending on the time of reaction. 
Sample 1.1 (full circle signs) was produced in 1h of reaction, sample 1.2 (star 
signs) was obtained in 24h of reaction using a 100 mL of 5 wt.% CaCl2 solution. 
4.4.2.2.2 Washing procedure 
Influence of the washing procedure on the microparticles formation and yeast viability was 
examined. For this set of experiment the microparticles were produced by adding 100 mL of 
a 40 wt.% CaCl2 solution directly to the starting emulsions obtained using the membrane. The 
mixture was stirred for 1h with the Dispersion Cell stirrer set at 500 rpm. Once solid the 
microparticles obtained were washed with two different procedures. Sample 2.1 was washed 
with 2 wt.% Tween 20 in water and subsequently centrifuged at 800 rpm (3 times) and 1000 
rpm (1 time). Sample 2.2 was filtered under vacuum and washed using a mixture of acetone: 
water (1:2). The obtained particles were dried at room temperature. A small amount of 
sample 2.1 and 2.2 was re- suspended in water and observed under the optical microscope. 
Figure 83 reports the images of the microparticles obtained with these two washing methods. 
It is possible to notice that the microparticles of sample 2.1 were almost transparent showing 
a soft nature, furthermore using the Tween 20 solution it was more difficult to remove 
completely the remaining oil: Several cycles of washing and centrifuging were necessary to 
clean the particles from the oil phase producing loss of the sample.  
  
Figure 83 Microparticles produced using a 40 wt.% CaCl2 solution and washed with (a) a 2 
wt.% Tween 20 in water solution (sample 2.1) and (b) a acetone: water (1:2) 
solution (sample 2.2). The microparticles shown are re-suspended in water.  
The use of the acetone: water solution was more effective in removing the kerosene 
furthermore the process was less time consuming. Since it was possible to filter the particles 
a b 
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and dry them directly from the filter paper, the loss of sample was reduced. Acetone is an 
organic solvent that could potentially damage the yeast, the analysis of the glucose 
consumption was performed on sample 2.1 and sample 2.2 to check cell survival. Figure 84 
reports the glucose consumed by the encapsulated yeast in sample 2.1 and 2.2. The 
percentage of glucose consumed by sample 2.1 reached the maximum in 125h. Sample 2.2 
showed a slower consumption rate as in 125h only the 30 % of the glucose present in the 
solution was metabolized. A glucose consumption of the 85% was reached after 175h. This 
data shows that the yeast cells are viable and able to metabolize the glucose present in the 
solution surrounding the particles. However, it was hypothesized that the washing using 
acetone (in a small amount) produces a further hardening of the particles, thus the diffusion 
of the glucose trough the alginate membrane requires longer time; increasing also the time of 
glucose consumption.  
 
Figure 84 Percentage of glucose consumed with time depending on the washing procedure 
used. Sample 2.1 (hollow triangle signs) was washed using 2 wt.% Tween 20 in 
water, sample 2.2 (full squares signs) was washed using a mixture of acetone: 
water (1:2). All the samples were crosslinked with a 40 wt.% CaCl2 solution. 
Crosslinking time was 1h.  
4.4.2.2.3 Glucose consumption depending on the amount of crosslinker used 
The glucose consumption with time was evaluated depending on the amount of crosslinker 
used for the microparticles production. 2 wt.% alginate microparticles containing 9.42x 107 
cells mL-1 were produced using respectively 5- 25- 40 wt.% of CaCl2 or a saturated solution 
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of CaCl2. The starting emulsions for all the samples were prepared using 2 wt.% Span 80 in 
kerosene as continuous phase, operating conditions of emulsions production were: dispersed 
phase flux= 350 L h-1m-2, shear stress= 11 Pa. The drops were solidified adding 100 mL of 
the CaCl2 solution with the appropriate concentration directly to the emulsion. The reaction 
was conducted under continuous stirring using the stirrer with a rotation speed of 500 rpm. 
The reaction was stopped for all the samples after 1h. The obtained particles were washed 
using a solution of acetone: water (1:2) and dried at room temperature overnight. Another 
sample was produced by gently pouring the starting emulsion in 100 mL of a CaCl2 saturated 
solution. The particles were washed after 1h and dried with the same procedure described 
above. 10 mg of particles were added to a 6 mM solution of glucose and the glucose 
consumption checked with time. Figure 85 reports the data gathered. It is noticeable that the 
glucose consumption is slower for high crosslinked microparticles, while is 0% for the 
samples prepared using the saturated solution. For the 5- 25 and 40 wt.% CaCl2 crosslinked 
particles the consumption reached a maximum of 85- 100% of the initial glucose present in 
the solution. This suggests that the encapsulated yeast is viable and the difference in the 
velocity at which the glucose is consumed can be attributed to the crosslinking density. High 
crosslinked alginate particles are characterized by more interconnected polymeric chains 
giving rise to a slower diffusion of the glucose through. The sample made with a saturated 
solution does not produce a reduction of the glucose up to 150h, which can be explained by 
the death of the yeast encapsulated or the formation of a too dense polymeric network which 
prevented the glucose permeation.  
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Figure 85 Glucose consumption as a function of the microparticles crosslinking density. The 
samples were crosslinked with a concentration from 5 wt.% to 40 wt.% of CaCl2 or 
a saturated solution. All the samples were washed using an acetone: water (5:2) 
solution.  
According to the data gathered, ME is suitable for the production of uniform microparticles 
for living cell encapsulation. In the previous chapters, the samples were produced using the 
Dispersion Cell device for a lab- scale investigation of the emulsification process and 
formulations. Possibility to scale- up the process of ME for the production of W/O emulsions 
(crucial for the subsequent microparticles production) is investigated in the next chapter. The 
Pulsed (Oscillatory) Flow system selected for the scale-up was previously used for the 
production of O/W emulsions with hydrophilic membranes (Holdich et al., 2012; Piacentini 
et al., 2013). Hydrophobic membranes are required for the production if W/O emulsions, 
hence in preliminary investigation, effect of the membrane coating type is also reported.  
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4.5 MEMBRANE COATING  
4.5.1 Effect of the membrane coating on the emulsion drop size and uniformity 
The importance of membrane wettability was demonstrated by Nakashima et al., (1992). 
They showed that membrane wetting by the dispersed phase should be avoided for successful 
production of monodispersed emulsions; therefore, in the production of W/O emulsions, the 
membrane should be thoroughly wetted by the continuous oil phase, in order to minimize the 
spreading of the dispersed phase on the membrane. Hydrophilic membranes can be converted 
into hydrophobic membranes by coating the membrane surface with different hydrophobic 
materials (Yamazaki et al., 2002; Vladisavljević and Williams, 2005) and this thesis have 
investigated the use of PTFE (polytetrafluoroethylene) and FAS (Fluoroalkyl Silane) coating. 
For testing of two membrane coatings the dispersed phase flux was 350 L h-1-m-2, and the 
shear stress was 17 Pa. The dispersed phase was composed by 5 wt.% gelatine in water, with 
a yeast concentration of 3.14 x 107 cells mL-1. The continuous phase was made of 2 wt.% 
Span 80 in kerosene. The emulsions were produced at 35- 40 °C. The results obtained using 
the two membranes (new PTFE and FAS coated) are compared in Figure 86. The PTFE 
coated membrane had a thermally bonded PTFE coating on the metal surface, which made 
recoating the membrane (to maintain its hydrophobicity with multiple use) troublesome. In 
addition PTFE coated membrane requires a delicate washing procedure to avoid membrane 
coating damage: warm soapy water and an ultrasonic bath for a maximum of 30 s was used 
for the washing. To overcome this disadvantage, a FAS coated membrane (obtained from 
Micropore) was also tested for the production of the W/O emulsions. The FAS is chemically 
bonded to the membrane surface (Jeong et al., 2001), it is more resistant to the washing and 
recoating of the same membrane is possible. Figure 86 a.1 shows the surface of PTFE coated 
membrane while Figure 86 b.1 the surface of the FAS coated membrane. Both used 
membranes had 30 µm pore diameter, 200 µm pore spacing (30/ 200 µm). The emulsion 
produced with the PTFE coated membrane was characterized by an average droplet size of 62 
µm with a CV% of 18%. For the emulsion produced with the FAS coating the average 
droplet size measured was of 82 µm while the calculated CV% was 22%. The drops produced 
using the FAS coated membranes were noticeably larger in size than the ones produced using 
the PTFE coated membrane, suggesting that the PTFE coated membrane has a greater degree 
of hydrophobicity than the FAS coated membrane, when new. However, FAS coating may be 
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more practical for membranes intended for multiple uses due to the higher resistance and 
possibility to recoat the same membrane.  
 
   
Figure 86 Dispersed phase flux = 350 L h-1m-2, and the shear stress = 17 Pa. The Dispersed 
phase was 3.14 x 107 cells mL-1 dispersed in 5 wt.% gelatine. The continuous phase 
was 2 wt.% Span 80 in kerosene. (a) Emulsion produced using (a.1) standard PTFE 
coated nickel membrane 30/200 µm, (b) emulsion produced using (b.1) standard 
FAS coated nickel membrane 30/200 µm.  
4.5.2 PTFE and FAS coated membrane for multiple uses  
Performance of a standard PTFE coated and standard FAS coated membrane were evaluated 
for multiple emulsions production. The membranes had 30 µm pore diameter and 200 µm 
pore spacing. The dispersed phase of the emulsions produced was made of G:CS (5:2) 
containing 3.14x 107 cells mL-1 or 9.42x 107 cells mL-1. The continuous phase was 2 wt.% 
Span 80 in kerosene. Operating parameters of the process for all the samples were: 350 L h-1 
m-2 as dispersed phase flux and 17 Pa as shear stress. The Dispersion Cell was submerged in a 
water bath with a constant temperature 35- 40°C during the production of the emulsions. 
Figure 87 reports the microphotographs of emulsions obtained using a new PTFE or FAS 
a
  
b 
a.1  b.1  
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coated membrane (Figure 87 a- PTFE and c- FAS) and PTFE or FAS coated membrane 
(Figure 87 b- PTFE and d- FAS) after they have been used 4 times. After the use; the 
membrane (PTFE or FAS coated) was washed according to the procedure described in 
section 3.1.3. After the washing, the membrane was dried and soaked overnight in pure 
kerosene without any surfactant. From Figure 87 a- PTFE it is visible that the emulsion 
obtained with the new PTFE coated membrane was uniform (CV%= 18%) while a reduction 
of the uniformity is visible after multiple uses: the fourth emulsion produced using the same 
membrane had a CV%= 35% (Figure 87 b- PTFE). Uniform drops were produced with a 
new FAS coated membrane with a measured CV% of 22% (Figure 87 c- FAS), a CV% of 
24% was measured for the fourth emulsion produced using the same FAS coated membrane 
(Figure 87 d- FAS). It is noticeable that a new PTFE coated membrane gives monosized 
emulsions as this type of coating resulted to be more hydrophobic than the FAS, however 
with the multiple uses the PTFE coating is partially removed producing less uniform drops. 
The FAS coating showed to be more effective for production of multiple W/O emulsions with 
a good uniformity. The membranes can be easily recoated with FAS coating in order to 
regenerate the hydrophobicity when required. 
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Figure 87 Emulsions produced using (a- PTFE) a new standard PTFE coated 30/200 µm 
membrane, (b- PTFE) a standard PTFE coated 30/200 µm membrane after 4 uses, 
(c- FAS) a new standard FAS coated 30/200 µm, (d- FAS) a standard FAS coated 
30/200 µm after 4 uses. Dispersed phase flux = 350 L h-1 m-2, shear stress applied = 
17 Pa. 
4.5.2.1 Influence of the soaking time 
Prior to the emulsification process the membrane is soaked for at least 30 minutes in the oil 
used as continuous phase without presence of any emulsifier to improve the hydrophobicity 
of the membrane. The effect of the soaking time on the uniformity of the emulsions obtained 
was investigated using both PTFE and FAS coated membranes with 30 µm pore size and 200 
µm pore spacing. Figure 88 shows the emulsions obtained using the PTFE coated membrane 
soaked for 30 minutes or overnight, for the emulsions production a shear stress from 7 to 17 
Pa was used. The dispersed phase flux was 350 L h-1m-2. The dispersed phase was 5 wt.% 
gelatine containing 9.42x 107 cells mL-1, as continuous phase 2 wt.% Span 80 in kerosene 
was used. The temperature of emulsions production was 35- 40 °C.  
a- PTFE b- PTFE 
c- FAS d- FAS 
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Figure 88 Microphotographs of emulsions produce at different values of shear stress using a 
nickel standard PTFE coated membrane with 30 µm pore size and 200 µm pore 
spacing soaked for 30 minutes or overnight in kerosene. The dispersed phase flux 
used was 350 L h-1m-2.  
It is visible that the uniformity of the emulsions obtained using a membrane soaked into 
kerosene for longer time was improved. Using a membrane soaked for 30 minutes emulsions 
with a CV% of 24%- 33% and 27% were produced applying respectively a shear stress of 7- 
11 and 17 Pa. At comparable values of shear stress applied; the obtained CV% was lowered 
7 Pa  Soaking time= 30 min Soaking time= overnight 7 Pa  
11 Pa  Soaking time= 30 min 11 Pa  Soaking time= overnight 
17 Pa  Soaking time= 30 min 17 Pa  Soaking time= overnight 
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to 23%- 17% and 15% respectively using the same membrane but soaked overnight into the 
oil. This data shows that the PTFE coated membrane is subject to a reduction of the 
hydrophobicity for shorter soaking times. A longer time of soaking means also an increase of 
the overall time of emulsions and subsequently microparticles production. Same investigation 
was done using a FAS coated membrane. The shear stress applied was 17 Pa, the dispersed 
phase flux used was 350 L h-1m-2. The system temperature was kept at 35- 40 °C. As 
previously discussed the FAS coated membrane gave larger and less uniform drops compared 
to the PTFE membrane under the same operating conditions. In Figure 89 are reported the 
images of the emulsions produced using the FAS coated membrane, using the membrane 
soaked 30 minutes a CV% of 20% was obtained. Increasing the soaking time by leaving the 
membrane overnight in kerosene produced a negligible increase in CV%.  
  
Figure 89 Emulsions produced using a standard nickel FAS coated membrane with 30 µm 
pore size and 200 µm pore spacing soaked for 30 minutes or overnight in kerosene. 
Shear stress applied was 17 Pa and dispersed phase flux was 350 L h-1m-2. 
Figure 90 summarizes the obtained values of Dav and CV% of the emulsions produced in this 
section using the PTFE or FAS coated membrane showing the effect of the soaking time. 
Using a PTFE membrane soaked for 30 minutes presence larger drops was observed 
comparing to the emulsions produced using the overnight soaked PTFE membrane. The 
CV% obtained using the 30 minutes soaked PTFE membrane was higher than the CV% of 
the emulsions produced with the overnight soaked PTFE membrane (probably as a 
consequence of the spreading of the drops at the membrane surface). The Dav of the 
emulsions produced with the FAS coated membrane did not change depending on the time of 
soaking and the obtained CV% was similar for both samples. Visually, the FAS coated 
membrane gave reproducible results independently from the soaking time. Error bars are 
17 Pa  Soaking time= 30 min 17 Pa  Soaking time= overnight 
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reported showing the standard deviation of the measurements. According to this observation 
the use of the FAS coated membrane could potentially reduce the time of emulsions 
production; 30 minutes resulted to be a sufficient soaking time to obtained uniform 
emulsions.  
 
Figure 90 Influence of the membrane soaking time on Dav and CV% of the emulsions 
produced using a nickel PTFE or FAS coated membrane with 30 µm pore size and 
200 µm pore spacing. Dispersed phase flux = 350 L h-1m-2. Error bars represent the 
standard deviation of the measurements. 
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4.6 SCALE UP OF W/O EMULSIONS PRODUCTION BY MEMBRANE 
EMULSIFICATION 
4.6.1 W/O emulsions production, Dispersion Cell preliminary tests 
For the W/O emulsion production scale up using the Pulsed (Oscillatory) Flow system, the 
optimization of the continuous phase composition was required. Miglyol is less flammable, 
less toxic and less volatile than the previously used kerosene. Furthermore the use of more 
viscous oil reduces the risk of leakages and loss of oil through the metallic connectors during 
the emulsification process. The use of Miglyol oil for the production of the W/O emulsions 
was tested using the Dispersion Cell and the results compared with ones obtained using 
kerosene as continuous phase. The dispersed phase was made of 10 wt.% fish gelatine in 
water. The emulsions were produced using a standard nickel FAS coated membrane with 30 
µm pore size and 200 µm pore spacing. The dispersed phase flux was 350 and 490 L h-1m-2. 
Figure 91 reports the Dav and CV% of emulsions produced using 2 wt.% Span 80 in kerosene 
or 2 wt.% ABIL EM 90 in Miglyol. Using Span 80 in kerosene; at comparable values of 
shear stress (11 Pa) the use of a higher flux produced more uniform drops: at 490 L h-1m-2 the 
CV% obtained was 29%. Resulting size of the drops produced in Miglyol at 22 Pa was in 
accordance with the size of the drops produced in kerosene (applying a shear between 11 to 
27 Pa); Miglyol can be successfully used in this formulation as replacement for the kerosene. 
Comparable CVs% were obtained using kerosene or Miglyol for the preparation of the 
continuous phase.  
ABIL EM 90, PGPR and Span 80 were tested in Miglyol as oil soluble emulsifiers; Figure 
92 shows the emulsions obtained varying the emulsifier type. For this test the dispersed phase 
used was 20 wt.% fish gelatine in water, the shear stress applied was 22 Pa and the flux was 
350 L h-1m-2. It is visible that both ABIL EM 90 and PGPR were able to stabilize the 
polymeric drops in Miglyol while the use of Span 80 produced extremely unstable emulsions 
causing bursting of the drops on the glass slide and at the bottom of the beaker. The PGPR as 
emulsifier was not preferred as the dissolution in Miglyol required the heating of the oil and 
longer mixing time compared to the ABIL EM 90; hence for comparable emulsifying 
properties the surfactant which is dissolved more easily in the oil was selected. 
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Figure 91 Influence of the continuous phase composition on emulsion droplet size and size 
uniformity. The membrane used was a standard nickel FAS coated membrane with 
30 µm pore size and 200 µm pore spacing. Dispersed phase flux used was 350 L h-
1m-2.  
 
 
Figure 92 Microphotographs of emulsions produced using as continuous phase (a) 2 wt.% 
ABIL EM 90 in Miglyol, (b) 2 wt.% PGPR in Miglyol and (c) 2 wt.% Span 80 in 
Miglyol. Membrane used was a nickel standard FAS coated membrane with 30 µm 
a b c 
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pore size and 200 µm pore spacing. Dispersed phase flux used was 350 L h-1 m-2, 
shear stress applied 22 Pa.  
Influence of the dispersed phase viscosity was investigated using as continuous phase 2 wt.% 
ABIL EM 90 in Miglyol and increasing concentrations of fish gelatine in the dispersed phase. 
The emulsions were produced using a nickel standard FAS coated membrane with 30 µm 
pore size and 200 µm pore spacing and the results are reported in Figure 93.  
 
Figure 93 Effect of the amount of gelatine in the dispersed phase on the emulsion Dav and 
CV%. Membrane type used was nickel standard FAS coated membrane with 30 
µm pore size and 200 µm pore spacing. Continuous phase used: 2 wt.% ABIL EM 
90 in Miglyol. Dispersed phase flux used was 350 L h-1m-2, shear stress applied 22 
Pa.  
The dispersed phase was varied from 5 wt.% to 30 wt.% of fish gelatine in water. The 
viscosity measured for the 5- 10- 20- 30 wt.% fish gelatine solutions were 4.0±0.1- 12.0±0.5- 
59.6±0.79- 380.5±0.8 mPa s-1 respectively (the viscosity measurements were taken at a 
constant temperature of 40°C to avoid solidification of the gelatine, the phases showed a 
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Newtonian behaviour). The operating conditions of emulsions production were: 350 L h-1m-2 
as dispersed phase flux and 1200 rpm as rotation speed of the stirrer corresponding to 22 Pa. 
It is visible from Figure 93 that increasing the amount of gelatine in the dispersed phase 
produced a reduction of the CV% obtained. The emulsions obtained using 5 wt.% of fish 
gelatine as dispersed phase had a Dav of 70 µm and a CV% of 40%. Microphotographs of the 
emulsions are presented in Figure 94, it is visible that the 5 wt.% fish gelatine sample is 
characterized by the presence of smaller drops which suggests that at this shear the low 
viscosity of the dispersed phase could cause breaking of the drops. Increasing the viscosity of 
the dispersed phase it is noticeable a slight reduction of the emulsion drop size for fish 
gelatine concentrations of 10, 20 and 30 wt.%. It is believed that the increasing viscosity of 
the dispersed phase could lead to a reduction of the dispersed phase flux, producing a 
reduction of the drop size. This trend was observed in previous work (Kukizaki, 2009). The 
CV% gradually reduced up to 23% for the sample prepared using 30 wt.% fish gelatine. 
However, 20 wt.% of fish gelatine was selected for the subsequent experiments because the 
viscosity of the resulting solution was not too high and a reasonable uniformity of the drops 
was achieved.  
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Figure 94 Images of the emulsions produced using as dispersed phase (a) 5 wt.%, (b) 10 
wt.%, (c) 20 wt.% and (d) 30 wt.% fish gelatine in water. Continuous phase 
composition was 2 wt.% ABIL EM 90 in Miglyol. Dispersed phase flux: 350 L h-
1m-2, shear stress: 22 Pa. 
4.6.2 Pulsed (Oscillatory) Flow system for W/O emulsion production scale up 
4.6.2.1 O/W emulsions production; preliminary tests 
The Pulsed (Oscillatory) Flow system was initially tested for the production of O/W 
emulsions in order to investigate the influence of the operating parameters on the mean drop 
size and size distribution. The composition of the O/W emulsion was 2 wt.% Tween 20 in 
water as continuous phase and sunflower oil as dispersed phase. For the tests the “generator 
voltage” was set on 1 V while the frequency was varied from 1 to 15 Hz. The membrane used 
was a hydrophilic tubular membrane with 20 µm pore size and 80 µm pore spacing. The 
system was initially filled with the continuous phase using a peristaltic pump and 
subsequently the pulsation was activated using the LabView executive software. The system 
was run for at least 30 minutes to ensure that all the air was removed. For the first set of 
experiments the continuous phase flow rate was 80 mL min-1 and the dispersed phase flow 
a b 
c d 
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rate was 20 mL min-1 (CP/ DP flow rate= 80/ 20 mL min-1). The resulting average drop size 
and uniformity of the emulsions obtained are shown in Figure 95, it is visible that increasing 
the frequency of the oscillation a reduction of the drop size is obtained and the trend is in 
accordance with the data reported in literature (Holdich et al., 2012). The measured CV% 
was above 30% using 1 and 3 Hz but it decreased up to 23% increasing the frequency from 5 
to 15 Hz. It was observed that for frequencies below 5 Hz the signal detected by the 
accelerometer was unstable and the shape of the oscillation was not in a regular waveform 
(i.e. sine wave), for low frequencies the amplitude detected was varying with time. In a 
second set of experiments the injection rates of the continuous and dispersed phase were 
changed: the CP flow rate was lowered to 70 mL min-1 and the DP flow rate was increased to 
30 mL min-1 (CP/ DP injection rate= 70/ 30 mL min-1). The frequency used was the one that 
gave the lowest CV% with the previous combination of injection rates. The average drop size 
was similar to the Dav obtained using a CP/ DP injection rate of 80/ 20 mL min-1. The 
uniformity of the emulsions produced with a CP/ DP flow rate of 70/ 30 mL min-1 was 
equivalent to the one obtained with a CP/ DP flow rate= 80/ 20 at comparable voltage and 
frequency of the pulsation.  
 
Figure 95 Influence of the frequency on the Dav and CV%, the membrane used was a tubular 
hydrophilic membrane with 20 µm pore size and 80 µm pore spacing. The voltage 
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was 1 V for all the experiments. Continuous phase was 2 wt.% Tween 20 in water, 
dispersed phase was sunflower oil.  
4.6.2.2 W/O emulsions production 
For the production of W/O emulsions in a continuous rate the use of the Pulsed (Oscillatory) 
Flow system was tested, the influence of the shear stress generated by the pulsation was 
investigated on the Dav and uniformity of the emulsions. For these tests the continuous phase 
was made of 2 wt.% ABIL EM 90 in Miglyol and the dispersed phase was 20 wt.% of fish 
gelatine in water. The membrane used for the production of the O/W emulsions showed the 
previous section (subchapter 4.6.2.1) was made hydrophobic by FAS coating. The continuous 
phase flow rate was initially set at 80 mL min-1 while the dispersed phase flow rate was 20 
mL min-1 corresponding to a dispersed phase flux of 413 L h-1m-2. The continuous phase was 
pulsed along the membrane module using frequencies between 10 to 30 Hz and peak to peak 
displacement values from 0.5 to 3.5 mm. The shear stress generated at these operating 
conditions was between 0.4 to 14.5 Pa. The resulting drop size obtained with the variation of 
the shear are reported in Figure 96, the line reports the theoretical Dav calculated using the 
model (Equ. 7, page 41). The experimental drop size measured was in accordance with the 
Dav determined using the model for equivalent values of shear stress applied. From Figure 96 
however is visible that the emulsions produced were characterized by values of CV% above 
30 for almost all the experiments. It was observed the formation of oil drops within the water 
drops of the W/O emulsions obtained. Initially it was hypothesized that the dispersed phase 
flow could be insufficient to avoid the continuous phase permeation through the membrane 
during the emulsification process when the pulsation is activated. Hence, in a second set of 
experiments the continuous phase flow was decreased to 60 mL min-1 and the dispersed phase 
flow was increased to 30 mL min-1 generating a dispersed phase flux of 620 L h-1m-2. Using 
frequencies between 10 and 25 Hz in combination with peak to peak displacement values of 
1.5 or 2.5 mm (i.e. amplitudes of 0.75 or 1.75 mm) the shear stress generated was between 
3.3 to 7.8 Pa. The Dav of emulsions produced at these operating conditions are reported in 
Figure 96 for comparison with the previous results; visually the experimental Dav are in 
accordance with the model. The size of the drops produced with a shear of 7.8 Pa is smaller 
than the predicted Dav for this value of shear; this could be a consequence of drops breaking 
due to the extreme conditions of production. For this set of experiments the resulting 
uniformity was improved as the CV% obtained was in a range of 25- 30%. Error bars report 
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the standard deviation of the measurements done on three samples. Adjustment of the CP/ DP 
flow rate improved the uniformity but formation of inner oil drops was still observed. Other 
combinations of CP/ DP flow rate were tested (90/ 10, 60/ 20, 60/ 25 mL min-1) giving 
extremely polydispersed emulsions hence the data were not included in the graph. It was 
hypothesized that this phenomenon is due to the membrane vibration during the process of 
emulsification giving a pre-mixing of the two phases, as a consequence of the high viscosity 
of the emulsions produced.  
 
Figure 96 Influence of the shear stress on emulsions drop size and size distribution varying 
the continuous phase injection rate and the dispersed phase flux. Membrane used 
was a FAS coated with 20 µm pore size and 80 µm pore spacing. DP: 20 wt.% fish 
gelatine in water, CP: 2 wt.% ABIL EM 90 in Miglyol. Error bars represent the 
standard deviation of the measurements. 
4.6.2.3 Comparison of emulsions produced using the Dispersion Cell system or the Pulsed 
(Oscillatory) Flow system 
The results obtained using the Pulsed system were compared to the Dav and CV% of 
emulsions produced using the Dispersion Cell system. The way in which the shear is 
generated is different for the two systems; for the Dispersion Cell the shear is generated by 
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the rotation of the stirrer on the top of a flat disk membrane; while for the Pulsed system the 
shear is generated by the pulsation of the continuous phase within the tubular membrane 
mounted in the membrane module. Consequently, the maximum shear stress is calculated 
using different equations (please refer to section 2.3.3.1); however the theoretical Dav 
depending on the shear stress applied was calculated using the shear- capillary model. Figure 
97 shows the average drop size vs the shear stress obtained using the Dispersion Cell system 
for the production of 15 wt.% PVA drops in a continuous phase made of 2 wt.% PGPR in 
Miglyol. The emulsions were produced using a hydrophobic PTFE coated (disk) membrane 
with 10 µm pore size and 200 µm pore spacing. The dispersed phase flux for this set of 
experiments was 12 L h-1m-2 and the shear stress applied was between 2 and 17 Pa. For 
comparison is reported the resulting average drop diameter of emulsions produced with the 
Pulsed system using a dispersed phase made of 20 wt.% fish gelatine in water and 2 wt.% 
ABIL EM 90 in Miglyol as continuous phase. These emulsions were produced applying a 
shear stress between 3.3 and 7.8 Pa, 60 mL min-1 was used as continuous phase flow and 620 
L h-1m-2 as dispersed phase flux. The membrane was a hydrophobic FAS coated (cylindrical) 
membrane with pore sized 20 µm and 80 µm pore spacing. The models reported in the graph 
with the line and the “dash- dot” line were calculated taking into account the pore size of the 
membranes. These two formulations were selected for the comparison has they had similar 
interfacial tensions, as reported in Table 4 (page 51): 2.2 mN m-1 was measured for the 
system 15 wt.% PVA in Miglyol with 2 wt.% PGPR and 2.5 mN m-1 for the system 20 wt.% 
fish gelatine in Miglyol with 2 wt.% ABIL EM 90. Form Figure 97 it is visible that the size 
of the drops is in accordance with the predicted Dav within a range of shear of 2- 5.6 Pa while 
a slight divergence is noticeable for shear above 6 Pa. However, the data illustrates that the 
Dav of emulsions produced with either the Dispersion Cell or the Pulsed Flow system can be 
predicted using the shear- capillary model and that the tests performed using the Dispersion 
Cell can be reproduced on a large scale using the Pulsed system.  
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Figure 97 Average droplet size and size distribution as a function of the applied shear stress. 
Comparison between the Dispersion Cell and the Pulsed (Oscillatory) system using 
membranes with 10 or 20 µm pore size. Error bars represent the standard deviation 
of the measurements. 
4.6.2.4 Continuous production of W/O emulsions using the Pulsed (Oscillatory) Flow 
system 
Scaling up the process of W/O emulsions production using the Pulsed system presents the 
main advantage of the continuous production of emulsions with a high dispersed to 
continuous phase ratio (up to the 30%) within a single pass. The possibility to produce 
emulsions in a continuous rate was tested running the system for 3h. The continuous phase 
was circulated within the system using the peristaltic pump for 1h, afterwards the dispersed 
phase was injected. After the production of the first emulsion (named Sample 1) the injection 
of the dispersed phase was stopped while the continuous phase was re- circulated an 
additional hour without opening the membrane module. After 1 hour time, the dispersed 
phase was pumped within the system and a second emulsion was produced (Sample 2) 
keeping constant all the operating parameters. The whole process was repeated a third time 
and the emulsion collected was Sample 3. The continuous phase was injected with a flow rate 
of 60 mL min-1 and the dispersed phase flux was 620 L h-1m-2 (i.e. 30 mL min-1). The shear 
stress was 3.3 Pa generated with a frequency of 20 Hz and a peak to peak displacement of 1.5 
mm  The resulting drop size and uniformity of the emulsions produced within 3h in total are 
shown in Figure 98. It is visible that  measured Dav was approximately 100 µm for all the 
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emulsions produced, Sample 1 showed a slight lower CV% (26 %) compared to Sample 2 
and 3 produced after 2 and 3h respectively. However, reproducible results were obtained 
running the system for 3h in continuous without washing the membrane which is 
advantageous if a high quantity of emulsion is required, furthermore the high concentration of 
dispersed phase in the emulsion is extremely advantageous as a higher amount of particles 
can be obtained with a lower consumption of continuous phase.  
 
Figure 98 Dav and CV% of emulsions produced running the Pulsed (Oscillatory) system 
continuously for 1h time. Continuous phase injection rate= 60 mL min-1, dispersed 
phase flux= 620 L h-1m-2. Shear stress applied= 3.3 Pa.  
 
 
 
184 
 
 
4.7 RESULTS SUMMARY  
The Membrane Emulsification technique was successfully applied for the production of 
microparticles for the encapsulation of model molecules or probiotic cells and their potential 
oral delivery. Size of the microparticles obtained was above 28 μm in accordance with the 
size of particles commonly used for the oral administration (20- 120 μm) (Rathbone et al., 
2002). The formulations were modified accordingly with the final use of the microparticles, 
while the size and size distribution were controlled optimizing the process of emulsions 
production.  
The Dispersion Cell device with flat disk membranes having cylindrical pores was used for 
the generation of the polymeric drops in a controlled manner. Varying the operating 
parameters of the process such as the shear stress applied at the membrane surface, dispersed 
phase flux and membrane type it was possible to manufacture uniform emulsions (under the 
best working conditions CV%=16%) with drops sized from 28 to 340 μm. The Dispersion 
Cell system resulted to be extremely useful for the preliminary investigation of the emulsion 
composition and best operating conditions for drop generation with the desired size.  
A post- emulsification treatment was adopted to convert the liquid polymeric drops into solid 
microparticles. The solidification procedure was varied accordingly with the polymeric 
material selected and the final application. Using PVA and blends of PVA with CS as the 
emulsion dispersed phase, the solidification of the drops was obtained using glutaraldehyde. 
It was seen that the extent of the crosslinking reaction had a direct effect of the swelling 
properties of the material and, as a consequence, on the release rate of the encapsulated 
model compound. The use of a cationic polymer in the formulation (i.e. chitosan) in 
association with a second polymer able to react with the GA (i.e. PVA), produced 
microparticles able to release the model molecule when the environmental pH is acidic.  
Alternative formulations were developed for the encapsulation of living cells, the cell passage 
through the membrane pores during the process of the initial emulsion production was tested 
showing that selecting a membrane with the appropriate pore size (in this case a 30 μm 
membrane was used) no filtration of the cell occurs. It was demonstrated that the emulsions 
properties (Dav and CV%) are not affected by the presence of the cells in the dispersed phase. 
The solidification of the liquid drops containing cells was obtained in mild conditions: by 
thermal gelation of the gelatine or with a combination of thermal gelation and ionic 
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crosslinking for the blends gelatine- CS. The release of the cells in neutral- basic conditions 
(to mimic the intestinal- colon tract) was obtained by coating the particles with the gastro-
resistant polymer Eudragit S100.  
Immobilization of yeast into particles was obtained using alginate as encapsulating material. 
Alginate drops were solidified by ionic crosslinking and it affected the porosity of the 
resulting material. Regardless the material used it was demonstrated that the yeast survived 
the process of encapsulation and it was shown that Membrane Emulsification is a suitable 
technique for the production of drops and particles containing cells with the required 
diameter and with a high uniformity. 
Hence, the industrial application of the technique of Membrane Emulsification is object of 
great interest. As the Dispersion Cell device was conceived for a lab- scale investigation, 
alternative devices have been developed for the process scale up. In this work the use of the 
Pulsed (Oscillatory) Flow system for the production of W/O emulsions was tested. Polymeric 
drops of fish gelatine were successfully generated in Miglyol oil containing a surfactant and a 
high concentration of the dispersed phase in the emulsion was obtained (~ 30%) in a single 
pass.  
For the continuous production of W/O emulsions an alternative coating for the production of 
hydrophobic membranes was tested, performances of a FAS (fluorinated compounds) coated 
membrane were compared with the classical PTFE coated membrane. The chemically bonded 
FAS coating resulted to be less hydrophobic than the thermally bonded PTFE producing 
larger drops at comparable conditions of production, but it resulted to be more appropriate for 
multiple uses, furthermore using a FAS coated membrane was possible to reduce the 
membrane soaking time required to obtain uniform emulsions.  
A simple shear- capillary model was adopted for the prediction of the drop size for both the 
Dispersion Cell and the Pulsed systems. It was shown that the experimental results were in 
accordance with the predicted ones using the model but a divergence between experimental 
and theoretical size is visible when increasing the dispersed phase flux during the drop 
production.  
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5. CONCLUSIONS AND FUTURE WORK 
Dispersion Cell system and formulations tested 
Poly (Vinyl) Alcohol (PVA) microparticles were obtained starting from W/O emulsions 
produced using the Dispersion Cell system. Droplets with a narrow size distribution (CV%= 
16% under the best operating conditions) were generated using hydrophobic membranes 
(nickel and stainless steel) having 10 μm pore size and 200 μm pore spacing.. Controlled 
mean drop diameter from 28 to 288 μm were obtained applying a shear stress from 2 to 59 Pa 
and using 12- 1250 L h-1m-2 as dispersed phase flux. 15 wt.% PVA in water was used as 
dispersed phase for most of the emulsions produced and using 2 wt.% ABIL EM 90 or 2 
wt.% PGPR in Miglyol stable emulsions were obtained. The stainless steel membrane (pre-
soaked in the oil continuous phase) produced smaller and more uniform droplets compared to 
a PTFE coated nickel membrane. Contact angle measurements confirmed the hydrophobicity 
of the nickel membrane therefore the pore surface (conical for the nickel and flat for the 
stainless steel membrane) had a greater influence on the size and uniformity possibly with the 
drop forming on an area greater than the pore itself for drops produced using the nickel 
membrane. Solidification of the PVA drops was obtained by a chemical crosslinking reaction 
using glutaraldehyde (GA); the amount of GA used was varied from 1 to 50 vol.% . Using 50 
vol.% of GA a reduction of approximately the 30% of the size was obtained passing from the 
liquid drops to the solid microparticles. 1 vol.% was the lowest GA concentration which 
produced solid microparticles. The crosslinking degree directly affected the capability of the 
PVA microparticles to incorporate water and swell: it was shown that concentrations of GA 
from 50 to 10 vol.% did not produce a visible microparticles swelling while for 
concentrations of GA below 5 vol.% the size of the solid microparticles increased 
significantly after 24h in water. This behaviour to swell is directly correlated with the ability 
of the particles to release an encapsulated compound. Blue Dextran (BD) and Cu2+ were used 
as model molecules for the encapsulation. No release of BD was detected up to 5 days, while 
70% of the encapsulated Cu2+ was released from the PVA particles prepared with 1 vol.% of 
GA copper within 3h. The release profile of Cu2+ from the PVA particles was characterized 
by an initial ‘‘burst release” probably due to the release of Cu2+ from the surface of the 
particles. However, no difference in the release of Cu2+ was seen from the PVA 
microparticles at different pH (3 and 7) suggesting that, at these conditions, PVA does not 
have pH sensitivity. 
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For the production of pH sensitive microparticles PVA and chitosan were selected as 
polymeric materials. Uniform emulsions were initially obtained using as dispersed phase 
mixtures of PVA and chitosan (CS) in different ratios or pure chitosan and 2 wt.% ABIL EM 
90 in Miglyol as continuous phase. Membranes used were a stainless steel ringed or a nickel 
standard membrane with 10 or 20 μm pore size respectively and 200 μm pore spacing. 
Average drop diameters obtained were between 32 to 56 μm applying a shear stress from 35 
to 59 Pa and a dispersed phase flux between 114 to 434 L h-1m-2. Lowest values of CV% 
obtained were 20 and 23%. Crosslinking of the drops was performed using GA and it was 
seen that 10 vol.% was the lowest crosslinker concentration required to obtain solid 
microparticles for all the formulations tested in this section. Copper and sodium salicylate 
(SS) were encapsulated in separate samples and the release was tested with time at pH=3 and 
7. Successful encapsulation of Cu2+ in the microparticles was confirmed by SEM analysis 
with Energy Dispersive X-ray Spectrometer (EDX) and using the release tests. Blending 
chitosan and PVA it was possible to have a release of Cu2+ up to 80% in 3h under acidic 
conditions. No significant release (less than 3%) was observed at neutral conditions. Pure CS 
microparticles did not show any pH sensitivity and the release of Cu2+ did not exceed 5% 
within 3h. Due to the higher MW and the ionic interaction with the polymeric matrix the 
release of SS was almost 4 times lower compared to Cu2+ after 3h in acidic environment and 
around 10% in neutral environment. 
Microparticles for cell encapsulation and pH depended release were obtained blending 
Gelatine with Chitosan and applying a polymeric coating on the microparticles surface. The 
Dispersion Cell was used for the production of the W/O emulsions with hydrophobic 
membranes of 30 µm pore diameter and 80 or 200 µm pore spacing. The aqueous dispersed 
phase composed of a mixture of gelatine and chitosan, or just gelatine with yeast cells, used 
as an example of encapsulating a living organism. The oil continuous phase used was 2 wt.% 
SPAN 80 in kerosene. The dispersed phase flux was varied from 70 to 700 L h-1 m-2 and the 
maximum shear stress at the membrane surface was between 1– 27 Pa. Using these operating 
parameters uniform (CV below 25% for most of the samples) emulsions were obtained with 
drops sized between 34 and 340 µm. Tests with and without cells showed that the emulsion 
drop size, and uniformity, was not affected by the addition of the cells in the disperse phase. 
Tests were performed up to a maximum yeast cell concentration in the encapsulated in the 
drops of 3.14×108 cells mL-1. The yeast cell encapsulation efficiency was 100%, checked by 
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ascertaining that the non-tortuous pore channel membrane used did not filter any yeast cells 
when operating under the flow rate and by observation of no cells occurring in the organic 
continuous phase. The process of solid microparticles formation consisted of a thermal 
gelation and/or ionic crosslinking using SHMP (sodium hexametaphosphate). Eudragit S100 
coating was performed on gelatine microparticles encapsulating cells using the oil in oil 
solvent evaporation method. The dissolution of the yeast loaded particles was checked at 
different time intervals in acidic (pH 1.2), neutral (pH 7) and slightly basic (pH 8) 
environments to mimic the transit conditions through the gastro-intestinal tract. The Eudragit 
coated particles did survive the acidic environment for 2h without dissolving, or releasing, 
the yeast cells. After surviving acidic conditions, dissolution of the particles occurred at pH 7 
within 3h, and within 1h at pH 8, with subsequent yeast release. A targeted pH dependent 
release of cells in simulated intestine-colon conditions was achieved. The cell viability after 
the release was demonstrated by the ability of the yeast to metabolize up to 90% of glucose 
added to the growth medium in 24h. A confirmatory test was performed using a live/dead cell 
staining with two fluorescent probes which showed that living yeast cells predominated. 
Yeast cells were chosen as a proof of concept showing that ME is a promising method for 
cell encapsulation; the process can be applied to a variety of micro-organisms according to 
the cell type and specific requirements.  
Immobilization of yeast cell within particles was obtained using alginate as encapsulating 
material. Emulsions made of 2 wt.% of alginate as dispersed phase and 2 wt.% SPAN 80 in 
kerosene as continuous phase were initially produced using 350 L h-1m-2 as dispersed phase 
flux and shear stress from 1 to 17 Pa. Using a 30 μm pore sized and 200 μm pore spacing 
nickel membrane, drops with average diameter between 84 to 270 μm were produced and the 
CV% obtained did not exceed 24%. The presence of the yeast inside the drops did not affect 
the emulsion drop size and size distribution, only for the highest concentration tested (1.88x 
108 cells mL-1) a slight increase of the CV% was observed. Magnesium ion was tested for the 
ionic crosslinking of alginate but the use of calcium ion resulted to be more appropriate for 
the formation of solid alginate microparticles. Solidification of the alginate drops was 
obtained by addition to the emulsion of a CaCl2 solution (in different concentrations) or by 
pouring the emulsion within a saturated solution of CaCl2. A solution of acetone: water (1:2) 
was used for the washing and further harvesting of the particles. It was shown that the yeast 
survived the process of particles production and washing procedure analysing the glucose 
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consumed by the yeast (still encapsulated in the particles) with time. It was seen that the 
glucose consumption rate was influenced by the amount of crosslinker used for the 
microparticles production: increasing the CaCl2 concentration from 5 to 40 wt.% a reduction 
of the glucose consumption with time was observed, for particles produced with a saturated 
solution of CaCl2 the amount of glucose consumed was approximately 0% up to 150h. This 
data suggested that the crosslinking density has a direct effect on the alginate porosity and a 
highly crosslinked polymer matrix delays the glucose diffusion.  
Membrane performance for W/O production  
The performance of hydrophobic membranes coated with PTFE and FAS (fluorinated 
compounds) was compared showing that the PTFE coated membrane gave smaller drops than 
the FAS coated membrane. From this result it was concluded that the PTFE coated membrane 
is characterized by a higher degree of hydrophobicity, but the coating method makes it less 
favourable for repeated use after cleaning. FAS coated membranes are promising for repeated 
production of W/O emulsions: it was seen that the FAS coating is more resistant and it does 
not require a long soaking time (30 minute in pure oil phase was sufficient to obtain uniform 
emulsions), furthermore a re-coating of the same membrane is possible if required. Hence, 
the use of the FAS coated membranes for a continuous production of W/O emulsions resulted 
to be more appropriate.  
Pulsed (Oscillatory) Flow system for process scale up  
Crucial for the scale up of the microparticles production process is the manufacturing of the 
emulsions with a high concentration of dispersed phase, the Pulsed (Oscillatory) Flow system 
was tested for the production of W/O emulsions on a large scale. The Pulsed system was 
successfully used to generate drops of 20 wt.% fish gelatine using 2 wt.% ABIL EM 90 in 
Miglyol as continuous phase. Operating parameters used were: 80 mL min-1 as CP flow rate 
in combination with 413 L h-1m-2 as DP flux or 60 mL min-1 as CP flow rate in combination 
with 620 L h-1m-2 as DP flux. The shear stress applied was between 0.4 to 14.5 Pa. Drops 
between 40 and 280 μm were produced, however, the lowest value of CV% obtained was 
25%. Emulsions concentrated up to the 30% were produced. The experimental results 
obtained with the Pulsed systems were in accordance with the results obtained using the 
Dispersion Cell showing that it is possible to optimize the emulsion composition and 
operating parameters using the lab-scale device and replicate the experiments using the 
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Pulsed system. However, more uniform emulsions were produced using the Dispersion Cell. 
Breaking of the tubular membrane was experienced showing that a vibration of the 
membrane occurs during the emulsion production probably due to the high viscosity of the 
phases. Nevertheless, due the great potential of the Pulsed system as method of scale up 
(possibility to produce emulsions with a high concentration of dispersed phase), the working 
conditions should be optimized in order to achieve higher emulsions uniformity. Possibility 
to produce emulsions in continuous manner was tested running the system for 3h, the 
emulsions produced within this time had the same Dav and CV% showing the reproducibility 
of the results.  
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5.1 RECOMMENDATIONS AND FUTURE WORKS 
Dispersion Cell system  
The Dispersion Cell was extremely useful for the investigation of the formulations in this 
work, it is easy to dismantle and to clean but, most importantly, it is possible to generate the 
emulsions using a small amount of dispersed and continuous phase (lowest volume used was 
50 mL). The use of Dispersion Cell is highly recommended for the preliminary tests when a 
new emulsion composition for Membrane Emulsification is tried and for the determination of 
the best operating conditions of production.  
PVA microparticles  
Possibility to obtain a sustained release from the PVA microparticles was shown as a function 
of the crosslinker used, an additional study of the influence of the microparticles size on the 
release rate is suggested as further parameter to consider when designing a microcarrier for 
the sustained release of a drug using this formulation. The use of an alternative crosslinker as 
the glyolxal (smaller aldehyde compared to the GA) might be tested to vary the crosslinking 
density and influence on the release profile might be investigated.   
PVA-CS and CS microparticles  
It was shown that the use of SS as model drug produced a delay in the release of compared to 
the release of copper, the higher molecular weight of SS is one of the reasons but also the 
charge of the molecule (SS is negatively charged) might be responsible of the slower release 
obtained. It is recommended when designing a drug delivery system to take into 
consideration the chemistry of the molecule to encapsulate; in this case the use of a cationic 
polymer as encapsulating material could partially retain the negatively charged drug molecule 
encapsulated. Influence of the charge of molecule encapsulated on the release rate using this 
formulation should be investigated. The use a positively charged model molecule with a 
molecular weight similar to SS could be used for the study of the release with time and 
depending on the pH.  
CS blended gelatine or Eudragit S100 coated gelatine microparticles 
The Eudragit S100 coated gelatine microparticles containing the yeast were dried at room 
temperature and stored in glass bottles; in some cases, some of the produced samples were 
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used after 1 week of storage. However, the released yeast was vital and able to consume 
glucose. For the potential commercialization of this formulation as carrier of probiotic cells it 
is advised to determine for how long it is possible to store the dried microparticles before 
being used. Dried samples of the microparticles containing cells could be stored for several 
months and vitality of the yeast evaluated as a function of the storage time.  
Alginate microparticles  
Influence of the crosslinking reaction on the yeast glucose metabolism with time was shown, 
it was hypothesized that this effect is due to the formation of a more dense polymeric network 
which delays the diffusion of glucose through the matrix of the microparticles. A further 
investigation could be done on the material porosity: a BET (Brunauer-Emmett-Teller) 
surface area characterization on microparticles samples solidified using increasing amount of 
crosslinker is suggested. Thus, it will be possible to correlate the yeast glucose metabolism 
time with the crosslinking density of the alginate particles. Alternatively, the use of other ions 
(e.g. Sr2+or Ba2+) for the formation of the alginate gel might be considered and a study on the 
porosity (and permeability to the nutrients) of the final material depending on the cation used 
for the ionic crosslinking is suggested. Incorporation of other polymers to the alginate 
represents also a popular direction in the probiotic encapsulation research field; chitosan 
could produce hydrogels by ionic gelation with alginate, which would provide an additional 
protection of the probiotic cells to the acidic stomach environment.  
Possibility to immobilize mammalian cells is also highly recommended as a future work, in 
this field the production of modified alginate hydrogels containing cell adhesion ligands onto 
the surface would be extremely interesting for the production of microparticles for 
mammalian cells adhesion.  
Scale up using the Pulsed (Oscillatory) system  
Advantages of the Pulsed system for the process scale up for the W/O emulsions production 
were discussed, however some issues were also reported associated with some operating 
settings. The uniformity of produced emulsions was not optimal, a premix of the dispersed 
phase with the continuous oil phase was observed probably due to the vibration of the 
membrane, oil drops were found inside the water drops of the dispersed phase for all the 
samples produced. Furthermore, membrane breaking occurred. It is recommended to improve 
the mechanical strength of the membrane (variation of the membrane material or membrane 
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length) for the production of W/O emulsions using this system and further investigation of 
the process operating parameter is required to reduce the CV% of the emulsions produced 
and reduce the premix.  
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APPENDIX 
A. TENSIOMETER  
All the interfacial tension measurements reported in this work were obtained with a White 
Electric Instrument Tensiometer (model DB2KS) using the Du Nouy ring method. The 
instrument is equipped with a precision lift mechanism to vertically move a glass beaker were 
the sample liquid/s are poured. The measurement of the surface tension is performed 
immerging a platinum ring (Du Nouy ring with defined geometrical dimensions) into the 
liquid. The ring hanging from the balance hook is then carefully pulled up, by lowering the 
sample beaker, through the surface of liquid. For the measurement of the interfacial tension 
the platinum ring is placed inside the dense liquid (water- polymeric solution) and pulled out 
to the light liquid (oil phase), until the detachment of the dense phase by lowering the sample 
cup. Tare of the instrument is required for the correct measurement hence for the 
determination of the surface tension the tare is done when the ring is outside the liquid; while 
for the interfacial tension the tare is done when the ring is submerged in the upper liquid. 
Wetting of the ring with the bottom liquid (i.e. the polymeric solution) is required prior to the 
immersion in the phases. The gravimetric assembly is recording the torque while pulling 
through the surface or the interface. The surface tension or interfacial tension is the maximum 
force needed to detach the ring from the liquid surface or from the bottom liquid to the upper 
liquid (A.Ullah, 2012). The instrument displays the determined value of interfacial tension in 
mN m-1.  
 
Figure 99 Schematic representation of the interfacial tension measurement using the Du 
Nouy ring method, the image is taken from a copyright free web page 
(http://www.mastrad.com/tsd1.htm). 
It is extremely important that the ring and the glass beaker are completely clean and free from 
impurities which could interfere with the correct measurement. A cleaning procedure is 
 
 
 
220 
 
 
followed and repeated for each measurement for each phase. Prior to each use the ring and 
the glass beaker are washed with acetone, water, aqua regia and again rinsed in water in this 
order; afterwards the ring is cleaned using the flame.  
 
B. UV-VIS SPECTROPHOTOMETER  
The UV- Vis Spectrophotometer (Lambda 35 Perkin Elmer, UK) was used for the analysis of 
the Blue Dextran (BD) and Sodium Salicylate (SS) concentration in water solutions. The 
spectrophotometer is equipped with different types of light sources required for the different 
spectral regions. Tungsten and deuterium lamps are used for visible (400-700 nm) and the 
ultraviolet (200-400 nm) regions, respectively. Absorbance measurements can be performed 
at a specific wavelength (that can be manually set by the operator) or it is possible to perform 
a scan of the spectrum from 200 to 700 nm. For all the samples an initial spectra scan was 
done in order to determine the wavelength of the peak of absorbance. The results were 
compared with the data reported in literature; for BD the peak of absorbance is expected as 
620 nm while for the SS at 300 nm. Calibrations were done accordingly with the expected 
working range of concentrations. For the BD the standard solutions measured had a 
concentration between 5 and 500 ppm (calibration reported in Figure 100) and for the 
detection of the SS standard solutions were prepared with a concentration between 1 to 100 
ppm. The standard solutions of SS were prepared in PBS or acidified water with HCl; a slight 
divergence of the calibration curves was found as shown in Figure 101. 
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Figure 100 Calibration for BD concentrations between 5 to 500 ppm.  
 
Figure 101 Calibration for SS concentrations between 1 to 100 ppm 
 
C. ATOMIC ABSORPTION SPECTROPHOTOMETER  
The determination of the Cu2+ ion concentration into water solutions was determined using 
the Atomic Absorption Spectrophotometer (Spectra AA-200 Varian, UK) interfaced with the 
“SpectrAA worksheet Oriented AA Software”. For Cu2+ ion detection the flame type selected 
was acetylene/ air and the lamp current was set on 4 mA; these operating settings were 
recommended from the user’s guide provided. PROMT mode was selected as mode of 
operation. For the instrument calibration standard solutions were made dissolving a 
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predetermined amount of copper in pure Milli-Q water, PBS buffer solution or acidified 
water with HCl accordingly with the composition of the release medium used. The standard 
solutions prepared were in a concentration rage of between 0.05 to 1000 ppm of Cu2+, the 
maximum standard concentration was selected considering the maximum concentration that 
should be measured. From the “calibration tab” the linear (Lambert- Beer) calibration 
algorithm was selected. The wavelength has to be set depending on the ion type to analyse 
and the expected concentration working range as reported in the manufacturer guide. Initially 
the wavelength used was 234.8 nm recommended for the detection of Cu2+ concentrations 
from 0.03 to 10 ppm. The standards measured had a concentration between 0.05 to 3 ppm. 
The corresponding values of absorbance obtained are reported in Figure 102. Each standard 
solution was measured 3 times and standard deviation of the values is reported as error bars. 
No difference of absorbance was found between the three different solvents used for the Cu 
2+ dissolution showing that the presence of other ions in the solution does not affect the Cu2+ 
detection. In the user’s guide is reported that no interferences have been recorded for Cu2+ in 
the acetylene/air flame. Calibration using higher Cu2+ concentrations (from 10 to 1000 ppm) 
was performed using the recommended wavelength of 244.2 nm that is reported to be 
appropriate for a working range between 10 to 2000 ppm. The standard solutions were 
prepared using acidified water with HCl. Figure 103 shows the detected value of absorbance 
as a function of the Cu2+ concentration. The instrument calibration was done twice; before 
starting the samples analysis (Calibration 1 in Figure 103) and after 20 samples measured 
(Calibration 2 in Figure 103); it is visible that the calibration curves did not vary 
significantly. To avoid signal variation due to thermal or humidity changes, the samples 
produced during the release studies were all analysed in the same assay (for the storage the 
samples were frozen), the wavelength of 244.2 nm (used in Figure 103) resulted to be most 
reliable for the concentrations obtained.  
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Figure 102 Calibration for Spectra AA using Cu2+ dissolved in different release medium in a 
concentration between 0.05 and 3 ppm. 
 
Figure 103 Calibration for Spectra AA using Cu2+ dissolved in different release medium in a 
concentration. 
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D. IMAGE ANALYSIS  
D.1 Image J 
Size of the produced drops and microparticles was determined by a direct analysis of the 
images acquired using an optical microscope Leitz Ergolux with attached Pulnix TM-6CN 
camera or or an optical/ fluorescent microscope (GXML3201, GX microscope) with an 
attached Retiga 6000 colour camera. The liquid drops of the emulsions had the tendency to 
burst on the microscope glass slide due to surface tension phenomena therefore the 
microphotographs were taken quickly and analysed using a Java- based image processing 
software (free download available from internet https://imagej.nih.gov/ij/download.html). 
The size of semi- solid and solid microparticles in the dried or wet state were analysed using 
the same method. For each sample at least 300 drops or particles were measured to obtain a 
representative estimation of the size.  
  
  
Figure 104 Image analysis using ImageJ; (a) microphotograph of the microscope graticule 
slide for calibration (b) microphotograph of a W/O emulsion (c) image conversion 
into a binary image (d) numbered drops outlined ready for the measurement.  
 
a b 
c d 
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Prior to the image analysis the scale has to be set (i.e. conversion of pixels into microns): the 
length in pixels of 100 µm was measured on the microphotograph of a microscope graticule 
slide reported in Figure 104 a, the measurement is done using the software Microsoft Paint®. 
The image to analyse was imported to the software ImageJ (Figure 104 b) and converted into 
a 8- bit image. Brightness and contrast of the image were modified and threshold adjusted in 
order to obtain a clear black and white image of the circles representing the drops; 
subsequently the borders of connected drops were separated using the watershed function 
together with manual corrections if required (Figure 104 c). Drops touching the edges of the 
microphotograph were neglected from the counting using the function “exclude on edges”. 
The Feret’s diameter and standard deviation were set as measurements to be displayed and 
the outlines of the circles considered into the counting were shown (Figure 104 d). The 
measurements performed were then imported into an excel file where the average drop size 
and the value of Coefficient of Variation % is calculated.  
D.2 Matlab script imfindcircles 
A more powerful tool for drops and particles size analysis was adopted using the 
programming language Matlab® developed by MathWorks®. Microphotographs of 
emulsions and microparticles were analyzed using a modified version of the “circles 
detector” scrip “imfindcircles” available from the MathWorks online documentation 
(https://it.mathworks.com/help/images/ref/imfindcircles.html). The script is run within a 
folder containing the images to analyse and it automatically detects circular objects or circles 
within the images. Before call imfindcircles on an image, a conversion to a grey scale 
image is required using rgb2gray, with the method imadjust the intensity values (i.e. 
saturation and contrast) were modified varying the numbers in brackets to obtain an image 
with clearly visible circles, the converted image is shown in Figure 105 b. 
   imgrey = rgb2gray(currentimage); 
   imadjusted = imadjust(imgrey,[0.3 0.4],[]) 
   imageBW = im2bw(imadjusted); 
In the second step of the analysis imfindcircles is run on imageBW, the command needs a 
range of radius (expressed in pixels) to search for circles which is added within the square 
brackets. Imfindcircles has an internal detection threshold which determines the 
sensitivity of the algorithm. The parameter “Sensitivity” (which is a number between 0 
and 1) is used to modify the internal threshold; increasing the “Sensitivity” value lower the 
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threshold and leads to detect a higher number of circles but also reduces the accuracy of the 
detection. 
[centers, radii] = imfindcircles(imageBW,[10 200], 
'ObjectPolarity','dark', 'Sensitivity',0.85,'Method','Phasecode'); 
With the reported below function viscircles the detected circles are drawn on the image 
and it is possible to check that most of the drops were detected as visible in Figure 105 c. 
The diameter is then calculated from the detected radius and the measurements are saved as 
an excel file generated in the original folder. The values of diameter are manually converted 
into µm accordingly with the scale previously measured as described in Appendix D.1.  
   h = viscircles(centers,radii); 
   radius = [radius; radii]; 
   diameter= radius*2; 
 
 
Figure 105 Image analysis using Matlab® (a) microphotograph of a W/O emulsion (b) image 
converted in a grey-scale image using the scripts rgb2gray and imadjust (c) 
circles measured by the software running imfindcircles. 
  
a b 
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